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Intelligent and more advanced therapeutic agents, capable of sensing and responding to their 
environment, are required to treat more complicated and complex diseases. Among all 
recently developed therapeutic agents, hydrogels are not only intelligent to sense and respond 
to external stimulus, but also they can be synthesized and designed in the cellular and sub-
cellular size scale, which enhance their therapeutic ability. Most body physiological 
processes are regulated as a consequence of pH gradient in different compartments of the 
body; besides, changes in pH are also associated with disease or damaged sites within the 
body. A unique feature of hydrogels is that they can provide a network for loading and 
release of drugs. Therefore, the drug loaded within pH-responsive nanogels are able to 
locally release onto the target sites because of their small size, and capability to sense and 
respond to environmental changes.  
The goal of this research is to design and implement novel pH-responsive magnetic 
nanogels for drug delivery that respond to changes in pH. Semi-continuous emulsion 
polymerization was conducted to synthesize polyampholyte nanogels comprising of 
methacrylic acid (MAA) and 2-(diethylamino) ethyl methacrylate (DEAEMA) in the 
presence and absence of steric stabilizer poly (ethylene glycol) methacrylate (PEGMA). The 
synthesized nanogels demonstrated swelling behavior at both acidic and basic pHs. Herein, 
procaine hydro chloride (PrHy) was utilized as cationic drug to investigate the release 





nanogels through hydrophobic interaction and hydrogen bonding, as confirmed by isothermal 
titration calorimetry. The release study of PrHy molecules from nanogels was conducted by 
applying the versatile and easy technique of drug selective electrode, in which the 
concentration of released drug was measured as a function of time. 
In order to facilitate the purification and enhance the detection of nanogels, iron oxide 
particles (Fe3O4) were co-precipitated within nanogels to form magnetic nanogels. 
Subsequently, layer-by-layer coating of polyelectrolytes were performed to control and 
eliminate the initial burst release of PrHy from nanogel by increasing the diffusion barrier 
and manipulating the permeability of nanogels. For the purpose of this research low 
molecular weight chitosan (CS) was used as polycation and poly (sodium 4-styrenesulfonate) 
(PSS) was acted as polyanion to coat magnetic nanogels. The more layers was applied, the 
more reduction in burst release was observed, which was revealed by using drug selective 
electrode to measure the concentration of the released drug from coated nanogels. Besides, 
layer-by-layer coating prolonged the time require to reach the steady state drug release. 
Therefore, this synthesized polyampholyte coated iron-oxide nanogels demonstrate great 
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Hydrogels are known as chemically or physically cross-linked organic or inorganic polymers that 
are able to absorb and retain large amount of water in response to external stimuli without losing 
their integrity upon dissolution in aqueous phase. Physical cross-linking agents are introduced 
via non-covalently connections between polymeric chains, due to the reversible sol-gel transition 
such as physical entanglement, hydrogen bonding, hydrophobic interactions, coordination bonds, 
and electrostatic interactions. Whereas chemical cross-linking agents are those that covalently 
connect at least three polymeric chains by cross-linker or chain transfer (Peppas et al., 2000). 
The development of stimuli-responsive polymer hydrogels, offer the pH-, thermo-, magnetic-, 
glucose- responsivity to polymeric hydrogels, which sometimes is called ‘’intelligence’’. The 
chemical structure of the polymeric network, particularly the functional groups on the side 
chains, characterizes the response mechanisms. Consequently, stimuli-responsive hydrogels have 
broad-spectrum applications in tissue engineering, diagnosis, drug delivery and biomaterials 
(Hendrickson et al., 2010b; Kopeček, 2007).  
When hydrogels are confined into a spherical space with a diameter ranging from 10 to below 
1000 nm are called nanogels. Nanogels are defined as a cross-linked polymeric network capable 





spheres, nanogels act like soft spheres because of both electrostatic repulsion of charges, which 
could induce compression as a result of imposing high concentration of nanogels (osmotic 
deswelling) or higher ionic strength (compression of electric double layers) and steric repulsion 
of dangling chains tethered on their rough surface (Sasaki and Akiyoshi, 2010). Because of the 
dominance of polymer-solvent interaction over polymer-polymer interactions, polymeric chains 
in nanogels without cross-linking agents would dissolve in solvent. Therefore, nanogels depend 
on the cross-linking in order to maintain their structure stability and integrity (Sasaki and 
Akiyoshi, 2010).  Nanogels demonstrate great potential in smart, controlled, and regulated 
applications due to their environmentally responsive character. Specifically, they increasingly 
became recognized as the carrier for therapeutic drugs and diagnostic agents. The porous 
polymer network structure of synthetic nanogels offers an ideal reservoir for loading drugs, 
protecting them from environmental degradation and hazards, and also providing a template for 
post-synthetic modification of the drug carrier (Rhee and Mansour, 2011;Wu and Mansour, 
2011).  
A responsive drug delivery system is one of the most known technologies for intelligent drug 
release. In effective drug delivery systems, the drug release must be regulated in response to 
external biological, physical, or chemical stimuli. Targeting character may be obtained by 
functionalizing nanogels with receptor-specific ligands. Main requirements for an effective drug 
delivery systems include small size, extended circulation time, colloidal stability, 
biocompatibility, biodegradability, and reduced interaction with serum proteins to prevent renal 





Magnetic nanoparticles (MNP) are known as core metallic particles, in which each nanoparticles 
exhibit inherent magnetic properties. A stable colloidal suspension of single domain magnetic 
nanoparticles, typically ferrites in aqueous or organic carrier liquids, is defined as a ferrofluid. 
The general chemical formula for ferrites in MFe2O4, in which M represents a divalent ion such 
iron (Fe+2), nickel (Ni+2), or cobalt (Co+2) (Li et al., 2002).     
In this research iron oxide incorporated within nanogels, to form magnetic nanogels, for the 
enhanced delivery of the encapsulated drug molecules was investigated. In order to control the 
drug release and also to reduce the burst release of the drug molecules from the magnetic 
nanogels the layer-by-layer coating technique was applied. Kinetic profile of the drug release 
was obtained in the lab through manufactured drug-selective membrane electrodes.  
1.2 Research Objectives 
The goal of this research is to design and apply coated magnetic iron-oxide nanogels for drug 
delivery applications. The particular goals to be addressed include: 
• Synthesis and characterization of polyampholyte nanogels, 
• Incorporation of iron oxide within nanogels to forms magnetic nanogels, 
• Construction of drug-selective membrane electrode in order to study the kinetic of drug 
release, 






• Coating the magnetic nanogels by layer-by-layer process in order to decrease the burst 
release of the incorporated drug and also to provide semi-permeable polyelectrolyte 
around the matrix. 
Different characterization techniques were used to characterize the nanogels and to assure the 
polyampholyte properties of the nanogels. To determine neutralization and microstructure 
character of nanogels the laser light scattering (LLS) was performed to determine the 
hydrodynamic radius (Rh), the zeta-potential measurement was conducted to elucidate the overall 
surface charge of nanogels and coated nanogels to study the binding behavior, and the isothermal 
titrating calorimeter (ITC) was utilized to determine the binding behavior of drug-nanogels 
systems.  
In order to provide insight into the drug release kinetic profile, the drug selective electrode 
method was used as an alternative approach to conventional dialysis membrane and centrifugal 
machine was applied, under different conditions such as varying pH, salt concentration, and 
concentration gradient. Moreover, in this research the multiple purification steps during layer-by-
layer coating process have been eliminated as a result of synthesizing magnetic nanogels.  
1.3 Thesis Overview 
The work presented herein illustrates the synthesis and characterization of pH-responsive 
magnetic nanogels along with drug release behavior from the interior of the bare and coated 
magnetic nanogels. Chapter 2 provides an introduction to polymer nanogels, magnetic 
nanoparticles, layer-by-layer coating, and their current applications. This chapter offers insight 
on how unique stimuli-responsive properties of polymer nanogels can be regulated to meet the 





techniques utilized throughout the course of the experiments. In chapter, 4, the insight on the 
drug-selective membrane electrode is provided along with its characterization method. Chapter 5 
describes the materials and methods used to synthesize different nanogel systems. In chapter 6, a 
detailed study on swelling and environmentally responsive behavior of polyampholyte nanogels, 
containing weak acidic and basic groups, is presented. Chapter 7 elucidates the kinetic profile of 
drug release from the polyampholyte nanogels. The results of these studies evaluate the influence 
of hydrophobic interactions on the successful physical incorporation of the drug molecules in the 
nanogels. Chapter 8 builds upon the synthesis of magnetic nanogels and the coating process of 
the magnetic nanogels. The layer-by-layer approach was conducted through alternate deposition 
of positively and negatively charged polyelectrolyte layers onto the magnetic nanogels. The 
results reveal the elimination of the burst release of the drug molecules from the nanogels as a 
result of coating layers. Besides, by manipulating the number of polyelectrolyte layers the 
release of the drug from the nanogels can be controlled and regulated. Finally, chapter 9 








Literature and Background Review  
 
2.1 Introduction to Hydrogels  
Accurately identifying a gel is difficult. This state of material can act both as a solid and liquid, 
possessing the cohesive properties of a solid and the diffusive transport properties of a liquid. 
Polymer gels may be defined in the following ways (Hoare and Kohane, 2008): 
1. Chemical gels: covalently-linked polymer chains together within the gel’s polymeric 
network. 
2. Physical gels: externally-induced topological change in polymer chain conformation by 
means of a system that reverses gelation.  
Hydrogels are known as a cross-linked hydrophilic polymer network, which are able to 
provide distinct advantages over other biomedical polymers. Some of these advantages can be 
outlined as (Hamidi et al., 2008; Hoare and Kohane, 2008): 
1. Covalent bonds held the polymer network together and offer control and integrity 
2. Soft, and the hydrated nature of hydrogel makes them very similar to tissue, cell and 
other biological matters 
3. Vastly controllable material properties 





In this study the smart polymeric system refers to both nanogels and microgels interchangeably, 
even though in nanotechnology, the term ‘nano’ describes technologies that possess size range of 
1-100 nm (Whitesides, 2005). 
2.1.1 Structural Characteristics of Hydrogels 
Hydrogels are described as a physically restricted hydrophilic polymer that can absorb and retain 
a large amount of water or biological fluids. There is no minimum amount of water a material 
has to absorb to be called a hydrogel (Kopeček, 2007). The presence of hydrophilic groups such as 
-OH, -CONH2-, -CONH-, and -SO3H in the polymeric units determines the water absorbance 
characteristic (Hamidi et al., 2008). The restriction within the hydrogels network is the result of 
covalent crosslinks between polymeric chains. These covalent bonds provide additional integrity, 
control, and maintain the robust structure of the gel while swelling or deswelling in aqueous 
medium, and also offer an environment to encapsulate guest molecules (Matyjaszewski et al., 
2007). The characteristic polymeric structure is responsible for a hydrogel’s unique ability to 
undergo abrupt phase transition from a swollen liquid-like hydrated state to a solid-like collapse 
state in response to changes in the external stimuli, such as pH, temperature, ionic strength, 
glucose concentration, and external electromagnetic field. However, the main focus of this 
research is on the synthesis and characterization of pH- and magnetic responsive nanogels. The 
changes in the equilibrium volume in a different solvent can vary from monomer to monomer, 
and depends on the interaction energy of side groups of the monomer with other monomers or 
solvent. Figure 2.1 illustrates the cross-linked structure of a hydrogel. This demonstration 
combines the Flory representation of an ideal network with that of an ideal ionic hydrogel. In the 





A crosslink can be imagined as a chain of atoms capable of joining at least two different polymer 
chains together. Hydrogels can be classified as neutral, cationic (Hu et al., 2007; Marek et al., 
2010) , anionic (Brugger et al., 2010; Hoare and Pelton, 2004), and amphiphilic or zwitterionic 
(Deng et al., 2009; Tan et al., 2006) depending on the origin of the incorporated functional 
groups. Hydrogels can also be classified based on their size. Macrogels are bulk gels and have a 
size range of one millimeter to a few centimeter; Microgels are colloidally stable hydrogels that 
range from 100 nm to several hundred microns. Microgels find great interest in intelligent, 
controlled and regulated application, due to their environmentally responsive behavior. It should 
be indicated that the terms nanogels and microgels are usually used interchangeably in the 
literatures, and through this thesis the term nanogels was used to describe the colloids that been 
synthesized in this research and the term microgels was utilized in the literature review section 
according to the referred papers.    
Microgels are composed of a porous, covalently-crosslinked, spherical network of randomly 
oriented polymeric chains that are swollen in a suitable solvent. The microgels possess a cross-
linked linear polymeric chain structure with a narrow range of particle size without a discrete 
core, which makes them appear visually as flawlessly spherical sponges (Kopeček, 2007). Figure 





                                                                       
Figure 2.1 Schematic of (a) collapsed and (b) swollen microgels. 
2.1.2 Nanogels Classifications 
Nanogels are more commonly classified in three ways. The first classification is based on the 
type of functional groups incorporated into their network. The second classification is based on 
their responsive behavior, which can be either stimuli-responsive or non-responsive. In the case 
of non-responsive microgels, they simply swell as a result of absorbing water, while stimuli-
responsive microgels swell or deswell upon exposure to environmental changes such as 
temperature, pH, magnetic field, and ionic strength. Multi-responsive microgels are responsive to 
more than one environmental stimulus. In the last classification of microgels, they are sorted by 
the nature of the crosslinks within their network, in which micorgels can be either physically or 
chemically crosslinked. As mentioned before, crosslinks play an important role to prevent 
dissolution of the polymer chain and also to keep the network structure of the hydrogels under 
different environmental conditions (Gupta et al., 2002; Sasaki and Akiyoshi, 2010). 
2.1.3 .1 Chemically Cross-linked Nanogels 
The chemically crosslinked nanogels formed by covalent interactions are stable and capable of 







group has been attached to the network. The method commonly used to synthesize chemically 
crosslinked microgels is copolymerizing monomers with multifunctional crosslinker. Radical 
polymerization or condensation polymerization is typically used to synthesize chemically 
crosslinked microgels with size ranging from 100 to 1000 nm (Gupta et al., 2002). A variety of 
physical properties such as the swelling capacity and viscosity of microgels are dependent on and 
controlled by the amounts of cross-linked agent used in the microgel synthesis. 
 Tan et al. (Tan et al., 2005b) synthesized pH-responsive microgels by semi-continuous 
emulsion polymerization consisting of methacrylic acid-ethyl acrylate (MAA-EA) cross-linked 
by di-allyl phthalate (DAP). They observed that in order to synthesize stable and compact 
microgels with 20 mol% MAA, the optimum cross-linking agent density of 1 wt.% was required, 
so that sufficient cross-linked junctions were formed to maintain a permanent structure in the 
microgels; otherwise insufficient cross-linked junctions were formed, which produced unstable 
microgels. Figure 2.2 illustrates that by increasing the cross-linking density, the microgel size 
decreased and the swelling was inhibited, resulting in a drop in the relative viscosity. In addition, 
the Mw of the microgels decreased below the 1 wt% crosslink density as a result of the expulsion 
of polymer chains from the microgel and due to the insufficient crosslinked junction, unstable 






Figure 2.2 The conformation evolution of (MAA-EA) microgels with 20 mol% MAA versus the 
crosslinking agent density (wt. % DAP). The filled circle shows Mw and the white circle shows the low 
shear relative viscosity (Tan et al., 2005a). 
2.1.4 .1 Physically Cross-linked Nanogels 
The formation of physically crosslinked microgels is due to the non-covalent interaction such as 
hydrophobic interaction, ionic interaction, and hydrogen bonding. This system is vastly applied 
in the encapsulation of drugs and proteins within the structural network of microgels, because the 
microgels can release incorporated agents from the interior network by the dissolution of their 
structure. Therefore, physically cross-linked microgels are of great interest in the field of 
biodegradable systems that are able to go from the solution state to stable gel state, and vice 





The main disadvantage of this system is that they can lose their stability and disintegrate upon 
exposure to many factors, such as temperature, ionic strength, and polymer composition as a 
result of weak non-covalent interactions. Therefore, physically cross-linked microgels are less 
stable compared to their chemically cross-linked counterparts (Hoare and Kohane, 2008). 
2.1.5 Nanogels Applications 
Latex copolymers have a wide range of applications, including paints, adhesives, synthetic 
rubber, paper coating, and carpet backing, and toughened plastics (Sudol et al., 1992). Other 
applications, such as waste water treatment and enhanced oil recovery involving microgel 
particles. In addition, microgels that have a stable, well-defined morphology (monodisperse) can 
be applied as opacifying agents, model colloids, calibration standards, and pharmaceutical 
applications (Sudol et al., 1992). Due to their high water content, which makes them very similar 
to natural tissue; microgels also have a variety of applications in biomedical field. They usually 
exhibit very good biocompatibility, and such characteristic makes microgels a very good 
candidate for biomedical application, e.g. in drug delivery systems, biosensors, contact lenses, 
catheters, and wound dressing. Moreover, because of their high water content they can also be 
used as membranes. The diffusion of solute through the microgel networks is facilitated by the 
water within the gel, and the crosslinks, which are characterized by the pore size of the hydrogels 
network. Together these determine whether a solute of a specific size is able to pass through the 





2.1.6 Nanogels Stabilization 
Colloidally stable nanogels that are stable against aggregation are crucial factors in designing 
nanogels. The stability of nanogels results from the equilibrium between attractive and repulsive 
forces.  Interparticle potential in the system is usually attributed to the van der Waals forces, 
which induce strong short-range isotropic attractions, and electrostatic repulsive forces. These 
two forces are theoretically explained by the Derjaguin-Landau-Verwey-Overbeek (DLVO) 
theory. Another force that should be considered especially for coated nanoparticles is steric 
repulsion (Laurent et al., 2008).    
Charged stabilized nanogels maintain a charge balance on the micorgel surface with small ions 
of opposite sign in the solution phase (counter-ion). Consequently, electrical double-layer forms, 
in which the nanogel’s surface has an electric potential depending on the surface group’s charge 
as shown in Figure 2.3a. When the charges no longer provide practical approach for stabilization, 
‘hairy particles’ can be employed. A common example of ‘hairy particles’ is the use of poly 
(ethylene glycol) chains as the stabilizer agent, which (Ottewill, 1982) leads to non-charged 
‘hairs’ extending into the solvent, providing a sterically stabilized system 2.3b.  
Nanogels synthesized via emulsion polymerization are not likely to be electrostatically stable, 
especially around their isoelectric point (IEP). Isoelectric point is the pH in which there are equal 
numbers of positive and negative charges present. As a result, one should view nanogels as a 
combination of charged group and ‘nano-hair’. From this description, the nanogel’s stabilization 
can occur through the following factors (Ottewill, 1982): 





2.  Steric effects: associated with the unfavourable entropy of mixing of chains from the 
surfaces of more than one particle, 
3. Solvating effects: arising from the association of solvent molecules near an interface or 
between polymer chains,  
4. Attractive effects: arising from the Van der Waals interaction between opposite charges.  
 
Figure 2.3 Nanogel stability (a) electrostatic stabilization (b) steric stabilization (Laurent et al., 2008). 
Electrical double-layer is distributed when electrostatic-stabilized nanogels are in dispersion of 
high electrolyte concentrations due to shielding of surface groups. The distance D between 
nanogel particles is decreased when the electrostatic repulsions are shielded. Concurrently, 
increasing the electrolyte concentration in the medium causes an osmotic effect, resulting in the 
reduction of solvent in the counter ion cloud. Polymer chains contract due to a loss of water and 
as a result the distance D between nanogel particles is increased. The deswelling of microgel 
particles in salt solution leads to van der Waals attractions resulting in flocculation and 
eventually coagulation.  
2.2 Polyampholytes  
Polymeric nanogels are functionalized with ionic groups and are known as polyelectrolyte 
microgels. When both positively and negatively charged functional groups exist and are 






microgels. Therefore, the properties of polyampholyte microgels are very different from those of 
polyelectrolyte, due to the presence of the oppositely charged group in the microgel network 
(Das and Kumacheva, 2006). The conformation of a polyampholyte chain with a net charge is 
the result of competition between the following two antagonistic effects (Tan et al., 2006):  
1. The polyampholyte effect: associated with the attraction between groups of opposite sign, 
which leads to chain compression, 
2. The polyelectrolyte effect: associated with the repulsion between like charges, which 
tends to expand the polymer chains 
Polyampholytes are capable of undergoing volume transition at both low and high pH 
conditions. Changing pH leads to ionization of acidic or basic groups within the microgel 
network, causing electrostatic repulsion between like charges, and subsequent swelling of the 
microgels, this then results in larger microgel size. In other words, the degree of swelling is 
increased by the repulsion between protonated cationic functional groups at low pH, and 
deprotonated anionic functional groups at high pH.  The intermediate pH, in which there are 
equal numbers of both cationic and anionic functional groups that are present in their charged 
state, is known as the isoelectric point (IEP). Isoelectric point leads to microgel deswelling, and 
also reduces the net surface charge to zero. At the IEP, ion pairing between charged cationic and 
anionic functional groups is dominant over repulsion between unpaired, like charges.  
2.2.1 Block Polyampholytes   
There are significant studies on the synthesis and characterization of both linear polyampholyte 
copolymers and diblock polyampholytes. Polyampholytes with diblock copolymer structure, 





polymerization conditions (anionic, cationic, or group transfer polymerization), which requires 
sequential addition of protected monomers (Tan et al., 2006). Dai et al. (Dai et al., 2003) 
reported on the synthesis and solution behavior of diblock copolymer of poly [2-(diethylamino) 
ethyl methacrylate-block-methacrylate acid] [P (DEAEMA-b-MAA)] that was synthesized 
through the atom transfer radical polymerization (ATRP) technique. They observed that at low 
pH, the DEAEMA block became hydrophilic due to the protonation of amines; while, at high pH 
value the MAA block became soluble due to ionization. Therefore, the hydrophile-lipophilic 
balance (HLB) of the block copolymer was varied at high and low pH values. In other words, 
micelles with a hydrophobic MAA core and protonated DEAEMA corona shell were formed at 
low pH condition. On the other hand, at high pH condition hydrophobic DEAEMA core 
deprotonated and hydrophilic MAA corona shell ionized, as seen in Figure 2.4 (Dai et al., 2003). 
As illustrated in Figure 2.4 the laser light scattering measurement was performed by this research 
group to study the micellization behavior of the block copolymer at different pHs. They obtained 
two hydrodynamic radii of about 2.7 and 70 nm at pH of 3, corresponding to the unimers and 
micelles, respectively. This happened because of the very low pKa ~ 5.4 of MAA in contrast to 
HLB. At intermediate pH, large aggregates formed due to phase separations. By increasing the 
pH to above 9, only one hydrodynamic radius was detected due to the high pKa ~ 7.3 value of 
DEAEMA (Dai et al., 2003). The same pH reversible micellization properties were also observed 






Figure 2.4 The hydrodynamic radius distribution and possible structure of P (MAA-b-DEAEMA) at 
different pH values (Dai et al., 2003). 
2.2.2 Polyampholyte Nanogels 
In comparison to linear and block polyampholyte, there are very few investigation on the 
synthesis and characterization of polyampholyte microgels. In a very recent study, 
Christodoulakis et al. (Christodoulakis and Vamvakaki, 2010) synthesized a series of pH-
responsive polyampholyte core-shell microgels comprising 2-(diethylamino)ethyl methacrylate 
(DEAEMA) as the ionizable cationic monomer, tert-butyl methacrylate (t-BuMA) as the 
hydrophobic monomer, and ethylene glycol dimethacrylate as the cross-linking agent through 
emulsion copolymerization and following acid hydrolysis to obtain methacrylic acid (MAA) 





poly (2-diethylamino) ethyl methacrylate (PDEAEMA) or poly methacrylic acid (PMAA) which 
was surrounded by a cross-linked PMAA or PDEAEMA shell, respectively. The synthesized 
sore-shell microgels have been illustrated in Figure 2.5 (Christodoulakis and Vamvakaki, 2010).  
 
Figure 2.5 TEM images of the (a) P (t-BuMA)-PDEAEMA shell microgels stained with potassium 
hexachloroplatinate, (b) PMAA core-PDEAEMA shell microgels stained with cadmium nitrate, and (c) 
PMAA core-PDEAEMA shell microgels stained with potassium hexachlo hexachloroplatinate 
(Christodoulakis and Vamvakaki, 2010).  
From potentiometric titration curves shown in Figure 2.6, it is revealed that acidic and basic 
ionizable groups of the core and the shell of the core-shell microgels were spatially separated and 
independently ionized because of the presence of two plateau regions in the titration curve. 
However, the simultaneous protonation and deprotonation of the basic and acidic segments was 







titration curve. In other words, upon ionization of the DEAEMA segments at low pH value or the 
MAA segments at high pH condition the core and the shell of the microgels were swollen. 
Besides, when both the core and the shell of the microgels were neutral at intermediate pH, the 
microgels collapsed (Christodoulakis and Vamvakaki, 2010).   
 
Figure 2.6 Potentiometric titration curves for a 0.2 wt% solution of the (a) PDEAEMA- PMAA random 
copolymer microgels showing single plateau region, and (b) PDEAEMA core- PMAA shell microgels 
illustrating two plateau regions (Christodoulakis and Vamvakaki, 2010). 
In another study Deng et al. (Deng et al., 2009) performed distillation dispersion 
copolymerization in acetonitrile (AN) to synthesize polyampholyte nanogels consisting of poly 
(ethylene glycol) methyl ether methacrylate (PEGMA) as macromonomer, N,N-(dimethylamino) 
ethyl methacrylate  (DMAEMA) as monomer, and methacrylic acid (MAA) as comonomer. 
These nanogels demonstrated great swelling ability and also core-shell structure away from 
isoelectric point (IEP). In addition, the size of the swelled nanogels did not change over time and 






nanogels composed of hollow core and cross-linked network shell, which was formed due to 
osmotic swelling (Deng et al., 2009).   
 
 
Figure 2.7 TEM images of P ((MAA-co-DMAEMA)-g-PEGMA) after swelling in pH=1.89 of PBS (a) 
after 24 h, (b) after 48 h, and (c) hollow core structure of nanogels in (b) (Deng et al., 2009). 
2.3 Nanogels Synthesis 
As previously discussed, microgels offer very unique characteristics, including tunable chemical 
structure, high surface area, porous network, good mechanical properties, high water content, 
and biocompatibility, all of which make them an interesting topic to study and explore (Oh et al., 
2008b). There are various synthetic techniques for the production of microgels. Some of these 
methods are summarized below. Since the microgels associated with this research were 
synthesized by both emulsion and inverse emulsion polymerization, more focus is given to these 
methods compared to the other synthesizing techniques.   





2.3.1 Emulsion Polymerization 
Emulsion polymerization was first introduced on an industrial scale in mid 1930s. Nowadays, it 
has developed into a very versatile approach that is widely used for the synthesis of stimuli-
responsive microgels from hydrophobic monomers (Lovell and El-Aasser, 1997).  Figure 2.8 
depicts the three steps in the emulsion polymerization. By adding a large amount of surfactant 
above its critical micelle concentration (CMC) in the continuous phase, usually water, micelles 
are formed and nucleation occurs. Micelles emulsify the hydrophobic monomers and act as 
micro-continuous reactors that contain all essential ingredients for the emulsion polymerization 
reaction. At this stage, both the large monomer droplets stabilized by surfactant and monomer-
swollen surfactant micelles exist in the continuous phase. The first step (Figure 2.8a) starts when 
the water-soluble initiator produces oligoradicals from slightly hydrophobic monomers. 
Subsequently, these oligoradicals enter the micelles and form particles. In the second step 
(Figure 2.8b), monomer droplets gradually diffuse through the water phase to the micelle during 
the course of polymerization to maintain a continuous growth of polymer particles. The last step 
(Figure 2.8c) corresponds to consumption of monomer droplet and polymerization of any 







Figure 2.8 Schematic diagram of the three steps involved in the emulsion polymerization. (a) the first 
step of emulsion polymerization, (b) the second step of emulsion polymerization, and (c) the last step of 
emulsion polymerization.  
Depending on the monomer droplet size, the emulsion polymerization can be classified into 
macroemulsion and microemulsion. The former refers to emulsion polymerization in which 
monomer droplets are large (hundreds of micron), and the latter describes emulsion 
polymerization with small size monomer droplets (nanometer). Hydrophobic microgels are 
commonly synthesized by microemulsion polymerization. Microemulsions are 
thermodynamically stable dispersion due to a very low interfacial tension, which can balance the 
very high dispersion entropy mostly caused by small droplets size (Chern, 2008). Van der Waals 
interaction between hydrophobic microgels is the dominant driving force for irreversible 
aggregation of these microgels, due to the high refractive index difference between the 
hydrophobic microgels and aqueous medium. Therefore, the colloidal stability enhancement 
obtained using surfactant (which possesses both hydrophobic and hydrophilic domains) to 





2.3.2 Inverse Emulsion Polymerization  
Inverse emulsion polymerization was first introduced in 1987. Similar to emulsion 
polymerization, this method involves the addition of large amounts of surfactant above its CMC 
into the system, which leads to thermodynamically stable water-in-oil (W/O) emulsions. Inverse 
emulsion polymerization is mostly suitable for polymerization of high molecular weight 
hydrophilic polymers that are capable of polymerizing in hydrophobic organic solvents. 
Polymerization occurs inside the water droplets, which act as nanoreactors that can encapsulate a 
high concentration of hydrophilic monomers that can produce microgels in the presence of 
hydrophilic crosslinking agents. Unlike emulsion polymerization, this technique does not include 
the step of monomer diffusion through the continuous medium. Preventing water droplets from 
aggregation through steric stabilization is another function of nonionic surfactants in the inverse 
emulsion polymerization (Capek, 2010).  
Figure 2.9 shows the schematic diagram of inverse emulsion polymerization; it can be 
observed that monomer droplets are not present in this system. Moreover, nonionic surfactants 
possess a unique value known as hydrophile-lipophile balance (HLB), which determines the ratio 
of hydrophilic to liphophilic portion on the surfactant. The desired HLB value can be obtained by 
mixing two different nonionic surfactants with different HLB values. Nonionic hydrophobic 
surfactants are generally used in the inverse emulsion polymerization to convert oil-in-water 
(O/W) emulsions at room temperature into water-in-oil (W/O) emulsions at higher temperature. 
The temperature at which this phase inversion occurs is referred to as the phase inversion 






























2.3.3 Precipitation/Dispersion Polymerization 
During the course of precipitation polymerization, the reaction proceeds from a homogeneous 
mixture of monomer, initiator and solvent to the heterogeneous solution, where produced 
polymers precipitate out of the solution and form microgels. Dispersion polymerization is a 
subdivision of precipitation polymerization, and where the growing hydrophobic polymer chains 
are sterically stabilized, and dispersed in a colloidal solution. In this method, the use of a cross-
linking agent is essential for the isolation of the formed microgels, because the synthesized 
microgels are not swellable but soluble in the medium (Odian, 2004). Peppas et al. synthesized 
narrow size distribution poly (methacrylic acid-g-ethylene glycol) (P (MAA-g-EG)) nanospheres 
through precipitation polymerization for the oral delivery of proteins. They obtained better 
control over particle size and particle size distribution by controlling monomer concentration in 
water. They also revealed that increasing the cross-linker concentration during polymerization 
decreased the equilibrium swelling of the nanospheres (Robinson and Peppas, 2002; Thomas et 
al., 2006).   
2.3.4 Photolithography  
Photolithography basically addresses a high throughput nano-molding process with high control 
over size, shape and composition of formed particle. As shown in Figure 2.10, photolithography 
consists of five steps. In the first step, the UV cross-linkable polymer, which possesses low 
surface energy, as a substrate is released on the pre-baked photo resist-coated water. The next 
step involves molding the polymer into patterns on the silicon wafer by pressing the quartz 





with a thin residual interconnecting film layer are uncovered by removing the quartz template. 
Subsequently, this residual thin layer is removed by a plasma containing oxygen that oxidizes it. 
In the last step, the fabricated particles are directly collected by dissolution of the substrate in 
water of buffer (Glangchai et al., 2008; Sasaki and Akiyoshi, 2010). 
 
Figure 2.10 Schematic diagram of five steps involved in photolithography (Glangchai et al., 2008). 
Photolithography can be classified into Particle Replication in Non-wetting Templates, known 
as a PRINT process, and Traditional Imprint Lithography based on the non-wetting substrate and 
wetting substrate, respectively. The former process leads to the fabrication of isolated particles in 
which the formation of the residual interconnecting film is eliminated, while the latter produces 
an embossed film that, as explained above, needs to be removed (Petros and DeSimone, 
2010;Rolland et al., 2005). Glangchai et al. (Glangchai et al., 2008) successfully synthesized 
cross-linked hydrogels of poly (ethylene glycol diacrylate) (PEGDA) and GFLGK-DA via the 
traditional imprinting technique. The imprinted particles were obtained in very small particle size 





such as plasmid DNA, antibodies, and model drugs, and release the incorporated agents in 
response to various external stimuli (Glangchai et al., 2008).  
2.3.5 Membrane Emulsification 
In the membrane emulsification technique, the to-be-dispersed phase is passed through the 
membrane (glass or ceramic), which possesses uniform pore size. Under certain conditions the 
emulsion droplets or microgels with specific morphology are formed on the surface of the 
membrane and afterwards, with a continuous phase that is flowing across the membrane, these 
fabricated emulsion droplets or microgels are recovered (Nakashima et al., 2000). These 
fabricated emulsion droplets can be in different emulsion formation such as water-in-oil (W/O), 
oil-in-water (O/W), oil-in-water-in-oil (O/W/O), and water-in-oil-in-water (W/O/W) (Oh et al., 
2008b). The size of the formed droplet is controlled by the membrane pore size, velocity of the 
continuous phase, and pressure of the trans-membrane. Figure 2.11 represents the diagram using 






Figure 2.11 Schematic diagram of the membrane emulsification technique 
(http://www.muschiolik.de/membrane_emulsification_process-desription.htm). 
2.4 Nanogels in Nanomedicine 
Smart therapeutic system is achieved when the sensing and treatment of a disease or health 
condition can be performed by the patient himself, without requiring human intervention. The 
classes of smart therapeutic agents are polymers, which play an active role in nanomedicine. The 
term nanomedicine was first used to describe technologies under category of nanotechnology 
with therapeutic applications in human health by the United States National Institutes of Health 
(Medina et al., 2007). The distinct difference between nanotechnology and nanomedicine lies in 
the fact that nanotechnology is the development and application of technology with novel 
properties on nanoscale, while nanomedicines are generally very small devices or systems that 
utilize the natural, nanoscale properties of the human body.  Figure 2.12 summarizes the most 





characteristics including size, targeting ligand surface chemistry, composition, and physical 
properties that need to be consider while designing nanoparticles for biomedicine applications.    
 
Figure 2.12 Schematic of how properties and characters of nanoparticles can be manipulated while 
designing nanoparticles for biomedicine applications (Chou et al., 2011). 
Responsive hydrogels that respond to changes in their surrounding environment can be exploited 
in ways that fulfill biomedical purposes.  As described earlier, these external changes can be 
temperature, pH, light, ionic strength and, more specific to the biomedical field, changes in blood 
glucose level. pH can be named as one of the most important property of the body because it can 
be manipulated by the body to control nutrient transport and more importantly, because it 
changes during disease (Peppas et al., 2000). Temperature is another factor in the controlled and 





diseased tissues. In this study the synthesized pH-responsive magnetite nanogels are developed 
and characterized to broaden the application of smart polymeric system in the promising area of 
nanomedicine and, ultimately leads to better healthcare for patients (Peppas et al., 2000).   
Since the use of plastics first became widespread in the middle of 20th century, polymers have 
become an emerging tool in biomedical science. Over 50 years ago the ability to synthesize 
polymers at small scales was developed and the early polymers synthesized in nanoscales were 
referred to as lattices or colloids (Peppas et al., 2000). Because of their very small size, existence 
as multi-components in nature, and the exclusive drug-polymer interaction, polymeric drug 
carriers have generated increasing interests in the field of medicine (Nahar et al., 2006).To better 
understand the advantages of responsive hydrogel systems over other synthetic polymer carriers, 
an overview of other systems is given below (Singh and Lillard, 2009). 
2.4.1 Dendrimers 
Dendrimers are an extreme state of branched polymers, which are also known as arborols or 
cascade molecules. Depending on whether synthesis starts at the core, or from the exterior, 
dendrimers are formed either by divergent (Liu et al., 2007a) or convergent synthesis (Lee et al., 
2006). Dendrimers are synthesized with well-defined chemical composition, and possess a 3D 
spherical morphology and tailored surface multi-valency. The number of branch generations 
determines the size, valence, and other properties of the dendrimers. Molecular weight for 
dendrimers can vary from 500 Da to 500 kDa (Duncan and Izzo, 2005). The multivalency 
property of dendrimers provides a conjugational site for functional groups, drugs, and ligands 





Although a wide selection of dendrimers and dendrimers-based compounds have been studied, 
such as dendritic hybrids, dendronized polymers, core-shell morphologies, dendrigrafts, cascade-
release dendrimers, cyclodextrin-dendrimer conjugates, and self-assembling dendrisomes, only 
approximately 25% of all the research has been devoted to biological applications (Duncan and 
Izzo, 2005). Most of the studies work on new synthetic chemistry of dendrimers. Currently, 
dendrimers are studied for a variety of biomedical applications, including cancer targeting, gene 
delivery, radiotherapy, transdermal and ocular drug delivery and imaging contrast agents (Samad 
et al., 2009). 
2.4.2 Self –Assembled Systems 
Self-assembled systems can be classified into liposome, micelles and polymersomes, which 
consist of amphiphilic block copolymers. Supramolecular forces cause the free energy of mixing 
between water and an amphiphilic polymer chain to decrease; as a result, the self-assembled 
systems are formed (Rhee and Mansour, 2011). 
Liposomes consist of synthetic or natural amphipathic compounds that are self-assembled into 
synthetic lipid bilayer vesicles. They are known as the most clinically successful approaches to 
drug delivery. They mostly consist of phospholipids or glycolipids, which are both double chain 
amphiphiles; therefore, due to the biomimetic resemblance to natural lipid bilayer of cell 
membrane, they are able to penetrate and enter the cytoplasm, releasing the drug, and ultimately 
targeting the tumor or cancerous cell. Like cell membrane, liposomes are also stabilized with 
high amounts of cholesterol (Silverthorn, 2010). Liposomes can carry both hydrophobic and 
hydrophilic drugs. The former are either encapsulated within the aqueous region of the core or 





liposome is a drug formulation known as Doxil®, which is currently approved for clinical use in 
AIDS-related Kaposi’s sarcoma. It is a doxorubicin encapsulated in PEGylated liposomes 
(Gabizon, 2001). Although lisosomes are most stable in an aqueous environment, they are also 
fairly stable in suspension. Thus, freeze drying and freeze/thaw cycles can cause cell lysis and 
drug loss (Rhee and Mansour, 2011). In addition, changing the pH and temperature has a 
significant effect on their property (Sułkowski et al., 2006).  
Aqueous micelles are composed of a large amount of surfactant, which makes them a two-
phase system, where the surfactant hydrophobic tail organized inward and the hydrophilic head 
ordered outward. Micelles are known for their ability to transport hydrophobic drugs that are 
encapsulated within their hydrophobic core (Torchilin, 2007). Critical micellar concentration 
(CMC) is defined as value in where the surfactants spontaneously forming micelles in water 
above this value. The risk involved using micelles as a drug carrier is the dilution of micelles to 
below their CMC during administration. This risk factor has recently been solved by 
synthesizing a highly stable surfactant with CMC below 10-6 M (Kabanov et al., 2002). Although 
the surfactant in the micelle structure increases their stability, it can further be enhanced by 
cross-linking the core. Miyata et al. (Miyata, Kanjiro 2005) cross-linked the core of PEGylated 
polyplex micelles with a disulfide bond to increase their stability during freeze drying. The 
majority of micelles are spherical in shape, but the shape and size of micelles can change 
according to the sizes of hydrophobic and hydrophilic blocks. Shapes such as rods, lamellae or 
others can be synthesized by increasing the hydrophobic blocks. The conventional spherical 
micelles can have diameter from 10-80 nm. Discher et al. (Torchilin, 2007) synthesized 
filomicelles characterized as highly stable and cylindrically shaped diblock amphipathic micelle. 





micelles and transported to the tumors site. They concluded that by manipulating the length and 
the shape of these PEGylated filomicelles, the circulation time in the blood was increased by up 
to one week.   
Polymersomes, also identified as mesoscopic synthetic polymer vesicles, self-assembled into 
the core-shell structure, in which the core is aqueous and the shell is diblock amphiphilic 
copolymers that formed bilayer structure. Although they are very similar to liposomes, they 
possess a ‘hyperthick’ hydrophobic block, because of the much larger hydrophobic polymer 
chains in their structure than their liposomes counterparts. This ‘hyperthick’ membrane makes 
polymersomes less permeable and also gives them extra thickness compare to the natural lipid 
bilayers. Polymersomes have shown great potential as targeting agent in vivo (Discher et al., 
2007; Pang et al., 2008). Since they are only quasi-stable, (similar to other self-assembled 
systems), Discher et al. ( Discher, B. M. 2002) synthesized polymersomes into polymer 
nanoshells by free radical polymerization in order to introduce stability to the system. 
2.4.3 Nanoparticles 
Synthetic nanoparticles are normally glassy, hydrophobic and amorphous in nature, or they could 
be highly crosslinked, stiff structured with integrity that cannot be obtained from dendrimers or 
self-assembled systems. Amorphous polymer nanoparticles acquire a broader size range 
compared to (1) dendrimers that can only form vessels when they approach the de Gennes dense 
packing point (Svenson and Tomalia, 2005), or (2) self-assembled systems that are size restricted 
due to the stability and conformation of the lipid bilayer. Nanoparticles can be synthesized with 
controllable morphology, from 1 nm to hundred of micron in diameter through emulsion or 





as polygonal structure (Glangchai et al., 2008), cones, bars and arrows (Euliss et al., 2006). 
Because for biodegradable nanoparticles, the control over degradation kinetics is more 
convenient, this system has been more developed for drug delivery applications. By reducing the 
particle size and increasing the hydrophobicity, the uptake of nanoparticles via the M-cells and 
payer’s patches will be raised significantly (Sahoo et al., 1998).   
2.4.4 Metallic Nanoparticles 
Metallic nanoparticles such as gold, silver, iron, cobalt, nickel, platinum, and other metal 
composite nanoparticles are among the most investigated materials in the field of biomedicine. 
Significant development in this area is attributed to iron oxide, gold and composite metal 
nanoparticles (Chiappini et al., 2010). Because of the accelerated detection (e.g. via electron 
microscopy, and Localized Surface Plasmon Resonance (LSPR)), availability, and also 
photothermal properties, gold and silver nanoparticles have been widely investigated (Chiappini 
et al., 2010). On the other hand, iron oxide nanoparticles’ unique magnetic property allows for 
easy detection by magnetic resonance contrast, and cell separation. Iron oxide nanoparticles offer 
more attractive property than other metallic nanoparticles. Many research groups have studied 
magnetic nanoparticles for application in gene and drug delivery, in vivo MRI enhancement, and 
cell labeling and detection (Chou et al., 2011; Lee et al., 2010). 
Furthermore, metallic nanoparticles are usually more stable in comparison to other polymeric 
and biological nanoparticles; metallic nanoparticles can be exploited for different applications 
due to the diversity and unique properties of metals. However, the toxicity of many metallic 
nanoparticles raises some concerns regarding their degradation and long term fate in vivo (Chou 






As previously mentioned, hydrogels are a hydrophilic, cross-linked polymer network that can 
absorb large amounts of water, and based on their size they can be classified as microgels or 
nanogels. They were one the earliest synthetic polymers that were used in the field of 
biomaterial. The hydrogel structure, mechanical properties and hydration imitate the human 
tissue. Because of their biocompatibility, flexibility, high water content, hydrophilicity, 
versatility, and controllable character. They are among the most successful polymeric systems in 
biomedicine (Kabanov and Vinogradov, 2009; Kopeček, 2007; Oh et al., 2009; Petros and 
DeSimone, 2010; Sasaki and Akiyoshi, 2010).  
Table 2.1 Summary of some of the nanogels advantages for drug delivery systems. 
Nanogels Properties Advantages 
Small size Increase drug up take 
Large surface area Maximize drug loading 
Stimuli responsive Improve drug release 
Cross-linked structure Enhance internal network 
Porous structure Facilitate drug loading and release 
Polymeric network Protect loaded drug 
High water content and hydrophilicity Facilitate delivery within the body 
 
Table 2.1 summarized some of the advantages of using nanogels for drug delivery systems.  
Nanogels not only can increase the circulation time of the drug in the blood stream, but also they 
are capable of actively or passively deliver the drug to the specific tumor sites in the body 
(Hamidi et al., 2008). Nano size hydrogels have recently found great popularity in the field of 





large free volume, which provide a suitable matrix for drug encapsulation. Crosslinking not only 
contributes to stability of the hydrogels, compared to other nanostructure systems, but it also 
gives them a highly porous structure that allows drugs to load into the hydrogel matrix and then 
successively released from the matrix (Hoare and Kohane, 2008). Although hydrogels are 
analogous to dendrimers, the difference is that hydrogels can be produced over a wider range of 
sizes. Functional groups are able to incorporate into the hydrogel polymeric backbone, 
crosslinks, pendant group, or on the surface.  In addition, controlled and targeted drug delivery is 
improved in hydrogels because therapeutic agents can be entrapped in or conjugated to the 
polymer network. There are several of methods for synthesizing hydrogels with controllable size 
and morphology, such as emulsion polymerization, dispersion/precipitation polymerization, and 
micro/nano fabrication (Oh et al., 2008a). Using hydrophilic monomer for hydrogel synthesis 
prevents phase separation during the reaction and also using organic solvents, it offers a more 
compatible environment for biological macromolecules. Cross-link junctions can be obtained 
either during the course of polymerization, or after the polymerization finished by means of 
chemical and physical techniques (Hoare and Kohane, 2008;Peppas et al., 2000).  
Moreover, hydrogels are able to act as drug conjugates with size manipulation, which make 
them capable of prolonged circulation of drugs. Because of the high free volume of cross-linked 
hydrogels, they can encapsulate more drugs in their interior matrix compared to uncross-linked 
chains. By binding ligand molecules onto the three dimensional surface of hydrogels during 
polymerization, their surface is decorated with high affinity receptors that resemble the surface 





Using amphiphilic macromolecules in the formation of hydrogels leads to formation of 
hydrophobicity domains, which have application in the delivery of small hydrophobic drugs. For 
instance, Missirlis et al. (Missirlis et al., 2005) through inverse-emulsion photo-polymerization 
synthesized amphiphilic Pluronic nanoparticles, which can be used in the delivery of 
hydrophobic drugs.  
2.4.6 pH-Responsive Nanogels 
As mentioned earlier, responsive hydrogels are capable of undergoing considerable changes in 
shape and volume in response to environmental stimuli, such as pH, temperature, light, ionic 
strength, or glucose concentrations (Hendrickson et al., 2010b; Oishi and Nagasaki, 2010). pH-
responsive hydrogels have attracted specific attention over other polymeric drugs carrier because 
of the pH variation in different part of the body.  
Addition of ionizable functional groups onto the hydrogels network can contribute to the 
responsive behavior of intelligent hydrogels. The shift from collapse to swollen state occurs 
when the functional groups are ionized. Buffering capacity of functional groups determines the 
pH at which the transition occurs. pH-responsive hydrogels can be synthesized from various 
types of functional groups which can be either acidic or basic. By adding acidic functional group 
such as carboxylate groups, the hydrogels will swell above the pKa of the acidic moiety; in 
addition, by incorporating basic functional groups such as a primary, secondary or tertiary amine 
groups the swelling of hydrogel occurs below their pKa values. For example, in the hydrogel 
network of MAA-DEA in which the methacrylic acid functional group works as an acidic moiety 
and 2-(diethylamino) ethyl methacrylate functional group acts as a basic functionality, causes the 





through the body compartments with pH above 6 and 7, such as small intestine, the acidic 
functional groups become ionized and subsequently the hydrogel swells and release the 
incorporated molecules. On the other hand, when this hydrogel passes through the low pH 
environment, such as stomach with pH ranges between 2 and 4, the hydrogel will also swell 
because its amine groups become protonated.   
2.4.7 Temperature-Responsive Nanogels 
Temperature-responsive nanogels in comparison to other responsive system have been 
extensively investigated.  Hydrophilic nanogels are capable of absorbing large amounts of water 
without changing their structure. However, thermo-responsive nanogels possess some 
hydrophobic functional groups such as methyl, ethyl or propyl in their structure, which induce a 
transition temperature at which a discontinuous volume changes occur; in other words, by 
increasing the temperature the volume of nanogels increase or decrease (Lapointe and Martel, 
2009a).  
The most common and popular temperature-responsive microgels are those composed of N-
isopropylacrylamide (NIPAM), and many research groups have examined the synthesis, 
characterization, and  applications of PNIPAM  systems (Brugger et al., 2010; Hendrickson et 
al., 2010a; Regmi et al., 2010). In 1968 Heskins and Guillet (Heskins and Guillet, 1968) were the 
first group to determine the lower critical solution temperature (LCST) of PNIPAM in aqueous 
solution. The linear PNIPAM reversibly changes its conformation from soluble, hydrophilic 
random coil to an insoluble, hydrophobic globule by increasing the temperature above 32oC. 
This phase transition is due to the adjustable hydrophilic-hydrophobic balance within the 





water cages are formed around these mildly hydrophobic moieties. By increasing the temperature 
above the LCST, the water cages are disrupted exposing the isopropyl groups that associate due 
to hydrophobic interactions (entropic part of Gibbs free energy) (Hendrickson et al., 2010a). 
When cross-linked microgels are synthesized using NIPAM, as a result of thermo-sensitivity of 
the monomer units, the microgels undergo a volume phase transition temperature (VPTT) near 
the LCST of PNIPAM. Analogous to LCST, by increasing the temperature above VPTT, the 
microgels shift from hydrophilic and swollen state to relatively hydrophobic and deswollen state 
(Hoare and Pelton, 2008). 
Poly (2-dimethylamino) ethyl methacrylate (PDMAEMA) exhibits excellent pH-responsive 
character, however, it is also known for its temperature responsive behaviour. Depending on pH, 
molecular weight and salt concentration, it possesses a LCST ranging from 32 to 53 oC (Zhou et 
al., 2008). Zhou et al. (Zhou et al., 2008) synthesized organic-inorganic hybrid nanoparticle 
SiO2-g-PDMAEMA via atom transfer radical polymerization (ATRP). They observed that by 
increasing the temperature from 20 to 50 oC the hydrodynamic radius increased from 150 to 
1000 nm at pH= 0 and from 500 to 1600 nm at pH= 11; which proves the presence of the 
temperature-responsive behaviour.   
2.4.8 Biomolecule-Responsive Nanogels  
Nanogels are presently under intensive studies as a matrix for the controlled release of the 
encapsulated bioactive molecule, in particular pharmaceutical proteins (Tirelli, 2006). 
Biomolecule-responsive microgels such as glucose-responsive microgels and protein-responsive 





significantly important because of their potential applications in the development of biomaterials 
and drug delivery systems (Hoare and Pelton, 2008; Lapeyre et al., 2008; Tirelli, 2006). 
2.5 Drug Delivery Specifications  
The first and vital consideration in developing a new biomaterial system is that the proposed 
system should not be harmful to the human body either locally or systematically (Farokhzad and 
Langer, 2006). In other word, the system should be biocompatible; it possesses quality of not 
having toxic or injurious effect on biological systems. Most of the design and development of 
drug delivery systems depend upon human biology. The most common and critical 
characteristics of drug delivery systems are: (Farokhzad and Langer, 2006):  
• Targeting 
• Stimuli responsiveness 
• Size 
• Prolong circulation 
• Biodegradation 
• Reporting and imaging 
All these characters are reviewed below. 
2.5.1 Targeting 
Most of the therapeutic agents used for the treatment of serious diseases especially cancer 
possess very severe side effects such as hair loss, congestive heart failure, sore mouth and throat, 
bladder or kidney tract infection, changes in taste or smell, etc. Most of the current therapeutic 





delivery is selectivity and specificity, and targeting can be achieved by functionalizing microgels 
with receptor-specific ligands (Das et al., 2006). The basic principle of this process is that these 
biofunctionalized microgels target diseased tissues outside the blood vessels, and while passing 
through the blood vessels they are taken up by intracellular compartment of targeted cells.    
2.5.2 Stimuli-Responsive Behavior 
Stimuli-responsive therapeutic agents are those that dynamically respond to environmental 
changes such as temperature, pH, ionic strength, photons, magnetic field or other phenomena. 
Diseases interfere with the biological and physicochemical equilibrium of human body, which 
eventually leads to environmental changes.  
2.5.3 Size 
The recent growth of nanomedicine is due to the fact that it is on the same length scale as many 
cellular processes. The size of the drug carrier not only determines the path of drug uptake to the 
targeted tissues but also specifies the course of delivery.  In most cases, nanogels are subjected to 
intravenous administration. Upon this process the body tends to naturally eliminate administrated 
nanogels from circulation via different approaches, depending on the hydrodynamic sizes of the 
nanogels (Deka et al., 2010). For example, particles larger than 4μm will be captured in the 
lungs, since the smallest capillaries in body are 4μm. Mononuclear phagocytes system (MPS) 
usually eliminates particles smaller than 4μm. Through histological investigation, particles with a 
size of 100 nm were able to diffuse through the submucosal layers; whereas, particles with size 
ranging from 500 nm to 10 μm were concentrated within the epithelial tissue lining (Arifin et al., 





Size is a crucial parameter that needs to be taken into account while designing the nanogels. 
Nanogels developed for in vivo drug delivery should possess size smaller than 200 nm because 
nanogels larger than 200 nm will be sequestered by reticulo-endothelial system right after 
intravenous injection. Nanogels smaller than 200 nm remain colloidally stable upon injection and 
will be in circulation for a sufficient amount of time until they approach the tumor sites (Deka et 
al., 2010). 
2.5.4 Extended Circulating Time 
For sustained drug release or constant targeting of a specific tissue, prolong circulation of the 
therapeutic agent is required. A number of researches have illustrated that hydrophilic, 
uncharged surface; with hydrogen bond donor groups without any ligand is the most effective 
synthetic surface to increase the circulation (Chonn et al., 1991). Poly (ethylene glycol) (PEG) 
chains are one of the most common surface grafting agents that can augment the circulation 
when attached to the surface of the particles. (Bradley et al., 1998) 
2.5.5 Biodegradation 
Biodegradation is a crucial character in developing smart drug delivery system that leads to the 
degradation of the drug carrier after the administration of the drug.  By ensuring that the drug 
carriers do not remain in the body for an extended period, potential side effects of the drugs can 
be minimized. Balogh et al. (Balogh et al., 2007) illustrated that the elimination of drug carrier 
can be achieved by controlling the size and charge of the drug carrier. They observed that over 4 
days about 50% of positively charged, 5 nm Au-dendrimers nanocomposites were excreted form 





larger, this value was larger. Polymeric systems are very promising candidate in the area of 
nanomedicine due to their degradation ability.  
2.5.6 Imaging 
In the field of biomedical engineering, imaging is an important tool for determining the targeting, 
degradation and biodistribution of the drug carrier. To achieve this goal, the drug carrier should 
be designed with functional groups or moieties that can easily be traced by conventional medical 
imaging devices. These instruments include magnetic resonance imaging (MRI), computed 
tomography (CT), positron emission tomography (PET) and ultra sound imaging. For example, 
supermagnetic iron nanogels to be developed in this thesis research can be targeted by MRI. 
Fluorophores and quantum dots are other techniques that can be used as targeted agents (Liu et 
al., 2007b).  
2.6 Magnetic Nanoparticles 
Core metallic particles that possess magnetic properties and have a size ranging from 1 to 100 
nm are known as magnetic nanoparticles (MNP). They are commonly classified into core 
materials and coatings (Sun et al., 2008). The most widely used magnetic nanoparticles are iron-
based core materials; the core can comprise of magnetite (Fe3O4) and/or maghemite (γFe2O3). 
The general formula for magnetite is AB2O4, where A stands for Fe (II) and B stands for Fe (III) 
(Thorek et al., 2006). The ferromagnetic cubic shape of Fe (III) oxide is defined as maghemite. 
The difference between magnetite and maghemite originates from differences in vacancies on the 
cation sub-lattice. In particular, in magnetite, half of Fe3+ takes up the interstitial tetrahedral (Td) 





maghemite, half of Fe3+ occupies the octahedral sites along with cationic vacancies instead of 
Fe2+. The structure of both magnetite and maghemite is illustrated below; (Laurent et al., 2008).  
Fe3O4: [Fe3+]Td [Fe3+Fe+2]Oh O4 
γFe2O3: 0.75 [Fe3+]Td [Fe+35/3V1/3]Oh O4 
Magnetite will be slowly oxidized to maghemite in an ambient environment; however, in 
biomedical applications these two materials do not differentiate, and are generally defined as iron 
oxide (Laurent et al., 2008). Other types of metal ferrites, such as MnFe2O4, CoFe2O4, and 
NiFe2O4, can be produced by replacing Fe2+ with the equivalent metal cations. Magnetic 
nanoparticles are formed either via synthetic approaches or through commercial production (Sun 
et al., 2008).  
Moreover, reactive functional groups such as amino or carboxyl groups must be present on the 
surface of nanoparticles to graft molecules onto the nanoparticles and form coatings around the 
nanoparticles. These chemical groups act as attachments between the core of the nanoparticle 
and coating like peptide or antibody. Not only do these coatings improve water solubility of the 
iron oxide nanoparticles, but they also impart stability to the iron oxide nanoparticles. Coatings 
can form multilayered nanoparticles in which each layer possesses its functional groups; 
therefore, coatings play an important role in intracellular targeting and internalization of 
nanoparticles (Sun et al., 2008; Zou et al., 2010).  
Super-paramagnetic is the magnetic property in which nanoparticles are only magnetized in 
the presence of an applied magnetic field; in the other words, by removing the magnetic field the 
super-paramagnetic particles such as Fe2O3 and Fe3O4 do not retain its magnetism (Park et al., 





in diameter. Moreover, super-paramagnetism reduces aggregation and physical interactions of 
nanoparticles, and also increases the relaxation rates and magnetic resonance contrast of the 
nanoparticles (Liu et al., 2010; Sun et al., 2008). Thus, super-paramagnetic particles have a 
promising application in biomedicine; because, in the dispersion they are not only subject to 
strong magnetic interaction but are also readily stabilized in the physiological condition (Xu and 
Sun, 2007). Furthermore, conversion of Fe3O4 to γFe2O3 occurs by oxidation of super-
paramagnetic iron oxide through oxidizing agents or oxygen exposure. During this process, as 
Fe2+ in the magnetite lattice oxidizes the color of the solution switches from black-brown to red-
brown (Thorek et al., 2006).  
Iron oxide magnetic nanoparticles have demonstrated great biocompatibility and a minimum 
toxicity compared to other metallic nanoparticles. There are three different processes involved in 
the cellular targeting of the magnetic nanoparticles (Sun et al., 2008; Thorek et al., 2006): 
• Passive targeting: the cellular uptake of nanoparticles occuring through a natural 
mechanism, such as endocytosis, 
• Physical targeting: the physical manipulation of magnetic nanoparticles by means of 
magnetic field, which facilitate the localization of the magnetic nanoparticles within 
desired area, 
• Bimolecular targeting: the biomolecules, such as antibody and peptide are conjugated 
within the magnetic nanoparticles, in order to facilitate their binding to the specific 
receptor on the cell or tissue. 
Detection of the magnetic nanoparticle is a significant challenge. Due to the very small size of 





be detected by standard analysis methods, such as light microscopy. Indeed, ultra sensitive 
microscopy approaches and elemental analysis techniques such as electron microscopy and 
magnetic resonance imaging (MRI) are used to study magnetic nanoparticles (Sun et al., 2008).  
In summary, as schematically illustrated in Figure 2.13 magnetic nanoparticles demonstrate 
notable properties including, super-paramagnetism, biocompatibility, feasible synthesize, post-
synthesize coating and modification, and also a high ratio of surface area to volume, which make 
them an attractive system in the field of biomedicine (Dias et al., 2011).  
 
Figure 2.13 Schematic of the significant properties of iron oxide magnetic nanoparticles for biomedical 
applications (a) super-paramagnetism, (b) heat effects as an influence of external magnetic field, (c) 
versatility in the synthesis and coating process, and (d) nano-size particle possesses high surface to 








2.6.1 Synthesis of Magnetic Nanoparticles  
Control of the nanoparticles size and homogenous dispersion of magnetic nanoparticles are two 
main challenges regarding the synthesizing magnetic nanoparticles. Various approaches have 
been investigated to synthesize magnetic nanoparticles, such as co-precipitation, reverse 
micelles, and thermal decomposition. Subsequently, after the magnetic nanoparticles are formed, 
three purification techniques can be employed in order to remove excess and unreacted 
materials: centrifugation, gel-exclusion chromatography (GEC), and magnetic sorting (Laurent et 
al., 2008) . Herein lie some of the techniques to synthesize magnetic nanoparticles. 
 The co-precipitation of ferrous or ferric salts with strong bases like ammonium hydroxide 
(NH4OH) or sodium hydroxide (NaOH) in aqueous medium is the most common and efficient 
approach to synthesize magnetic nanoparticles, due to the fact that magnetic nanoparticles are 
easily and economically synthesized in large scale by this process (Gupta and Gupta, 2005). 
Through this process different types of polymers like poly(ethylene glycol), dextran, and 
dendrimer can be coated onto the nanoparticles surface to prevent aggregation and provide steric 
repulsion that creates a balance between attraction and repulsive forces between the 
nanoparticles (Veiseh et al., 2010). The advantages of the co-precipitation technique is that it is 
easy and can be readily produced in large quantities; despite the fact that the control over 
nanoparticle shape, size, crystallinity, and magnetization is restricted to the kinetic control of the 
growth of the nanoparticles (Hyeon, 2003;Thorek et al., 2006). The following is the general 






In this reaction M can be a divalent ion such as iron (Fe+2), nickel (Ni+2), or cobalt (Co+2). 
Because of thermodynamic consideration, complete precipitation of this reaction is occurring in 
oxygen free environment between pH=8 and pH=14, and the stoichiometric ratio Fe+3: Fe+2 is 
2:1 (Laurent et al., 2008). Stabilization then occurs by introducing strong bases, either nitric acid 
(HNO3) which gives a positive charge on the surface of the particle due to adsorption of H3O+ 
ions or tetramethylammonium hydroxide ((CH3)4NH4OH), which provides a negative charge to 
the nanoparticles as a result of OH- ions adsorption (Laurent et al., 2008). This method produces 
polydisperse size distribution magnetic nanoparticles and also causes cluster-like aggregations 
(Thorek et al., 2006). Figure 2.14 demonstrates the general form of this method. Commonly, this 
process consists of the following two steps (Laurent et al., 2008): 
1. Once the concentration of the species has reached the critical super-saturation stage, a 
short burst nucleation happened, 
2.  By diffusing the solutes to the surface of the nanoparticles, nuclei encounter a slow 
growth. 
Moreover, in order to form monodisperse magnetic nanoparticles, nucleation should be 
prevented during the growth process; in other words, these two steps should be separated from 







Figure 2.14 Schematic of co-precipitation approach for synthesizing magnetic nanoparticles. 
Another method to synthesize magnetic nanoparticles involves reverse micelles, which provide 
templates to control the nanoparticle size and dispersity. This system involves the dispersion of 
surfactant molecules in a continuous hydrocarbon phase along with the formation of well-defined 
nanodroplets in the aqueous phase (Laurent et al., 2008). Calero et al. (Calero-DdelC and 
Rinaldi, 2007) synthesized cobalt ferrite nanoparticles with size range of 3-10 nm via reverse 
micelles. In order to form reverse micelles they used sodium bis (2-ethylhexyl) sulfosuccinate 
(AOT) as a surfactant, which separated bulk organic medium from the aqueous phase. They 
mixed a solution of reverse micelles consisting the aqueous ammonium hydroxide (NH4OH) as 
the precipitating agent with another solution of reverse micelles consisting of a mixture of metal 
salts (Fe+3:2Co+2) at room temperature. Even though the particle has a narrow size distribution 






Another technique to synthesize magnetic nanoparticles is known as thermo decomposition. Park 
et al. (Park et al., 2004) were able to successfully synthesize monodisperse magnetic 
nanoparticles in large-scale via thermo-decomposition of a metal-oleate precursor, which formed 
from the reaction between  sodium-oleate and metal chloride, in high boiling point 1-octadecene 
as a solvent. The general overview of this process is represented in Figure 2.15. In this process 
by controlling the temperature of the solvent, the nucleation and growth phases were separated. 
They observed at nucleation phase that one oleate ligand was dissociated from the metal-
precursor at temperature from 200 to 240 oC, and the remaining two oleate ligands were 
dissociated at 300 oC, where the main magnetic nanoparticles growth occurred. Then, the 
magnetic nanoparticles were allowed to grow further at the boiling point of the solvent (1- 
octadecene), which was 320 oC, for 30 minutes. Subsequently, the formed magnetic 
nanoparticles were washed with ethanol and precipitated by centrifugation at room temperature. 
Although the reaction stoichiometry represents only about 2 grams corresponding to magnetite, 
they were able to synthesize 40 g of monodisperse magnetic nanoparticles through this process 
(Park et al., 2004). Figure 2.16 shows the TEM images of synthesized MNP via thermal-
decomposition. 
 
Figure 2.15 Schematic of thermal-decomposition method to synthesize magnetic nanoparticles from 






Figure 2.16 TEM images of synthesized MNP via thermal-decomposition where (a) highly monodisperse 
synthesized MNP (b) 40 g (high-scale) formed monodisperse MNP in comparison to 1 cent (Park et al., 
2004). 
2.6.2 Surface Modification of Magnetic Nanoparticles  
Magnetic nanoparticles possess high surface-to-volume ratio, which promote their aggregation 
due to the high surface energy, strong magnetic dipole-dipole interactions, and hydrophobic 
surface. Therefore, their stabilization through coating with specific molecules and polymers is 
crucial in order to form colloidally stable magnetic nanoparticles; otherwise, for in vivo 
applications, aggregation of magnetic nanoparticles can lead to rapid recognition by macrophage 
cells and undesired elimination from circulation through RES, and ultimately cause unexpected 







nanoparticles can also be achieved through electrostatic and/or steric repulsion. The former can 
be predicted by understanding the diffusion potential through the Debye-Huckel length and the 
zeta potential (ζ) which both depend on the pH and ionic strength; however, the latter is quite 
difficult to follow and quantify particularly for magnetic nanoparticles, but it is well-explained 
for polymers (Dias et al., 2011; Laurent et al., 2008).   
In iron oxide magnetic nanoparticles, the surface iron atoms act as Lewis acids and coordinate 
with molecules that donate one-pair electrons (Dias et al., 2011). In aqueous solutions, the iron 
atoms coordinate with water, which impart hydroxyl groups on the iron oxide surface. These 
hydroxyl groups are amphoteric and are able to react with both acids and bases (Gamarra et al., 
2010). The surface of the magnetite can be either positive or negative, based on the pH of the 
solution. Around the isoelectric point (IEP) of magnetic nanoparticles, which is observed at pH 
6.8, the surface charge density (Ʃ) is too small and the particles are not stable in water and 
simultaneously form aggregation. Therefore, in order to obtain stable magnetic nanoparticles 
both electrostatic and steric stabilization should be introduced (Gamarra et al., 2010). In 
particular, because of coordination and dissociation with water, the surface of iron oxide 
nanoparticles is dominated by hydroxyl groups in aqueous medium, which leads to protonation 
and formation of positive surface charges (Fe+3-OH+2) below the isoelectric point and 
deprotonation and the formation of negative surface charges (Fe+3-O-) above the isoelectric point 
(Dias et al., 2011). 
Coating of the magnetic nanoparticles not only forms a steric barrier to prevent nanoparticles 
agglomeration, but also provides a platform for surface modification and biocompatibility of the 





and biological medium preventing adsorption of plasma protein, which may induce the formation 
of larger nanoparticles and faster recognition by macrophage cells, and subsequent clearance of 
the nanoparitcles by immune system (RES) (Laurent et al., 2008). As shown in Figure 2.17, a 
variety of monomers, polymers, and inorganic materials can be applied for this purpose.  
 
Figure 2.17 Schematic of different kind of polymers exploited as a coating onto the MNP (Veiseh et al., 
2010). 
The coating of magnetic nanoparticles can be obtained either as a one-step synthesis or as a post-
synthetic process, or it can be done by in-situ or encapsulation (Dias et al., 2011). In other words, 
the result of coating through encapsulation, end-grafting, hydrophobic interaction, or hyper-
branching produces more homogeneous hydrophilic nanoparticles. In addition, properties of the 





nanoparticles. For example, the hydrophilic surface could extend the circulation of the magnetic 
nanoparticles in blood and enhance the diffusion into marrow and lymph. Conversely, the 
hydrophobic surface could increase the chance of magnetic nanoparticles being trapped in the 
liver or spleen (Hong et al., 2008).  
Poly (ethylene-glycol) methacryalte (PEGMA) and poly (elthylene-glycol) (PEG), which 
contain one hydroxyl functional group on every monomer unit, are among the most common 
materials used for surface modification, especially for biomedical applications due to their 
biocompatibility, water solubility, and hydrophilicity (Laurent et al., 2008). Grafting on the 
surface of magnetic nanoparticles is efficient in decreasing non-specific adsorption (such as 
protein plasma), increasing the stability of magnetic nanoparticles in plasma, and enhancing the 
circulation time (Xie et al., 2007) .  
One of the efforts in this area was conducted by Xie et al. (Xie et al., 2007) through 
PEGylating of iron oxide nanoparticles with a homemade ligand dopamine-PEG-COOH. They 
were able to synthesize monodisperse 9 nm Fe3O4 magnetic nanoparticles in organic medium, 
and then grafted with dopamine (DPA), which is known for its high affinity to Fe3O4 surface 
linked to one of the carboxylic groups in the PEG by EDC/NHS reaction. As a result of this 
linkage, the dopamine-PEG-COOH ligand was covalently grafted onto the magnetic 
nanoparticles to replace the original organic coating, oleate and oleyamine, of the magnetic 
nanoparticles, and rendered the hydrophobic magnetic nanoparticles water-soluble. Figure 2.18 






Figure 2.18 Schematic of surface modification of Fe3O4 magnetic nanoparticles by DPA-PEG-COOH 
(Xie et al., 2007). 
The stability of the formed coated magnetic nanoparticles was investigated in phosphate buffered 
saline (PBA) plus 10% (FBS). As shown in Figure 2.19 only about a ~10-20 nm increment in 
size was observed in comparison to nanoparticles in water. This could be due to the interaction 
with the FBS in the incubation environment. This small change in size was also improved by 
introducing higher molecular weight PEG, which caused the formation of the dense coating and 
subsequent reduction of these interactions; thus all four types of PEG demonstrated great 
stability without significant size enhancement (Xie et al., 2007). They observed through DLS 
that by changing the length or molecular weight of the PEG, the overall size of the magnetic 
nanoparticles could be manipulated, while the core size remained the same. For instance, as 
shown in Figure 2.20, by coating the magnetic nanoparticles with PEG 3000, the overall 
diameter increased from 9 to 50 nm, whereas by applying PEG 20000, the overall diameter of the 
magnetic nanoparticles increased to 90 nm in aqueous solution. Along with DLS, the zeta 





nanoparticles, due to the negatively charged surface. Furthermore, this group confirmed that all 
four types of synthesized PEGylated magnetic nanoparticles, PEG 600, 3000, 6000, and 20000, 
showed a much lower uptake by macrophages cell in contrast to dextran coated magnetic 
nanoparticles (Xie et al., 2007).  
 
Figure 2.19 DLS curves, showing the hydrodynamic sizes of the different PEG molecular weight utilized 






Figure 2.20 Hydrodynamic radius (size) of the Fe3O4 magnetic nanoparticles coated with different Mw of 
PEG and incubated in PBS and 10% FBS for 24 hours at 37 oC (Xie et al., 2007). 
Barrera et al. (Barrera et al., 2009) synthesized monodisperse colloidally stable magnetic 
nanoparticles through the thermal decomposition technique, in which an iron precursor 
decomposed in a high boiling point solvent in the presence of a non-polar surfactant; afterward, 
the hydrophobic magnetic nanoparticle was covalently coated with PEG-silane. PEG-silane was 
prepared in a two steps process. In the first step, terminal hydroxyl groups in mPEG were 
converted to carboxylic acids (mPEG-COOH) with the help of strong oxidizing agent; in the next 
step, through amidation reaction at 180 oC under N2 atmosphere, carboxyl groups (mPEG-
COOH) reacted with –NH2 in 3-aminopropyl triethoxysilane (APS). The stability of PEG-coated 
magnetic nanoparticles was confirmed by zeta potential and dynamic light scattering 
measurements. From the DLS measurement, an increase of 35 nm in size was observed. As 
shown in Figure 2.21a, the nanoparticles were stable in water for pH of 3-9, except at the 
isoelectric point around pH=7.5. These charges were correlated to ions absorbed on the PEG-





did not carry any ionizable groups. In addition, the particle stability was further confirmed by 
varying the ionic strengths, as seen in Figure 2.21c and Figure 2.21d, through varying NaCl 
concentrations from 0.038 M to 0.32 M at pH=7. Although the hydrodynamic radius fluctuated 
between 35 and 45 nm, no significant aggregation was reported, as revealed by DLS 
measurements shown in Figure 2.21b (Barrera et al., 2009). 
 
Figure 2.21 (a) zeta potential measurement as a function of pH, (b) hydrodynamic radii as function of pH, 
(c) zeta potential measurement as a function of NaCl concentration, and (d) hydrodynamic radius as a 
function of NaCl concentration (Barrera et al., 2009). 
The only drawback regarding coating of magnetic nanoparticles is due to the fact that coatings 
provide strong thermodynamic stabilization that causes the steric repulsion of magnetic 









them is reduced. An efficient solution is to control the stability of the formed clusters, so that the 
clusters stay stable to further aggregations, while maintaining their ability to be captured for 
separation applications (Barrera et al., 2009).  
Ditsch et al. (Ditsch et al., 2005) were able to synthesize clusters with controlled size and 
stability. They investigated the effects of (I) varying molecular weight of the coating polymers, 
and (II) addition of the second polymer on the stability and aggregation of magnetic 
nanoparticles. As shown in Figure 2.22, the magnetic nanoparticles were synthesized by co-
precipitation of iron oxide salts in an aqueous solution; afterward, synthesized magnetic 
nanoparticles were coated in two steps with optimal molecular weight of random copolymer 
consisting of styrene sulfonic acid, acrylic acid, and vinyl sulfonic acid. In the first step, a limited 
amount of low molecular weight polymer was added, which caused the formation of clusters due 
to insufficient coating. In the second step, low molecular weight hydrophilic polymer was added 
to provide additional coating of the magnetic nanoparticles. In this step, the clusters were 
completely stabilized over a wide range of ionic strength and pH with no effect on the cluster 






Figure 2.22 Schematic of the coating process of the synthesized magnetic nanoparticles (Ditsch et al., 
2005). 
They observed that by adding high molecular weight polymer in the first step produced smaller 
size clusters, due to the formation of thicker coating and steric stabilization. In contrast, by using 
low molecular weight polymer, larger size clusters formed. However, the largest size cluster 
produced in this step was not large enough to be captured with a high gradient magnetic 
separator (Ditsch et al., 2005). Therefore, they concluded that changing the molecular weight of 
a single coating is insufficient for forming stable clusters. In another set of experiments, they 
noticed that the instability and subsequent clustering was more susceptible by adding a limited 
amount of coated polymer or by reducing the density of attachment groups, because of the 
incomplete coating of the surface of the magnetic nanoparticles. They also realized that the size 





added polymer, because of the larger polymer size and greater steric repulsion associated with 
the hydrophobic groups. Although this system was stable in water due to strong surface charges 
and interparticle electrostatic repulsion, however with a slight change in the ionic strength, 
instability occurred (Ditsch et al., 2005). Thus, as a final experiment, they examined the effect of 
adding a secondary polymer as a coating. The role of the secondary coating was to cover the 
vacant sites on the surface that were not sufficiently covered by the primary polymer coating.  
In addition, by adding a low molecular weight secondary polymer, the cluster size remained 
constant, while, a higher molecular weight polymer formed a larger size cluster, due to bridging 
interactions (Ditsch et al., 2005). These effects were illsutrated in Figure 2.23. As illustrated in 
Figure 2.23a, before the addition of a second polymer, the particle size increased slowly; when 
the second polymer became larger that the first polymer (around Xw = 85) the particle size 
increased due to bridging. This also confirmed the incomplete coating. Figure 2.23b indicated 
that by adding large amounts of the first polymer the cluster size increased, but in lower values in 
comparison to adding less amount of the first polymer. It also indicates that the bare surface of 
the magnetic nanoparticles is still present and Figure 2.23c demonstrated the stability of the final 






Figure 2.23 (a) the particle size as a function of secondary polymer (acrylic acid) size for clusters starting 
at 74 nm, (b) cluster size vs. different ratios of second polymer to surface iron, and (c) stability of the 
final particle as a result of adding the second polymer (Ditsch et al., 2005). 
In another study, Sondjaja et al. (Sondjaja et al., 2009) prepared magnetic nanoparticles via co-
precipitation technique and grafted the magnetic nanoparticles with double hydrophilic block 
copolymer (DHBC), poly (ethylene oxide)-block- poly (acrylic acid) (PEO-b-PAA). In this 
structure, one block enhanced the colloidal stability of nanoparticles, while the other block acted 
as polyelectrolyte and caused interaction with the precursor. Subsequently, the synthesized 







only controlled the particle growth, but also acted as stabilizer and clustering agent. They 
reported that clustering of magnetic nanoparticles, which formed larger aggregates of magnetic 
nanoparticles more than 100 nm in size, was required in order for magnetic nanoparticles to be 
permanently and effectively trapped in a magnetic separator; otherwise, the nanoparticles with 
size less than 50 nm could not be trapped and efficiently separated by the magnetic separator. By 
altering the iron loading-to-polymer ratio, they observed that inadequate amounts of polymer 
destabilized the nanoparticles resulting in clusters formation. This phenomenon occurred as a 
result of the van der Waals attraction between the regions of the nanoparticles that were not 
sufficiently coated with the polymer; thus, the nanoparticles aggregated at these uncoated 
regions. Figure 2.24 demonstrates that the cluster yield was inversely proportional to the ratio of 
grafting group (COO-) to surface iron atoms (Fe Surface). These plots illustrate that when a 
polymer was in excess (𝑅 > 0.8) there was less than 10% cluster yield and the magnetic 
nanoparticles size were around 126 nm. However, by decreasing the polymer amount (𝑅 ≤ 0.2) 
the magnetic nanoparticles aggregated due to incomplete surface coverage, and yielded more 
than 87% clusters with a size of about 280 nm. This group was able to successfully obtained 
homogenous magnetic nanoparticles clusters, which were also colloidally stable for about 48 






Figure 2.24 Graphs of (a) yield, and (b) hydrodynamic radius versus R for three different solutions:  
(  ) permanently captured clusters solution, (  ) bleed off solution, and (×) non-captured particles solution 
(Sondjaja et al., 2009). 
Super-paramagnetic iron oxide nanoparticles coated with hydrophilic polysaccharide known as 
dextran, which act as contrast agents for MRI, have been approved for the Food and Drug 
Administration (FDA). Hong et al. (Hong et al., 2008) successfully synthesized dextran-coated 
Fe3O4 via a one-step conventional co-precipitation method with a novel modification using 








Figure 2.25 Schematic of the coating process of the Fe3O4 magnetic nanoparticles with dextran (Hong et 
al., 2008). 
This group (Hong et al., 2008)  investigated the particle size and coating efficiency of dextran on 
the synthesized magnetic nanoparticles. They observed that by increasing the weight ratio of 
dextran to magnetic nanoparticles to more than 2.5, the size and aggregation of magnetic 
nanoparticles decreased dramatically and the magnetic nanoparticles dispersion was enhanced 
due to the steric hindrance provided by dextran. By increasing the ratio to 7.5, as a result of 
adsorption of magnetic nanoparticles with entanglement of dextran chains aggregation was 
minimized. Although increasing the molecular weight of the dextran significantly increased the 
size of the magnetic nanoparticle, resulting in more dextran coming in contact with magnetic 
nanoparticles, only a minor impact on the coating efficiency was observed. Figure 2.26 shows 
that by coating the magnetic nanoparticles with dextran, the size was decreased and the colloidal 






Figure 2.26 TEM images represent (a) bare magnetic nanoparticles, and (b) dextran-coated magnetic 
nanoparticles (Hong et al., 2008).      
In another study of dextran coated magnetic nanoparticle, Gamarra et al. (Gamarra et al., 2010) 
observed that the so-called Endorem, which was the colloidal suspension of  iron oxide 
nanoparticles coated with dextran, had a great potential for use as a contrast agent in MRI 
detection. They observed a transition temperature from Fe3O4 to the γFe2O4 phase by deferential 
scanning calorimetry (DSC). As shown in Figure 2.27, the DSC curve consisted of an 
endothermic and exothermic peak. The former at 166.6oC represented the melting temperature of 
mannitol (C6H14O6), which existed to increase the colloidal stability, the latter at 253.1 oC 
corresponded to the oxidation of Fe3O4 to γFe2O3, which was further confirmed by the reduction 







Figure 2.27 DSC graph of dextran-coated Fe3O4 magnetic nanoparticles (Gamarra et al., 2010). 
Another polysaccharide that has been widely studied as a coating agent is chitosan.  Its natural 
properties, such as biocompatibility, biodegradability along with antibacterial activity, and also 
its affinity for many biomacromolecules leading to bioadhesion makes this polysaccharide an 
interesting and promising system for further investigation (Lopez-Cruz et al., 2009). Lopez-Cruz 
et al. (Lopez-Cruz et al., 2009) successfully prepared Fe3O4 magnetic nanoparticles by thermal 
decomposition and functionalized them with carboxylic group. Later, further functionalization of 
magnetic nanoparticles occurred by coating them with both chitosan oligosaccharide and low 
molecular weight chitosan. They studied the effects of chitosan molecular weight on the 
morphology and colloidal stability of the nanoparticles. The coating process was done through 
covalent linkage, carbodiimide activation, between amine groups in chitosan and carboxyl 






Figure 2.28 Schematic of coating process of the Fe3O4-COOH magnetic nanoparticles with chitosan 
oligosaccharide (Lopez-Cruz et al., 2009). 
As can be seen in Figure 2.29, this research group (Lopez-Cruz et al., 2009) demonstrated that 
coating the magnetic nanoparticles with chitosan and chitosan oligosaccharide influenced the 
morphology of the primary magnetic nanoparticles. In the former, aggregated clusters were 
observed, while in the latter a single core was produced. They noticed that the size and size 
distribution of the magnetic nanoparticles did not change and remained at 11 nm in diameter 
with different coatings.  In other words, using chitosan oligosaccharide as a coating resulted in 
magnetic nanoparticles as distinct entities, while using chitosan as a coating produced magnetic 
nanoparticles clusters. In this case, particles in each cluster possessed 11 nm mean diameter 







Figure 2.29  TEM images represent (a) Fe3O4-COOH magnetic nanoparticles, (b) chitosan-coated Fe3O4 
magnetic nanoparticles, and (c) chitosan oligosaccharide-coated Fe3O4 magnetic nanoparticles (Lopez-
Cruz et al., 2009). 
Moreover, Lopez-Cruz et al. (Lopez-Cruz et al., 2009) observed a wide size distribution of the 
chitosan coated nanoparticles. A very low stability was observed at pH greater than 6, due to the 
deprotonation of amino groups of the chitosan segments, which also indicated that the 
stabilization in this system was facilitated by electrostatic repulsion. However, chitosan 
oligosaccharide coated nanoparticles had a narrow size distribution and were also colloidally 
stable at pH=6 or higher, which confirmed that its stability was a result of steric repulsion rather 
than electrostatic repulsion. In addition, Figure 2.30 illustrates the zeta potential of the three 
different systems as a function of pH. It showed that at low pH, coated magnetic nanoparticles 
were positively charged as a result of protonation of the amino groups, which further confirmed 
the presence of chitosan on the surface of the nanoparticles (Lopez-Cruz et al., 2009). 






Figure 2.30 Zeta potential graph as a function of pH for (a) chitosan oligosaccharide-coated Fe3O4 
magnetic nanoparticles, (b) chitosan-coated Fe3O4 magnetic nanoparticles, and (c) Fe3O4-COOH 
magnetic nanoparticles (Lopez-Cruz et al., 2009). 
Another technique for coating magnetic nanoparticle is to use thick and dense inorganic 
materials such as silica. As a result of their rigid structure, inorganic materials are able to protect 
magnetic nanoparticles from interacting with each other and also with their environment. Yi et 
al. (Yi et al., 2006) synthesized iron oxide particles via thermal-decomposition and then used 
reverse microemulsion to form a silica coating on the nanoparticles. Following dispersion of 
polyoxyethlylene (5) nonylphenyl, which acted as a surfactant, in cyclohexane by sonication, 
reverse microemulsion was produed by the addition of iron oxide nanoparticles in cyclohexane 
and ammonium hydroxide. Afterwards, tetraethyl orthosilicate (TEOS) was added and the 
solution was agitated overnight. The TEOS was hydrolyzed and condensed during this process 








research group studied three different structures with different coating thickness, which was 
derived from this iron oxide coated silica template (Yi et al., 2006).  
 
Figure 2.31 Schematic of the reverse microemulsion polymerization of silica coated iron oxide and the 
three other structures formed from the template (Yi et al., 2006). 
In another study, a pH-responsive polymer was applied to coat magnetic nanoparticles. Zhou 
et al. (Zhou et al., 2009a) utilized the atom transfer radical polymerization (ATRP) technique to 
graft poly ((2-dimethylamino) ethyl methacrylate) (PDMAEMA) onto the surface of magnetic 
nanoparticles (Fe3O4-Br), which were synthesized through the co-precipitation process. The 
general procedure is shown in Figure 2.32. Due to the biocompatibility, hydrophilicity, and pH 
sensitivity of PDMAEMA, the reported hybrid nanoparticles with core-shell structure 
demonstrated great potential to load drugs into the polymer shell. In addition, this system was 
confirmed to be able to release the drugs in a steady and controllable manner by changing the pH 
(Zhou et al., 2009a). This research group observed more stable dispersion of magnetic hybrid 





low pH value, the amine groups on the PDMAEMA segments were protonated; thus, the 
hydrodynamic radius was increased by decreasing pH. This phenomenon was attributed to the 
electrostatic repulsion, strong polymer-solvent interaction, and also geometrical restriction that 
resulted in polymer chains extension along the radial direction. On the other hand, at high pH 
value the PDMAEMA segments were deprotonated, the high grafting reduced the available 
space, and also polymer-polymer interactions were stronger than polymer-solvent interaction; 
thus polymer chains agglomerated and reduced the hydrodynamic radius (Zhou et al., 2009a; 
Zhou et al., 2009b). 
 
Figure 2.32 Schematic of the synthesizing of the magnetic nanoparticles grafted with PDMAEMA (Zhou 
et al., 2009a). 
This research group incorporated the model drug, phenolphthalein, into the polymer shell, and 
subsequently studied the release of the drug. As can be seen in Figure 2.34, the release of the 
drug is significantly faster at pH=3 than pH=7, because of the protonation resulting in the 
expansion of the hybrid magnetic nanoparticles, where more drug molecules were able to diffuse 






Figure 2.33 Hydrodynamic radius of Fe3O4 / PDMAEMA as a function of pH (Zhou et al., 2009a). 
 
Figure 2.34 Release profile of phenolphthalein from the Fe3O4 / PDMAEMA at (a) pH=3, and (b) pH=7 








2.7 Nanogels and Magnetic Nanoparticles  
Because of the specific characteristics and properties of iron oxide magnetic nanoparticles 
conjugated within nanogels or microgels, and also their promising potential in the field of 
biomedicine, this system has attracted increasing attention in recent years. In the following 
section we will briefly describe some of the most recent studies in this field.  
Deka et al. (Deka et al., 2010) developed a novel approach to incorporate both magnetic 
nanoparticles and oligonucleotide through the pH-responsive nanogels. They synthesized 
nanogels based on a copolymer of divinyl benzene (DVB) and vinyl pyridine (VP) via surfactant 
free emulsion polymerization. Then, the iron oxide nanoparticles (IONPs) were separately 
synthesized and wrapped into an amphiphilic polymer shell consisting of poly (maleic anhydride 
alt-1-tetradecene). Subsequently, these iron oxide nanoparticles were coated with diamino-PEG 
through EDC reaction in order to introduce better stability to the nanoparticles.  
Afterward, the PEG-coated iron oxide nanoparticles and oligonucleotide were both 
simultaneously loaded within the nanogels by mixing a specific concentration of both solutions 
for 24 hours with nanogels solution at pH=3.5, where the nanogels were swollen. When the pH 
was increased to pH=7, the nanogels collapsed, and the excess amounts of both iron oxide 
nanoparticles and oligonucleotide not incorporated within the nanogels were removed by the 
electro-magnets (Deka et al., 2010). As described in Figure 2.35 they were able to successfully 
entrap iron oxide and oligonucleotide within the pH-responsive nanogels. In this study, iron 
oxide nanoparticles were not covalently attached to the nanogels network, and they escaped from 
the nanogels network once the nanogels swelled due to changes in the pH. As shown in Figure 





switching the pH of the loaded nanogels solution from pH=7 to pH=3.5, where the nanogels 
were in swollen state (Deka et al., 2010).  
 
 
Figure 2.35 Schematic and TEM images of (a) general picture of loading of IONPs and oligonucleotide 
within nanogels at acidic pH where nanogels swell and then increased the pH so that nanogel deswell (b) 
IONPs and oligonucleotide in the nanogels solution (c) IONPs and oligonucleotide entrapped within 
nanogels at swelling state (d) removal of excess IONPs and oligonucleotide from the solution by magnet 














Figure 2.36 TEM image of the IONP and oligonucleotide release from the nanogels at pH=3.5, which 
induced swelling of the nanogels (Deka et al., 2010). 
In another study utilizing microgels as a carrier for drug, Bhattacharya et al. (Bhattacharya et al., 
2007) synthesized colloidally stable magnetic hybrid microgels, which are also sensitive to 
temperature and pH. These core-shell microgels consist of thermo-sensitive N-vinylcaprolactam 
(VCL)-rich shell, acetoacetoxyethyl methacrylate (AAEM)-rich core, and pH-responsive 
vinylimidazole (VIm) and were polymerized via batch copolymerization. Afterwards, up to 15 
wt% ferric oxide was incorporated into the microgels by co-precipitation of aqueous solution of 
FeCl3 and FeCl2 with NH4OH. From dynamic light scattering, they observed the reduction in 
microgel shell thickness and partial collapse of the microgel network, as a result of magnetic 
nanoparticles incorporation. Maximum swelling of microgels occured at pH=4, and was 
correlated to the complete ionization of VIm segments.  
In addition, the volume phase transition temperature of microgels was observed at 28 oC, 





responsive VIm segments. In other words, they confirmed that the VPTT can be shifted towards 
higher temperature by manipulating the amounts of VIm in the microgels or the pH of the 
system, and this effect is shown in Figure 2-37 (Bhattacharya et al., 2007).  
 
Figure 2.37 The effect of VIm content and pH on the volume phase-transition temperature of VCL-
AAEM-Vim microgels (Bhattacharya et al., 2007). 
They observed that low magnetic nanoparticles content was clearly noticeable inside the VCL-
rich core of the microgels; however, when high magnetite content was used, the microgels 
partially deformed and aggregation of magnetic nanoparticles occurred at the microgels shell. 
These microgels remained colloidally stable and are pH-responsive inspite of the incorporation 
of large amounts of magnetic nanoparticles into them. Nevertheless, the degree of swelling and 
consequently the hydrodynamic radius shifted to lower values for the magnetic microgels in 
contrast to bare microgels as shown in Figure 2.38. This phenomenon can be attributed to the 







Figure 2.38 Hydrodynamic radius of the hybrid maicrogels, and bare microgels at pH=4 and pH=7 
(Bhattacharya et al., 2007). 
As a result of the incorporation of iron oxide mostly onto the shell of the microgels, the 
electorphoretic measurements of hybrid microgels represented in Figure 2.39 signify a strong 
positive charge at low pH. In addition, due to the presence of magnetic nanoparticles, the 
electrophoretic mobility was significantly higher in comparison to bare microgels. In a basic 
environment, the microgels shell partially collapsed due to the deionization of VIm segments, 
and also the negative charges of the magnetic nanoparticles were effectively shielded by the 
polymer coating. Therefore, at pH 7-10, hybrid microgels demonstrated the same trend as bare 






Figure 2.39 Electrophoretic mobility of the hybrid microgels, bare microgels, and magnetic nanoparticles 
(Bhattacharya et al., 2007). 
Jaiswal et al. (Jaiswal et al., 2010) were able to successfully encapsulate iron oxide magnetic 
nanoparticles, which were synthesized by co-precipiaiton with a size of ~10 nm, into nano-
hydrogels matrix, with a size of ~200 nm. Nano-hydrogels consisting of poly (N-
isopropylacrylamide) (PNIPAAm)-chitosan were synthesized through free radical 
polymerization. Figure 2.40 shows the TEM images of the encapsulation of the magnetic iron 
oxide nanoparticles within the matrix of nano-hydrogels. Chitosan plays an important role in this 
system; it imparts biodegradability to the system, acts as cross-linking and surface active agents 
during polymerization. It controls the growth of the nano-hydrogels, and also improves the lower 
critical solution temperature (LCST) by increasing the weight ratio of chitosan to NIPAAm. 
Furthermore, they noted that the LCST of PNIPAAm increased from 32 to 42 oC, which is 
known as hyperthermia temperature, as a result of the encapsulation of iron oxide nanoparticles 





cancer, because the LCST could be shifted either through grafting chitosan or/and by 
encapsulating the magnetic nanoparticles (Jaiswal et al., 2010). The former was attributed to 
reduction in the mobility of water molecules as they were trapped in cross-linked nano-hydrogels 
matrix. On the other hand, the latter was suggested to be responsible for the dipole-dipole 
interactions, which inhibits the collapsed of the cross-linked polymer segments (Jaiswal et al., 
2010). They observed no significant changes in the size of magnetic nano-hydrogels, after the 
encapsulation of magnetic nanoparticles into nano-hydrogels matrix, in comparison to the nano-
hydrogels, before the encapsulation of the magnetic nanoparticles. As seen in Figure 2.41, by 
increasing the feed ratio of chitosan to PNIPAAm, the nano-hydrogels size decreased due to the 
adsorption of free positively charged chitosan onto the negatively charged PNIPAAm chain 
(Jaiswal et al., 2010).  
 
Figure 2.40 TEM Images (a) bare Fe3O4 magnetic nanoparticles, (b) nano-hydrogels particles, (c) MNP 






Figure 2.41 Determination of the LCST by transmittance as a function of the temperature at different 
compositions (a) illustrate shift in LCST as a result of MNP encapsulation, and (b) particle size and LCST 
of different nano-hydrogels compositions, by increasing the chitosan feed percentage from NHG-1 to 
NHG-6 (Jaiswal et al., 2010). 
Sun et al. (Sun HanWen et al., 2009) synthesized super-paramagnetic Fe3O4 nanogels via the co-
precipitation approach. As shown in Figure 2.42, the synthesized nanogels were stabilized by 
coating poly (ethylene glycol) methacrylate (PEGMA) as monomer and N, N'- methylene-bis-
(acrylamide) (MBA) as cross-linking agent onto the surface of the nanogels by photochemical 
polymerization under UV irradiation. In photochemical reaction, magnetic nanogels absorbed a 
majority of the photons due to a larger cross section area, in comparison to the monomer and the 
cross-linking agent (Sun HanWen et al., 2009). Therefore, valence band holes and conduction 
band electrons were formed on the surface of the magnetic nanoparticles. A high tendency of the 
valence band holes to absorb electron caused the formation of free radical formation in the 
PEGMA, which induced photochemical polymerization and grafting of PEGMA on the surface 








Figure 2.42 Schematic of photochemical polymerization of the magnetic nanoparticles by UV irradiation 
(Sun HanWen et al., 2009). 
Sun et al. (Sun HanWen et al., 2009) investigated the drug delivery application of these 
stabilized magnetic nanogels using the anti-cancer drug, doxorubicin. As illustrated in Figure 
2.43a, by increasing the quantity of doxorubicin into the coated-magnetic nanogels solution to 
130 μg, 110 μg was encapsulated by the nanogels. They concluded that the high drug-loading 
capacity was attributed to the grafted PEGMA chains, which provide looser internal structure for 
the nanogels. In addition, Figure 2.43b demonstrates the release profile of doxorubicin from the 
nanogels. Drug release reached a maximum value of 85.4% after 90 hrs through desorption and 






Figure 2.43 (a) Loading profiles of doxorubicin and (b) release profile of doxorubicinprofile from the 
magnetic nanogels (Sun HanWen et al., 2009). 
Lapointe et al. (Lapointe and Martel, 2009a) reported the synthesis of thermo-responsive 
hydrogels with embedded magnetic nanoparticles. The thermo-responsive hydrogels consist of 
PNIPAAm synthesized by free radical polymerization, which was then inpregnated by dextran-
coated Fe3O4 nanoparticles. Magnetic nanoparticles are able to produce heat when placed in an 
external magnetic field. This feature was applied in this system to provide the required heat for 
the actuation of the thermo-responsive hydrogels. They took advantage of thermo-responsive 
behavior of the hydrogels, in which a volume change of the hydrogels was induced when 







increasing the temperature beyond the LCST, the PNIPAAm hydrogels embedded with magnetic 
nanoparticles lost more than 90% of their mass over 6 hours. Whereas, when there was no 
embedded magnetic nanoparticles the volume lost was as high as 88% (Lapointe and Martel, 
2009a).  
 
Figure 2.44 The volume reduction of PNIPAAm hydrogels embedded with magnetic nanoparticles 
(Lapointe and Martel, 2009a). 
They (Lapointe and Martel, 2009a) also observed that hydrogels with embedded magnetic 
nanoparticles possessed a shorter stabilization (response) time of about 30 minutes, while 
hydrogels without magnetic nanoparticles stabilized in about 24 hours. This phenomenon was 
related to the fact that the internal structure and the surface characteristics of the hydrogels were 
altered as a consequence of embedding iron oxide nanoparticle into them, Moreover, as can be 
seen in Figure 2.45, by embedding magnetic nanoparticles into hydrogels the volume transition 
occurred at a higher temperature of 34 oC, compared to bare PNIPAAm hydrogels (Lapointe and 






Figure 2.45 (a) Mass loss rate for samples with and without embedded magnetic nanoparticles, and (b) 
Volume changes of the hydrogels embedded with magnetic nanoparticles occurred at 34o C (Lapointe and 
Martel, 2009a). 
Menager et al. (Menager et al., 2004) utilized a different approach to encapsulate magnetic 
nanoparticles in microgels. In this study, stable colloidal dispersion of magnetic particles was 
prepared by the co-precipitation technique. They used inverse emulsion and miniemulsion 
polymerization to incorporate iron oxide nanoparticles in the final microgels. In this process, the 
cross-linking agent and the hydrophilic acrylamide monomer were added to the magnetic fluid, 
which was colloidally stable, by adjusting the ionic strength and pH. These magnetic microgels 
were stable in water at pH=7 because of electrostatic repulsion induced by negative charge 







Figure 2.46 TEM images of magnetic microgels (a) without magnetic field (b) under magnetic field 
(Menager et al., 2004). 
These magnetic microgels exhibited fast and reversible response to a weak magnetic field, as 
illustrated in Figure 2.46. The synthesized magnetic nanoparticles swelled when placed in the 
right solvent, which is demonstrated in Figure 2.47. Because this reversible swelling was only 
induced by the diffusion of water and ions from the solution into the microgels through the 
porous medium of the microgels, there was no reported release of the magnetic content (Menager 









Figure 2.47 Optical micrographs of the swelling degree of magnetic microgels, (a) In dried state, (b) 0.7 
s, (c) 1.8 s, (d) 3.9 s, (e) 6.6 s, (f) 16 s after adding water (Menager et al., 2004). 
In another study, Lee et al. (Lee et al., 2010) synthesized magnetic nanoparticles via the co-
precipitation approach, and then conjugated them within pH-responsive microgels. Microgels 
were prepared using methacrylic acid (MAA), ethyl acrylate (EA) and di-allyl phthalate (DAP), 
which is the cross-linking agent. They developed these microgel iron oxide nanoparticles 
(MGIO) for the cell labeling applications. Due to the high MRI contrast of MGIO nanoparticles, 
which could be feasibly cellular tracked by MRI, great cellular uptake of these nanoparticles was 
observed.  They confirmed that MGIO nanoparticles were effective for labeling and detecting 









2.8 Magnetic Nanoparticles Applications 
Because of the biocompatible and magnetic properties, magnetic nanoparticles have been 
evaluated as novel cancer therapeutic agents.  The heat produced as a consequence of natural 
magnetic properties can be used to induce the release of a heat-sensitive probe or to destroy 
cancerous cells. Besides, magnetic nanoparticles have a great potential for use in the therapeutic 
treatment and can be exploited as magnetic resonance imaging (Berry, 2009; Gupta and Gupta, 
2005; Sun et al., 2008). The summary of magnetic nanoparticles applications is illustrated in 
Figure 2.48.  
 
Figure 2.48 Schematic of magnetic nanoparticles (MNP) applications, (a) through the Drug Delivery 
Systems (DDS) functionalized MNP build up in the tumor tissue, (b) as a diagnosis tool for cancer by 
magnetic resonance imaging (MRI) or for magnetoimpedance (MI) sensor, (c) as a hyperthermia 








2.8.1 Magnetic Resonance Imaging and Cell Labeling 
Due to its noninvasive character, and also ease of analysis, magnetic resonance imaging (MRI) is 
the most common technique for detecting and tracking magnetic nanoparticles. It is also a 
powerful imaging instrument in clinical medicine that provides high spatial resolution of contrast 
difference between tissues without ionized radiation (Berry, 2009; Veiseh et al., 2010). MRI is 
capable of detecting super-paramagnetic nanoparticles because of their magnetic susceptibility, 
which results in sturdy magnetic field distortions. MRI and other optical imaging devices have 
made feasible the in vivo tracking of magnetic nanoparticles uptake by tumor or cell (Gupta and 
Gupta, 2005). Furthermore, MRI accelerates the detection and separation of cells labeled with 
MRI-visible particles, such as iron oxide nanoparticles (Gupta and Gupta, 2005).  
Regarding the recent development in stem cell and progenitor cell based therapies; labeling 
cell and tracking the injected cells by MRI are anticipated to ultimately change the treatment of 
many fatal diseases (Thorek et al., 2006). The important factor in cell labeling is the loading of 
sufficient quantity of iron oxide into the cells. This can be achieved via two strategies. In the first 
method, the internalization efficiency increased by simply using higher concentration, and in the 
other technique, electrostatic interactions concept were employed by using different form of 
transfection agents (Thorek et al., 2006). Moreover, large particles can be introduced into the 
cells to make them detectable, as a substitute of introducing millions of particles into the cells. It 
was found that MRI could detect micro-sized iron oxide nanoparticles in vitro in agarose sample, 
in cultured cells and in mouse embryos. This technique provides cells with a capacity to 
accommodate approximately 100 pg of Fe (Chen et al., 2011; Chou et al., 2011). Cell labeling 





antigens and receptors is common for separating cancer and stem cells. The cell labeling 
approach is achieved through coating magnetic nanoparticles with antibodies or peptides, which 
are capable of binding to a desired surface receptor. Because of the magnetic properties of these 
nanoparticles, only cells that are labeled with magnetic nanoparticles should respond to an 
external magnetic field, and only those targeted cells can ultimately be collected for further 
investigation. For example, Yoon et al. (Yoon et al., 2006) incorporated CD10 antibody into 
silica-coated CoFe2O4 magnetic nanoparticles for the purpose of targeting leukemia cells. By 
means of TEM images and magnetic capture, they confirmed the binding and internalization of 
magnetic nanoparticles. In order to efficiently separate and distinguish cancer cells and stem 
cells, which are magnetically labeled, from multicellular fluids such as blood; a powerful 
quadruple magnetic flow-through device was developed recently (Chou et al., 2011; Lee et al., 
2010). Although the presence of magnetic nanoparticles can not be directly proved by magnetic-
based cell labeling technique, the qualitative information regarding the efficiency of labeling 
targeted cells can be provided by this approach. However, this technique can be utilized to 
separate rare cells in a multicellular environment for further investigation (Dias et al., 2011; 
Faraji et al., 2010; Laurent et al., 2008; Sun et al., 2008). 
 The parameters, such as magnetic nanoparticles diameter, targeting molecules size, magnetic 
nanoparticles distribution, and formulation widely influence the MR signal intensity, and 
detection of nanoparticles accumulation. As a result, predicting the sufficient amount of local 
nanoparticles concentration for MRI detection is complex. Considering magnetic nanoparticles 
for biomedicine applications, MRI is known as an important and powerful in vivo imaging 





2.8.2 Drug Delivery systems 
The most common application of magnetic nanoparticles is their utilization in the area of site-
specific drug delivery application, particularly in cancer treatment where serious side effects are 
caused by conventional chemotherapy and radiotherapy (Veiseh et al., 2010). Widespread 
pharmaceutical agents delivered by magnetic nanoparticles are chemotherapy drugs such as 
doxorubicin, methotrexate, and paclitaxel, which are hydrophobic drugs and due to the 
electrostatic interaction they can be physically or chemically conjugated with nanoparticles 
layers. They are concentrated to the area of interest by their modified targeting ability, where the 
drug will be released in a controlled manner. Consequently, through this technique significant 
reduction in the dosage of drugs occurs, which ultimately reduces the side effects (Sun et al., 
2008; Thorek et al., 2006; Veiseh et al., 2010). Parameters such as the size, charge, surface 
morphology, and surface chemistry of magnetic nanoparticles have major impact on both the 
blood circulation time and also bioavailability of the particles within the body (Berry, 2009; 
Gupta, 2005).  
By modifying the surface chemistry of iron oxide nanoparticles with different functional 
groups, drugs can be incorporated onto the surface of nanoparticles through mild chemistry 
and/or suitable cross-linking agents. For instance, Veiseh et al. (Veiseh et al., 2005) synthesized 
iron oxide nanoparticles via co-precipitation and then the surface was covalently coated with an 
amine terminated PEGylated saline; afterwards, an anticancer drug methotrexate (MTX) via 
EDC/NHS (N-hydroxysuccinimide) mediated coupling was loaded onto the surface synthesized 
magnetic nanoparticles. This study confirmed that loaded iron oxide nanoparticles with MTX 





technique can be extended to other drugs as well, but the major problem is the fact that some 
chemically active groups for coupling must be present for the conjugation of the drugs (Veiseh et 
al., 2005).   
Conversely, through physical absorption, the drugs can also be loaded into the iron oxide 
nanoparticles. This technique is more versatile compared to the chemically incorporated method, 
since many drugs do not have appropriate functional groups for coupling or they may loose their 
activity after coupling. Silica nanoparticles are favored for drug delivery, due to their porous 
structure. Piao et al. (Piao et al., 2008) through hydrolysis of FeCl3 in aqueous solution produced 
spindle-shaped akagenite (β-FeOOH) nanoparticles and subsequently performed a three-step 
process on these β-FeOOH nanoparticles, which was called wrap-bake-peel process. As 
illustrated in Figure 2.49, this process included the following steps: (1) silica coating, (2) heat 
treatment, and (3) silica removal by NaOH to achieve hollow iron oxide nanoparticles. As shown 
in Figure 2.49, depending on the process of silica removal, hematite or magnetite water-
dispersible nanoparticles can be obtained. Then the anticancer drug doxorubicin (DOX) was 






Figure 2.49 Schematic diagram of the formation of hollow iron oxide nanoparticles by wrap-bake-peel 
process (Piao et al., 2008). 
In another study, Park et al. (Park et al., 2007) synthesized iron oxide nanoparticles with PEG 
and lecithin layers, which were loaded with doxorubicin (DOX). They studied the drug effects on 
the nanoparticle by investigating loading efficiency and release kinetics of the doxorubicin from 
the layered coated nanoparticles both in vitro and in vivo. As shown in Figure 2.50, they 
observed that over 30 hours, 60% of the loaded doxorubicin was released from the DOX-PEG-






Figure 2.50 DOX released from each of the DOX loaded PEG-magnetic nanoparticles and lecithin 
magnetic nanoparticles over 150 hour (Park et al., 2007). 
Combining cellular targeting and MR contrast with the drug’s therapeutic effect is the main 
objective of using magnetic nanoparticle as drug carrier. The most fundamental drug delivery 
system is formed by applying these three concepts, and this drug carrier is able to target diseased 
cells, offer delivery therapy at the cellular level, and provide diagnostic information (Sun et al., 
2008). 
2.8.3 Gene Therapy  
In recent years, gene delivery has been a field of great interest and intense research. Analogous 
to drug delivery, plasmid DNA and small interfering RNA (siRNA) can be easily conjugated 
with nanoparticle layers. These incorporations occur generally as a result of electrostatic 





linear sequences can also lead to the incorporation of DNA and siRNA into the nanoparticles 
(Sun et al., 2008; Veiseh et al., 2010). The main obstacles in obtaining an efficient gene delivery 
system are lack of specificity in targeting, short in vivo half-life, and low permeability through 
cell membrane (Berry, 2009). Because of the fact that nanoparticles have to be delivered to the 
nucleus for the transfection of the plasmid DNA, the research in this area is also related to 
cellular and intracellular targeting approaches (Sun et al., 2008).  
Berry et al. (Berry, 2008) delivered plasmid DNA and green fluorescent protein (GFP) using 
the cell penetrating peptide (CPP), HIV virus derived TAT peptide, which transport the DNA 
into the nucleus. On the other hand, some research groups exploited a magnetofection method, in 
which magnetic properties of magnetic nanoparticles are used to physically deliver DNA-loaded 
magnetic nanoparticles into the cells through external magnetic field. In the magnetofection 
method, the magnetic nanoparticles were coated with the polycation polyethylenimine to make 
them positively charged in order to conjugate magnetic nanoparticles with negatively charged 
plasmid DNA (Gupta, 2005). Although each of the two approaches can be used separately to 
deliver or change genetic information, a combination of both bimolecular and magnetic targeting 
methods would be the ideal technique to effectively accomplish gene delivery in vivo.  
Moreover, iron oxide nanoparticles demonstrate great enzyme mimicry. They are able to 
catalyze reacting peroxidise substrate such as o-phenylenediamine (OPD), di-azo-aminobenzene 
(DAB), and 3, 3, 5, 5-tetramethylbenziidne (TMB) into their colourful oxidized states, because 
of the presence of H2O2 (Gao et al., 2007). In contrast to peroxides, which denature and lose their 
activity very rapidly in harsh environment such as high pH and temperature, iron oxide 





activity of iron oxide nanoparticles is 40-fold higher than that of peroxides. In addition, because 
of the magnetic properties of iron oxides, they can be easily separated and recovered; therefore, 
permitting recycling and repeated applications (Gao et al., 2007).  
2.8.4 Hyperthermia 
Local heating of cancer or tumour cells leading to necrosis is known as hyperthermia; in other 
words, instead of killing the cancerous cell with drugs, the targeted nanoparticles become hot 
under the magnetic field, and the heat generated would kill the diseased cell (Berry, 2009; 
Laurent et al., 2008). To reduce the adverse side effects, and the exposure of surrounding healthy 
cells to the hyperthermia treatment, the treatment should be restricted solely to the targeted cells; 
which is one of the major challenges with hyperthermia. Exploiting magnetic nanoparticles 
targeting of cancer cells is a promising approach to enhance localization of this treatment and 
overcome the challenge; since targeted magnetic nanoparticles are capable of accumulating at the 
desire site and subsequently be heated by the magnetic field during which the electromagnetic 
energy is converted to heat and raised the temperature of the targeted site (Berry, 2009; Piao et 
al., 2008).  Because of the susceptibility of tumour cells to high temperature in comparison to 
normal cells, hyperthermia is capable of specifically delivering magnetic nanoparticles to the 
tumour cell, and generates heat locally to damage them, without affecting the normal tissues 
(Dias et al., 2011).   
The heat progression rate defined as specific absorption rate (SAR) is an important parameter 
in hyperthermia. Factors such as size distribution, shape, surface functional groups, frequency, 





the value of SAR. Due to the high biocompatibility, sufficient SAR value of the iron oxide 
nanoparticles have been reported (Berry, 2009; Dias et al., 2011; Ito et al., 2005).  
Ito et al. (Ito et al., 2004) delivered magnetic nanoparticles-loaded immuneliposome to SkBr-3 
breast cancer cells and subsequently heated the cancerous cell up to 45 oC by high frequency 
magnetic field. Their investigation revealed a killing efficiency of greater than 90% for the 
targeted breast cancer cells. Although side effects such as inflammation and immune response in 
vivo are still present as a result of necrotic cellular death, hyperthermia treatment with magnetic 
nanoparticles demonstrates great influence on targeted cellular therapy for cancer (Ito et al., 
2004).      
2.9 Layer-by-Layer Coating 
The layer-by-layer coating approach involves the sequential adsorption of oppositely charged 
polyions onto the outer surface of particles that is permeable, stable and compatible, resulting in 
the reversal of the terminal surface charges after deposition of each layer; thus, allowing the 
controlled release of the encapsulated materials through these layers. The first report on 
sequential adsorption of oppositely charged colloids dated back to 1966 by Iler et al. (Antipov 
and Sukhorukov, 2004). Versatility, simplicity, control over structure, robustness, and low cost 
are the most significant advantages of layer-by-layer coating approach in preparing multilayered 
films that contributed to the popularity of this technique over the last two decade (Tang et al., 
2006). In other words, the availability of a wide variety of material that can be used as coatings, 
diversity of precursor and core materials, and versatility of coating techniques increased the 





In layer-by-layer coating by means of alternate adsorption of oppositely charged polyions, 
nanoparticles, and biomolecules, ultrathin layers can be formed. The produced layers acquire 
tuneable properties to their environment and also possess thickness in the nano- to micro- range 
(Wong and Richtering, 2008). The fundamental of this technique is the use of electrostatic 
attractions between oppositely charged polyelectrolytes; as a result, layers with controllable 
thickness, different compositions, functional groups, and morphologies are produced onto the 
surface (Burke and Barrett, 2004).  
Although electrostatic interaction play an important role in the formation of layer-by-layer 
coating film, hydrogen bonding, covalent bonding, charge transfer, biological recognition, and 
hydrophobic interaction could also contribute to the formation of layer-by-layer coatings. 
Therefore, in physiological conditions, the stability of layers was enhanced as a result of these 
multiple interactions in layer by layer coatings (Tang et al., 2006; Wong and Richtering, 2008). 
In this approach not only there is more control over the position and order of multiple layers, but 
also by altering the number of polyelectrolyte layers, the concentration of incorporated chemicals 
can be changed. Moreover, the coated layers are able to protect and retain the encapsulated 
materials from environmental hazards, and by changing the coating layers the solubility of the 
coated materials in different solvents can be manipulated. Another advantage of this method is 
the selective permeability for different materials. By manipulating the thickness, porosity, 
structure, and chemistry of the coating layers, the permeability of the coated component can be 
tuned (Tang et al., 2006; Wong and Richtering, 2008).  
As a result of great success of layer-by-layer coating on planar and rigid substrate, this 





nano- micro- gels. Consequently, interface characterized porous colloidal particles that are able 
to incorporate biomacromolecules within their network, due to their high surface-to-volume 
ratio, gain special attention as a depositing template for layer-by-layer surface engineering in 
order to achieve sustained and controlled release of the drug (Wong and Richtering, 2008). 
Application of layer-by-layer procedure in the field of drug delivery offer higher efficiency, 
lower toxicity, and enhanced patient convenience in comparison to conventional techniques 
(Tang et al., 2006). Layer-by-layer coating has illustrated wide perspective for encapsulating, 
and controlling the delivery of drugs. The controlled release of incorporated drug from the layer-
by-layer coated material depend on the permeability or breakdown of the multilayer structure, 
and can further be extended by employing the polyelectrolytes possessing semi permeable 
properties (Tang et al., 2006). For example, for polyelectrolyte layers formed by electrostatic 
interaction, pH is a dominant driving force for structural alteration. By placing coated component 
in a medium with a pH close to the pKa of one of the polyelectrolytes, the charge density of that 
polyelectrolyte is decreased. Consequently, the intermolecular binding of the multilayers are 
loosen due to the repulsive forces between polyelectrolytes of similar charges. These repulsive 
forces are no longer compensated by the attraction forces of the oppositely charged 
polyelectrolytes. This phenomenon leads to permeabilization and decomposition of the 
polyelectrolyte layers and ultimately the release of incorporated components (De Geest et al., 
2009).  
In order to form functionalized particles, magnetic nanoparticles have potential to utilize the 
layer by layer approach to accomplish both “localizing” of encapsulated drugs to a desired site 
followed by “switching” to release the encapsulated materials (Tang et al., 2006). 





or synthetic, which can further be categorized as fully or partially charged, and into strong or 
weak interactions. In weak polyelectrolytes, the charges are manipulated by pH. Furthermore, 
natural polyelectrolytes including natural polypeptides or polysaccharides have the advantage of 
forming diverse configuration due to the folding and unfolding of the chains (Wong and 
Richtering, 2008). The polyions that predominately employed in the layer-by-layer coating are 
(Tang et al., 2006; Wong and Richtering, 2008): 
• Polyanions: poly (sodium 4-styrenesulfonate) (PSS), poly (acrylic acid) (PAA), poly 
(vinyl sulfate) (PVS), sodium alginate (SA), sodium carboxylmethyl cellulose (CMC), 
chondroitin sulfate sodium salt (CS),deoxyribonucleic acid (DNA), dextran sulfate 
sodium salt (DS), tannic acid (TA), and gelatin B (GB). 
• Polycations: chitosan (CH), poly (allylamine hydrochloride) (PAH), poly 
(dimethyldiallylammonium chloride) (PDDA), poly (ethylenimine) (PEI), gelatin A 
(GA), poly-L-lysine (PLL), and protamine sulfate C (PS). 
The layer-by-layer approach is a very simple and versatile process, a standard approach for 
coating formation on both a solid planar and nano/micro gels illustrated in Figure 2.51a and 
describe below (De Geest et al., 2006; Tang et al., 2006): 
• Aqueous solution of polyelectrolyte, nanoparticles, or proteins is prepared and the pH is 
adjusted in such a way that the components are oppositely charges. 
• A solution of nanogels or a planar substrate possessing a surface charge for layer-by-layer 
deposition is prepared. 
• Alternately polyelectrolyte solution is added to the nanogel solution or alternately the 





reversion. For instance, immersing a negatively charged substrate in a positively charged 
polyelectrolyte solution leading to net charge reversal to positive due to the adsorption of 
positively charged polyelectrolyte. Then, by further immersion in a negatively charged 
polyelectrolyte a charge reversal to overall negative will occur. 
•  Subsequently after each immersion into polyelectrolyte solution or addition of 
polyelectrolyte solution, the coated planar substrate is rinsed with distilled de-ionized 
water or in case of coated nanogels they can either be filtered or centrifuged; in order to 
remove excess or unbound polyelectrolyte chains. The water should carry a pH that 
reserved the respective coated components (Antipov and Sukhorukov, 2004). 
• Previous steps can be repeated until all the desired layers have been deposited, and 
multilayered coated substrate or nanogels are obtained with desirable structure and 
thickness. 
The surface charge reversal upon deposition of layers is the only crucial factor that should be 
taken into account for successful deposition; which can be obtained by proper selection of 
deposition conditions. Afterwards, by means of electrostatic interactions a variety of 
polyelectrolyte materials could be adsorbed onto the surface of substrate, forming layered 
structure with specific properties (Antipov and Sukhorukov, 2004). Moreover, by using different 
materials such as organic or inorganic nanoparticles, biomolecules, lipids, or viruses in the 
coating process, various shapes of multilayer coating can be produced. Properties such as 
mechanical strength, elasticity, electrical characteristics, and other properties make polymers as 
suitable building blocks for the formation of layer-by-layer coating in contrast to their low-





technique was used to develop coating onto the magnetic nanogels to better control the burst 
release of the drug from the nanogels network.  
 
 
Figure 2.51 Schematic of layer-by-layer coating on (a) planar substrate (b) nanogels. Polyelectrolyte is 
added into a system adsorb onto the template surface inducing the surface charge reversal. Then, the 
excess or loosely adsorbed polyelectrolyte is removed by washing of planar substrate or centrifugation or 
filtration of nanogels; afterwards, oppositely charged polyelectrolyte is added. The desired number of 
layer is added by repeating this circle (De Geest et al., 2009; Tang et al., 2006). 
One of the first studies on the layer-by-layer coating on the colloidal particles was conducted 
by Sukhorukov et al. in 1998 (Sukhorukov et al., 1998). They investigated this technique on the 
charged polystyrene latex particles by alternate deposition of PSS/DNA as polyanion and 
PAH/PDADMAC as polycation and subsequent centrifugation. The formation of the layers was 







polyelectrolyte layer was at or above saturation, a reversal of the electrophoretic mobility 
occurred, which confirmed the deposition of the charged layer. Furthermore, they concluded that 
centrifugation between each consecutive adsorption was required in order to prevent the 
aggregation of large numbers of particles, although centrifugation had some disadvantages such 
as reduction of particle number, which made deposition difficult (Sukhorukov et al., 1998).    
In a recent study, Diez-Pascual et al. (Diez-Pascual and Wong, 2010) performed layer-by-layer 
assembly of polysaccharides and polypeptides onto negatively charged Poly (NIPAM-co-MAA) 
microgels. Poly (L-lysine) bromide salt (PLL) and chitosan were used as polycation and 
poly(glutamic acid) sodium salt and dextran sulfate were employed as polyanion in this research 
followed by three ultracentrifugation cycle after each deposition up to 12 polyelectrolyte layers. 
They observed, as depicted in Figure 2.52, that microgels retained their thermo-responsive 
behavior upon coating with different layers of polyelectrolyte. For example, the uncoated 
microgels possessed a hydrodynamic radius of 330 nm at 20 oC, and then exhibited the Rh of 180 
nm upon heating to around 32-33 oC. This was due to a volume phase transition of the 
PNIAPAM chain. During cooling, the microgels returned to their original size (Diez-Pascual and 
Wong, 2010). On the other hand, the coated microgels demonstrated the same trend upon 
heating, which indicated the preservation of the thermo-responsive nature of the microgels. 
Moreover, they noticed that by depositing polycation layer, the Rh decreased remarkably, while 
by adsorbing polyanion layer the Rh increased again. The former phenomena contributed to the 
collapse of the microgels as a result of electrostatic attraction between negatively charged 
microgels and the first positive PLL or chitosan layer. The latter one was related to the fact that 





microgels and the new absorbed polyelectrolyte, which further weakened the attraction between 
the microgels and the polycation and caused the Rh to increase (Diez-Pascual and Wong, 2010).   
 
Figure 2.52 Hydrodynamic radius (Rh) vs. temperature for different layers of (a) microgels with 
PLL/PGA, and (b) microgels with chitosan/dexstran (Diez-Pascual and Wong, 2010). 
They (Diez-Pascual and Wong, 2010) observed that in the swollen state, both polysaccharide 
and polypeptide coating demonstrated the same Rh profile, increment and reduction in Rh as a 
result of absorbing negatively and positively charged layers, respectively. However, in the 
collapsed state, this effect was only seen for polysaccharide coating microgels. As can be seen in 
Figure 2.53, the net surface charge of the microgel became positive and negative upon adsorbing 
polycation and polyanion, correspondingly (Diez-Pascual and Wong, 2010).  
Although chitosan adsorption demonstrated higher charge reversal in comparison to PLL, 
which was attributed to higher number of functional groups and also charge density when 
chitosan presented, the overall trend for both polysaccharide and polypeptide was similar. 
Furthermore, this group confirmed that by increasing the number of layers onto the microgel the 






explained as a result of the soft and porous structures of the microgels, which promote diffusion 
of the polyelectrolytes into and out of the microgels, causing neutralization of the accessible 
charges (Diez-Pascual and Wong, 2010).  
 
Figure 2.53 Plots of electrophoretic mobility vs. the number of layers deposited onto the (a) microgels 
with (PLL/PGA), and (b) microgels with (chitosan/dextran) (Diez-Pascual and Wong, 2010). 
Nolan et al. (Nolan et al., 2005a) studied the influence of temperature and film thickness on 
the controlled pulsatile release of insulin from microgel thin films, consisting of poly (N-
isopropylacrylamide-co-acrylic acid), which were constructed by layer-by-layer assembly 
technique. The presence of NIPAM induced a temperature responsive behavior, whereas acrylic 
acid caused a pH sensitivity of the system. This group took advantage of the pH sensitivity and 
swelling of the system at high pH condition to load insulin into the microgels. The layer-by-layer 
assembly preformed by deposition of PAH as polycation and the insulin incorporated microgels 
at pH=7.4 was served as negatively charged layer. Figure 2.54 illustrates that they were able to 








Figure 2.54 Successful formation of insulin loaded microgel thin film up to 30-layer film. (a) By 
increasing layer number, film absorbance is increased, and (b) film absorbance vs. layer number (Nolan et 
al., 2005a). 
 
Figure 2.55 The influence of number of layers (3- 6- 9- layers) on the release of the insulin from 
microgels thin film. The more the layers, the longer time insulin can retain within the microgels (Nolan et 
al., 2005a). 
They (Nolan et al., 2005a) observed that by increasing the number of layer and subsequently 
enhancing the film thickness, the released of the insulin can be extended to the longer period of 






layer film reached a plateau. Whereas, the 6- and the 9- layer film yet showed an upward slope. 
Therefore, there was strong connection between the number of film layer, thickness of the film, 
and insulin release (Nolan et al., 2005a). 
Xu et al. (Xu et al., 2010) prepared super-paramagnetic mesoporous silica coated Fe3O4 
nanoparticles. Afterwards, the synthesized nanoparticles were loaded with chemotherapeutic 
agent (PM-19) and then alternately coated with total of 10 layers of PAH and PSS, respectively. 
Once the net surface charge of the magnetic nanoparticles is negative at pH 2-3, which was 
above its isoelectric point, the PAH was deposited onto the nanoparticles, and subsequently 
negative PSS was deposited onto the positively charged nanoparticles. This process is 
schematically demonstrated in Figure 1.56.  
 
Figure 2.56 Schematic of drug loading, coating, and drug release as a result of decreasing the pH from 





Xu et al. (Xu et al., 2010) studied the effect of layer-by-layer coating on the release profile of 
PM-19, as depicted in Figure 2.57. They observed that both the coated and uncoated 
nanoparticles could release about 70% of the loaded drug at pH=1.4 over 48 hours; whereas, at 
high pH, such as pH=8, the coated and uncoated nanoparticles demonstrated different patterns, 
where the release was 23% and 97%, respectively. These results confirmed that the release of 
drug depended mainly on the polyelectrolyte multilayers (Xu et al., 2010). Because the release of 
the drug from uncoated magnetic nanoparticles were not affected by pH; whereas, the coated 
nanoparticles showed pH-control behavior, for example, at pH=1.4 the polyelectrolyte 
multilayers of the coated nanoparticles swelled, causing more release of the drug and at pH=8 
polyelectrolyte multilayers were contracted and restricted the release of the drug (Xu et al., 
2010). 
 
Figure 2.57 Drug release profile in (  ) pH 8, (  ) pH=1.4 from non-coated magnetic nanoparticles, 





De Geest et al. (De Geest et al., 2006) introduced a novel class of biodegradable microgels 
surrounded by polyelectrolyte membrane through layer-by-layer technique, and these microgels 
were capable of releasing the encapsulated drug without applying any external trigger. The 
rupture of the microgels occurred, when the swelling pressure of the microgels exceed a critical 
value upon degradation of the microgels; degradation was due to the hydrolysis of the cross-links 
and the reduction in the cross-link density. They (De Geest et al., 2006) synthesized cross-linked 
dextran-hydroxyethyl methacrylate microgels, which possessed positive or negative charges 
through linking MAA or DMAEMA to the dextran backbone, respectively. Afterwards, six 
layers of PSS as polyanion and PAH as polycation were consecutively deposited, by 
centrifugation technique onto the synthesized microgels, as depicted in Figure 2.58a. The zeta-
potential measurements confirmed the incorporation of both MAA and DMAEMA charged 
groups, and also the PSS and PAH layers onto the microgels, as can be seen in Figure 2.58b. In 
the case of MAA and PSS, negative zeta-potential was observed, while in case of DMAEMA 
and PAH, positive zeta-potential was measured, which were in agreement with the expected 
values. Besides, it was proven that the coating could also be performed on neutral microgels, and 
the driving force, which were hydrophobic interactions and physical entanglements, were strong 






Figure 2.58 Zeta-potential vs. the layer number, during the layer-by-layer coating of (a) positively and 
negatively charged microgels, and (b) neutral microgels (n=5) (De Geest et al., 2006). 
By means of confocal microscopy, they (De Geest et al., 2006) concluded that only the 
oppositely charged polyelectrolytes were able to migrate into the microgels during the layer-by-
layer coating. They also illustrated that the microgels wall was pH-dependent, and it was more 
permeable at pH=7 than at pH=9. Moreover, by increasing the number of polyelectrolyte layers 
the microgels became more impermeable at pH=7, as well as more mechanically stable. As can 
be seen in Figure 2.59, a burst release of the encapsulated material from uncoated microgels did 
not occur when microgels were coated; in other words, the coated microgels demonstrated 
slower release profile in comparison to the uncoated microgels and the majority of the release in 
the coated microgel occurred in a few hours, which further confirmed the pulsatile release of the 
encapsulated material in this case (De Geest et al., 2006). Figure 2.60 describes the process of 
layer-by-layer coating the microgels, and ruptured of the layer aonce the swelling pressure 
reached the critical value, the point in which cross-linked could no longer hold the microgels 







Figure 2.59 Release of the encapsulated material from (open circle) uncoated microgels, (closed circle) 
coated positively charged microgels (De Geest et al., 2006). 
 
 
Figure 2.60 Schematic of the sequential adsorption of oppositely charged polyelectrolytes onto the 
degradable microgels. Degradation occurred by hydrolysis of the cross-links and reduction in cross-links 
density. Layers ruptured when the swelling pressure of the microgels reached a critical value (De Geest et 









3.1 Laser Light Scattering 
The incident light is scattered in all directions by each illuminated particle, when a coherent light 
is focused on a dilute colloidal solution, where the solvent molecules and colloidal particles have 
different refractive indices. The scattered lights from different particles are captured in a 
photomultiplier tube, and generate a net scattering intensity I(t) or photon counts n(t). Ideally, 
under condition that all the particles are stationary, the scattered light intensity in each direction 
is independent of time and would be constant (Chu, 1970). Conversely, in reality, all the particles 
are under Brownian motion, which leads to instability of the intensity pattern on the detection 
plane and if the detection area is sufficiently small it causes fluctuation in I(t). The fluctuation 
rate depends on different relaxation process, such as translational diffusion, rotational diffusion 
and internal motion of the particles. The faster the relaxation is, the faster the fluctuation is going 
to be. In general, laser light scattering (LLS) could be classified as follow (Chu, 1970): 
1. Inelastic light scattering: raman, fluorescence and phosphorescence, 
2. Elastic light scattering: no absorption. 
However, in the field of polymers and colloids, light scattering is usually referred to as static 
light scattering (elastic) and dynamic (quasi-elastic) light scattering measurements. Static light 





analytical technique that has been widely applied to characterize both synthetic and natural 
macromolecules (Chu, 1970). The static light scattering determines the parameters, such as 
molar mass or weight-average (Mw), second virial coefficient (A2), z-average radius of gyration 
or RMS radius (Rg), and particles structure. Dynamic light scattering (DLS) measures the 
intensity fluctuation over a very short period of time (μs). The reason why dynamic light 
scattering is also named quasi-elastic is as follows. Because of the Doppler Effect the detected 
frequency of the incident light that scatters from moving particles will be slightly higher or lower 
than the detected frequency of the original incident light, depending on whether the particles 
move towards or away from the detector (HUGLIN, 1977). Therefore, the frequency distribution 
of the scattered light is slightly broader that the incident light. The frequency augmentation (~ 
105- 107 Hz) is so small in contrast to the incident light frequency (~ 1015 Hz) that it is very 
difficult to detect it in the frequency domain. Accordingly, dynamic light scattering is sometimes 
referring to as photon correlation spectroscopy (PCS) (HUGLIN, 1977). From dynamic light 
scattering, parameters such as translation diffusion coefficient (DT) hydrodynamic radius or 
stokes radius (Rh), polydispersity, and particles size distribution can be obtained.  
In summary, dynamic light scattering collects the fluctuation in the scattered intensity and 
applied them to determine the autocorrelation function. Then, from the decay of the 
autocorrelation function the diffusion coefficient is measured. Light scattering measurements 
were analyzed by the Stokes-Einstein Equation to obtain hydrodynamic radius (𝑅ℎ): 









𝑘𝐵 : Boltzmann’s constant,  
T: Absolute temperature,  
η: Viscosity of the continuous phase, 
𝐷𝑇: Diffusion coefficient for the colloid, 
3.2 Isothermal Titration Calorimetry 
Isothermal titration calorimetry (ITC) is an appropriate instrument to study the thermodynamic 
properties of colloidal systems such as: enthalpy (ΔH), entropy (ΔS), heat capacity (Cp), and 
Gibbs free energy (ΔG). The schematic diagram of ITC is shown in Figure 3.1. ITC consists of 3 
major components: sample cell, syringe, and reference cell. The sample cell is filled with the 
sample solution, while the syringe containing a titrant (ligand) that is injected over a specific 








Figure 3.1 Schematic diagram of Isothermal Calorimetry (ITC). 
(http://www.med.yale.edu/wmkeck/biophysics/VP_ITC_MANUAL_11_20_02a.pdf) 
ITC measures the heat exchange between two systems when specific amount of reactants are 
added. In other words, ITC measures the temperature difference between the sample and 
reference cell and converts it into units of power known as the differential power (DP). This 
power is needed to maintain the reference and sample cell at the same temperature by 
exchanging the heat between them which is associated to either an exothermic or endothermic 
process The former one occur when the sample cell is hotter than the reference cell and this 
causes the DP to deflect in the negative direction, while the latter deflects the DP in the positive 
direction as a result of hotter reference cell compare to sample cell. The degree of binding and 





proportional to the amount of heat that causes the exothermic or endothermic process. The ΔH of 
interactions can be calculated by integrating the DP peaks with respect to time. 
3.3 Differential Scanning Calorimetry  
Differential scanning calorimetry (DSC) is a precise instrument to study thermal transition of 
colloidal systems. Like ITC, DSC consists of a sample and reference cell. The temperature 
difference between sample and reference cells, during heating or cooling of the sample cell at the 
constant heating or cooling rate, is measured and correlated into the units of power known as 
differential power (DP). The exothermic reaction occurs when the sample cell is hotter that the 
reference cell and this causes the DP to deflect in the negative direction, likewise, the 
endothermic reaction deflects the DP in the positive direction as a result of hotter reference cell 
compare to sample cell. 
3.4 Zeta-Potential Analyzer 
Zeta potential analyzer is an instrument that measures the electrophoretic mobility and zeta 
potential of the colloidal system to verify colloidal stability and ensure that the ionic functional 
groups were incorporated into the nanogel during copolymerization. Electrophoresis is defined as 
the motion of charged colloidal particle towards the oppositely charged electrode when subjected 





 𝜇𝑒: Electrophoresis mobility,  





𝜂: Solution viscosity 
r: Particle radius 
As illustrated in Figure 3.2, by dispersing colloidal particles into a solution, an electrical double 
layer formed around the particle between the charged particle and the solution medium, as a 
result of the presence of counter ions. The inner layer associated to the particle that contains 
counter ion is known as the Stern layer, while the outer layer contains mobile ions and is known 
as diffuse layer. The loss of counterions from the diffuse layer induces a charge at the slipping 
plane. Zeta potential is a potential difference at the slipping plane when a voltage is applied to 
the colloidal solution. In this experiment a Laser Doppler Eelctrophoresis (LDE) is used to track 
the movement of charged particles. When light is scattered form a moving particle, its frequency 
is shifted depending on the velocity and direction of the movement. The velocity at which the 
charged colloidal particle moves toward the oppositely charged electrode is proportional to the 
zeta potential.  
Since colloidal systems, especially nanogels, have a large ratio of surface area to volume the 
electrical double layer is more apparent in these systems. The zeta potential value of -30 to 30 
mV means that the system is electrically unstable and may lead to aggregation. On the other 
hand, zeta potential greater than -30, +30 is considered as stable system. The higher the zeta 






Figure 3.2 Schematic diagram of zeta potential and electrical double layer 
(http://www.malvern.com/LabEng/technology/zeta_potential/zeta_potential_LDE.htm). 
Zeta-potential may be calculated from the following equation using either the Huckel or 





𝜂: Solution viscosity 
𝜇𝑒: Electrophoresis mobility 
𝜀: Sample dielectric constant 





3.5 Potentiometric and Conductometric Titration 
Potentiometric and conductometric titrations were performed to provide further insight into the 
ionization and neutralization degree of nanogels; besides, the exact acid and base composition of 
nanogels can be determined. Simultaneous measurements of pH and conductivity were 
performed using a Metrohm 809 Titrando autotitrator. All experiments were conducted in a 
closed jacked vessel, where the temperature was maintained at 25 oC under continuous stirring. 
By gradually titrating acid or base into the system, the pH can shift from a range of 2-11. From 
the pH and conductivity curves the actual mole percent of monomer segments used during the 
course of polymerization can be calculated based on the method developed by Homola and 
James (Homola and James, 1977). 
3.6 High-Gradient Magnetic Separation  
High-gradient magnetic separator (HGMS) recovers and separates the magnetic nanoparticles as 
a result of their unique magnetic properties. This instrument possesses a column filled with 
magnetically prone wires, fine-grade stainless steel wool; and placed between the poles of the 
electromagnets. During the process, the magnetic field is set at 2 T (Sondjaja et al., 2009). Figure 







Figure 3.3 Schematic describing the HGMS. The magnetic fluid after sonication (a) is passed through the 
column while the electromagnet is on, (b) immediate collection of non-magnetic particles, then water 
passed through the column with turn on electromagnet, which washed-out non-magnetic particles, (c) the 
non-magnetic particles are collected, and washing continues until the effluent is clear like in (d), and (e) 
the electromagnet is turned off and by introducing water the captured magnetic nanoparticles are collected 
(Sondjaja et al., 2009). 
The role of the wires is to generate a strong field gradient, which is required for capturing the 
magnetic nanoparticles, around the wire surface by dehomogenizing the applied magnetic field. 
The force applied on magnetic nanoparticles from this instrument not only depends on the 
gradient of the magnetic field but also depends on the size of the particles. This relationship can 
be seen according to the following equation (Ditsch et al., 2005): 
𝐹 =  −𝜇0𝑉 𝑀 𝛻 𝑯 
Where, V is the volume of the magnetic nanoparticles, and M is the magnetization of the 
magnetic nanoparticles in the given magnetic field, H. It has been confirmed theoretically and 





experimentally that small individual magnetic nanoparticles can overcome the magnetic 
attraction forces to the wires, due to diffusional and drag forces (Ditsch et al., 2005; Sondjaja et 
al., 2009). Therefore, the capture of individual magnetic nanoparticles cannot effectively occur 
through high gradient magnetic separation; however, small cluster of magnetic nanoparticles, 
larger than 50 nm, can be efficientlycaptured by a high gradient magnetic separation process 








Drug Selective Membrane Electrode 
   
4.1 Experimental Setup 
A PrHy selective membrane electrode was used as a drug selective electrode to measure the 
PrHy concentration by measuring the electromotive force relative to an Ag/AgCl reference 
electrode. The experimental setup used in this study consisted of a 4-channel ion analyzer, a 
reference electrode, the ion selective electrode, an electrode cap, and drug selective membrane. 
As illustrated in Figure 4.1, the 4-channel ion analyzer completes the circuit, along with the 
reference electrode and the ion selective electrode. The ion selective electrode and a membrane 
cap were both handmade at the University of Waterloo machine shop, as will be discussed later 
in this chapter. The material used for membrane can be either polyvinyl chloride or Teflon. On 
the tip of the membrane cap, an ion selective membrane is attached. The solution inside of the 
membrane cap is 10-3 M procaine hydrochloride (PrHy) in a 10-2 M NaCl solution. This cap 
completes the electrochemical cell, which is made up of two solutions with the same active ion 
(in this case PrHy) and a salt bridge. 
The reference electrode is also based on a silver chloride (AgCl) construction. It is made up of 
an inner wire coated with AgCl, as well as inner and outer filling solutions, shown in Figure 4.1. 
The filling solution is usually saturated potassium chloride (KCl) or sodium chloride (NaCl). 





and it minimizes the effect of evaporation, purchased from Research Solution & Resources LLC. 
When working with ion selective electrodes, the ion selective membrane takes the place of the 
salt bridge, and is selective only to the target drug. As a result, it forms the basis for the entire 
experiment, since a potential difference builds up across the membrane. 
 
Figure 4.1 Schematic diagram of ion-selective electrode setup. 
(http://www.chemistry.nmsu.edu/Instrumentation/IS_Electrod.html) 
4.2 Background Reviews 
Drug-selective electrodes are the subdivision of ion-selective electrodes, which are 
electrochemical sensors that are capable of potentiometric determination of the activity of 
specific ions in the presence of other ions. They become one of the most important and simple 
techniques for fast, precise, and low cost analysis. The main progress in the history of ion-





Arrhenius in 1887, Nernst in 1888-1889, Oswald and Planck in 1890 proposed many concepts 
such as diffusion potential, potential difference, and ion mobility through their relevant studies 
on the properties of semi-permeable membrane, thermodynamic relationships for membrane 
equilibrium, and the theory of electrolyte solutions. The achievement of all these early works 
was the birth of membrane electrochemistry (Rong, 2001).  
Ion-selective electrodes can be categorized based on the nature of the basic membrane 
material. The crucial criterion is that the membrane remains as immiscible as possible with 
respect to the bathing solution and solid contacts. Therefore, ion-selective electrodes can be 
classified into four major groups (Vytras, 1989): 
• Solid-state membrane electrode 
• Liquid (plastic) ion-selective electrodes 
• Glass membrane electrodes 
• Electrodes with proper additional membrane 
The most common type of ion-selective electrodes is the pH electrode. It utilizes a hydrogen 
ion H+ selective glass electrode, which only allows H+ ions to pass through, to record the H+ 
according to the electromotive force (EMF). When the pH electrode is immersed in H+ ions 
containing the solution, the external ions will diffuse through the membrane until equilibrium is 
reached between the external and internal concentration. The number of hydrogen ions in the 
bulk solution is proportional to a buildup of charge inside the membrane.   
Ion-selective electrode responds selectively to the activity of ions in solution rather than their 





relationship between the activity and concentration can be fixed through adding a constant 
concentration of an inert electrolyte to the samples in order to swamp out minor variations in the 
sample concentration. The ion-selective electrode should perfectly respond according to the 
Nernst equation (Rong, 2001): 




∆𝐸𝑜 : The standard potential of the cell containing an i-selective electrode and an ion i 
𝑎𝑖 : The activity of ion i  
z : The charge number of i,  
R : Tthe universal gas constant (8.314) in J𝑚𝑜𝑙−1𝐾−1 
T : The temperature in K  
F : The Faraday constant (96485) in C𝑚𝑜𝑙−1 
The sign (±): When i is a cation, the sign is taken as positive and when it is anion the sign is 
taken as negative.   
The drug selective electrode consists of four major parts:  
1) Electrode body,  
2) Inner reference electrode Ag/AgBr 
3) Tip or end cap 





The silver bromide is used to coat the inner reference electrode, Ag/AgBr by electrolysis. In this 
process the silver rod was immersed in a 100 ml of 1 M NaBr solution for 20 minutes, in which 
the silver rod acts as anode and Pt electrode acts as the cathode. Although most of the 
pharmacopoeias illustrate precise techniques for analytical control, many of them are lengthy and 
difficult (Stefan et al., 1996). The development of membrane electrode over the past decade 
offers interesting advantages such as simple operation, fast response, reasonable selectivity, low 
cost, low detection limit, wide linear concentration range, excellent accuracy, applicability to 
color, turbid solution, and possible interfacing with automated and computerized system (Al 
Attas, 2009b; Alizadeh and Mehdipour, 2002; Frag et al., 2010; Morf et al., 2007; Shahrokhian 
et al., 2002; Stefan et al., 1996; Zayed et al., 2006). In addition, these electrodes can be easily 
fabricated in a variety of shapes and sizes, and they are less affected by the response of 
biological substrates, such as proteins, enzymes, and antibodies (Alizadeh and Mehdipour, 
2002).   
There are some disadvantages associated with electrode membrane including extensive pre-
conditioning treatment, care in storage, ionic strength of the solution sensitivity to some 
hydrophobic counter-ions, and relatively short life-time (Alizadeh and Mehdipour, 2002; Frag et 
al., 2010). The formation ability of drug ions with the ion exchanger determines the 
potentiometric performance of the electrode. Primary amines, among other form of amines, 
usually present the slightest affinity to form such ion-associates causing poor response (Katsu et 
al., 1999). 
The drug selective membrane were mostly fabricated from a liquid plasticized poly (vinyl-





exchanger (Alizadeh and Mehdipour, 2002; Frag et al., 2010).  In other words, these electrodes 
can be made by conjugating any of the ion-exchangers or neutral-sequestering agents within a 
liquid plasticized PVC matrix, and they can be employed as a very practical tool for clinical, 
chemical, environmental analyses (Al Attas, 2009b). Applying modified PVC consisting of ionic 
end groups as ion exchange sites along with a plasticizer, gradually resolved many of the 
disadvantages and problems associated with the electrode membrane. The modified PVC 
prevents the dissolution of the ion-exchanger and the plasticizer yields membrane with a longer 
life-time (Alizadeh and Mehdipour, 2002).  
In the current study, drug selective electrode consisting of procaine hydrochloride (PrHy) 
membrane was used to selectively determine the drug release from different nanogels. Drug 
release is commonly studied by many different analytical techniques including high performance 
liquid chromatography (HPLC), capillary zone electrophoresis, and UV-spectrometry.  
In addition, most of these techniques require sophisticated instruments, and they involve time-
consuming procedures, and also they cannot be automated (Al Attas, 2009b; Alizadeh and 
Mehdipour, 2002; Frag et al., 2010). Moreover, in all of these techniques, a dialysis membrane 
or centrifugal machine is needed to isolate the nanogels or nanoparticles from free drugs before 
the measurements are conducted. Both dialysis and centrifugation methods will affect the 
determination of free drug concentration, in the former released drugs may be absorbed onto the 
dialysis membrane surface, as the dialysis membrane acts as a diffusion barrier that restricts the 
accurate measurement of drugs release into the solution. Thus, the drug release profile measured 
the diffusion of drugs from the dialysis membrane rather than the diffusion of drugs from the 





from the carrier (Tan et al., 2007). In UV spectrophotometry, the results could not be obtained in 
real time and also a limited number of data points can be acquired. With the ion-selective 
electrode method, electromotive force readings can be recorded during the course of actual drug 
release study (as frequently as every 2 seconds). In addition, the concentration of the released 
drug can be directly measured, without requiring any intermediate steps such as the use of 
dialysis membrane or centrifugation. 
Selectivity and qualified response for the primary and specific ion over other interfering ions 
in the solution is the major characteristic of a drug selective membrane electrode. The effects of 
inorganic cations like Na+, K+, Ca2+, and Mg2+, on the drug selective electrode was examined by 
several research groups. Alizadeh and Mehdipour (Alizadeh and Mehdipour, 2002) used the 
Mixed Solution Method (MSM), while Frag et al. and Katsu et al. employed Separate Solution 
Method (SSM) (Al Attas, 2009a; Frag et al., 2010; Katsu et al., 1999) to determine the selectivity 
coefficients (Kij) according to  the Nikolsky equation (Alizadeh and Mehdipour, 2002; Frag et 
al., 2010; Katsu et al., 1999): 
𝐾𝑖𝑗𝐶𝑗
𝑍𝑖
𝑍𝑗� = �exp �𝐸𝑗− 𝐸𝑖𝑅𝑇
𝑍𝑖𝐹�
�� −  𝐶𝑖  
Ei : the potential measurements of the drug ion i 
 Ej : the potential measurements of interfering ion j  
Zi : the charge of drug ion i  
Zj : the charge of interfering ion j  





Cj : the concentration of interfering ion j  
In order to obtain the selectivity coefficient, the EMF values of desired solution, PrHy,  in 
varying concentration of interfering ions were measured; afterwards, the slope of a 
grah �exp �𝐸𝑗− 𝐸𝑖𝑅𝑇
𝑍𝑖𝐹�
�� −  𝐶𝑖 versus 𝐶𝑗
𝑍𝑖
𝑍𝑗�  was used to determine the selectivity coefficient (𝐾𝑖𝑗) 
(Alizadeh and Mehdipour, 2002; Frag et al., 2010; Katsu et al., 1999).  
Alizade et al., Frag et al. and Katsu et al. (Alizadeh and Mehdipour, 2002; Frag et al., 2010; 
Katsu et al., 1999) they all reported the similar trends, that is the selectivity coefficient for 
monovalent cations and divalent cations were in the range of 10-3 and 10-4, respectively. Because 
of the differences in ionic size of these common cations and consequently their motilities and 
permeability, the presence of these cations in solution will not influence the effectiveness of the 
drug selective electrode (Alizadeh and Mehdipour, 2002; Frag et al., 2010). Therefore, the 
sensitivity of the membrane can be enhanced by the incorporation of ion-exchanger. The 
optimum amount of ion-exchanger will convey added stability and also provide more 
electroactive site carriers for the efficient transfer of ions (Alizadeh and Mehdipour, 2002; Katsu 
et al., 1999).       
The effect of pH on the drug selective electrode was also investigated by several research 
groups. As shown in Figure 4.2, Alizade et al. (Alizadeh and Mehdipour, 2002) reported that the 
EMF values of ketamine hydrochloride electrode stayed constant over the pH range of 4 to 8.5. 
The same trend was also observed by Tan et al. (Tan et al., 2007; Tan et al., 2008b) and Frag et 
al. (Frag et al., 2010) regarding procaine hydrochloride electrode and naphazoline hydrochloride 





8.5, while the latter one was constant over pH value of 3 to 8. The significant reduction in EMF 
at high pH values is due to high concentration of deprotonated ketamine. On the other hand, at 
low pH values, the EMF increased because of large amounts of H+ ions which cause high ionic 
interference (Alizadeh and Mehdipour, 2002).  
 
Figure 4.2 The effect of pH on the potential of the ketamine electrode, which is stable over pH range of 4 
to 8.5 (Alizadeh and Mehdipour, 2002). 
For potentiometric studies with ion-selective electrode, it is necessary to determine the EMF of a 
cell. The cell has two solutions separated by the membrane and the reference electrode in the 
following order (Tan et al., 2008b): 
Inner     
Ag/AgBr Internal Drug Test Ag/AgCl 
reference  solution  selective solution reference 






The drug-selective electrodes in this study were connected to the Ion Analyzer instrument that 
permits the collection of data, which will be plotted as the cell electromotive force (EMF) vs. 
time. According to the Nernst equation, the potential of the cell in terms of concentration when 
the drug-selective electrode is immersed in a test solution is expressed as follow: 
𝐸𝐶𝑒𝑙𝑙 =  𝐸𝑜𝐶𝑒𝑙𝑙  ±  
𝑅𝑇
𝑧𝐹




Therefore, by plotting 𝐸𝐶𝑒𝑙𝑙 versus log 𝐶𝐷𝑟𝑢𝑔 the drug concentration can be obtained according 
to the following equation: 
𝐸𝐶𝑒𝑙𝑙 = intercept ± (slope) × (log𝐶𝐷𝑟𝑢𝑔 ) 
4.3 Preparation of Drug Selective Membrane 
Since the membrane is a very crucial part of the Ion Selective Electrode, the preparation methods 
of the membrane become critical. Drug selective membranes are commonly prepared by 
incorporating a suitable ion-exchanger and solvent mediator into a poly (vinyl chloride) (PVC) 
membrane matrix.  
Carboxylated polyvinyl chloride and procaine hydrochloride were both purchased from Sigma-
Aldrich Chemical Co. Tetrahydrofuran was obtained from Merck. Poly (ethylene-co-vinyl 
acetate-co-carbon monoxide) as a polymeric plasticizer and solvent mediator was purchased 
from Acros Organic. NaTPB as an ion-exhcanger was purchased from Sigma-Aldrich. The 
following technique with some modifications was obtained from Tan et al. (Tan et al., 2007; Tan 
et al., 2008b). 
The first step in the membrane preparation process was to form the carboxylated polyvinyl 





of this complex is the electrostatic attractions between drug and carboxylated PVC. The 
formation of drug complex was performed by separately dissolving 0.5 g carboxylated PVC in 
30 ml tetrahydrofuran (THF) and 0.955 g of PrHy in 90 ml THF and 10 ml of distilled de-ionized 
water. Once these solutions were dissolved separately, they were combined and allowed to stir 
for 48 hours. This drug complex was then precipitated in 1 L of distilled de-ionized water by 
steadily adding it to the water using a column. The precipitate was then filtered using a 20–25 
μm filter paper and washed repeatedly with distilled de-ionized water and dried at room 
temperature (Tan et al., 2007; Tan et al., 2008b).  
The next step involved formation of drug selective membrane by dissolving an optimum 
relative amount of the drug complex precipitate, polymeric plasticizer and NaTPB in 30 ml of 
THF. One particular recipe was used throughout the entire project, where 0.18 g of polymeric 
plasticizer, poly (ethylene-co-vinyl acetate-co-carbon monoxide) (PE-co-PVA-co-CO), 0.114 g 
of carboxylated PVC-PrHy drug complex precipitate and 0.006 g of sodium tetraphenylborate 
(NaTPB) were dissolved in THF. Once all the components dissolved in THF over a month, it 
was filtered through a glass wool using a glass funnel, a vacuum pump and a Buchner flask. The 
dissolved plasticizer filtered through the glass wool while the un-dissolved particles did not. 
Afterwards, the obtained liquid membrane was poured into a petri dish and the THF evaporated 
after 2-3 days, controlled evaporation at 25 °C was conducted, which formed the uniform 
membrane. Finally, circular disks were cut out of the membrane and adhered to the PVC or 
Teflon ion selective electrode caps using THF (Tan et al., 2007; Tan et al., 2008b). The 





4.4 Manufacturing Drug Selective Electrode 
As described in Figure 4.3, the drug ion selective electrode possesses four main components: 
electrode body, inner Ag/AgBr reference electrode, end cap, and drug membrane. By means of 
electrolysis for 20 minutes in a 100 ml of 1 M NaBr the silver rod was coated with silver 
bromide to form the inner Ag/AgBr reference electrode. Through electrolysis the silver rod act as 
anode, while the platinum electrode act as cathode (Tan and Tam, 2007; Tan et al., 2007; Tan et 
al., 2008b).  
The previously prepared drug membrane was cut and adhered onto the contact end area of the 
Teflon end cap tip by THF. After the THF was evaporated, the end cap was being filled with de-
ionized water in order to check leakages of the tip with drug membrane. Then, the dried end cap 
with drug membrane was placed in closed container and stored in a refrigerator and kept away 
from the light. Prior to use, the PrHy membrane was placed in a 0.01 M PrHy solution for 15 















Material and Experimental Techniques 
 
5.1 Introduction  
In this chapter the experimental technique used to synthesize various series of polyampholyte 
nanogels, which are the cross-linked polymeric particles that possessed both positive and 
negative charges on their backbone. These polyampholyte nanogels were synthesized by both 
emulsion polymerization and inverse emulsion polymerization. The techniques were 
correspondingly adopted from Tan et al. (Tan et al., 2006; Tan et al., 2007), and Ho et al. (Ho et 
al., 2008) with some modifications.  
5.2 Cross-linked MAA-DEAEMA Nanogels 
5.2.1 Materials 
2 (di-ethylamino) ethyl methacrylate (DEAEMA, 99%), and methacrylic acid (MAA, 99%) were 
both used as monomers. Ethylene glycol dimethacrylate (EGDMA, 98%) was used as the cross-
linking agent, and poly (ethylene glycol) methyl ether methacrylate (PEGMEMA, Mn 300 Da) 
was used as macromonomer, i.e., steric stabilizer. All of the above materials were purchased 
from Sigma-Aldrich, and were passed through a basic alumina column for purification and 
inhibitors removal. Anionic surfactant dioctyl sulfosuccinate sodium salt (Aerosol OT, 96%) was 
purchase from Sigma-Aldrich. Sodium persulfate as an initiator was purchased from Acros 





both were used as received. 2-sulfoethyl methacrylate, which acts as a stabilizing agent was 
purchase from Scientific Polymer Products. De-ionized water was obtained throughout 
experiments from Millipore Milli-Q purification system equipped with a 0.22 μm filter, and has a 
resistivity of 18.2 μ.Ω.cm.  
5.2.2 Synthesis Approach 
Polyampholyte nanogels of methacrylic acid (MAA) and 2 (di-ethylamino) ethyl methacrylate 
(DEAEMA) cross-linked with ethylene glycol dimethacrylate (EGDMA) were synthesized 
through a conventional semi-continuous emulsion polymerization, and this technique was 
discussed in detail in section 2.3.1, and the synthetic procedure is represented in Figure 5.1. This 
technique was adopted from Tan et al. with some modifications (Tan et al., 2006). First of all, the 
75% surfactant solution comprising of 15 g of Aerosol OT in mixture of 19 ml de-ionized water 
and 1 ml acetone was prepared. In order to obtain nanogels comprising of 60 mol% MAA, 40 
mol%, and 4 wt% EGDMA, the monomer mixture consisting of 13 g MAA, 19 g DEAEMA, 
1.13 g EGDMA, and 60 ml de-ionized water was added into the 250 ml beaker equipped with 
overhead stirrer at 250 rpm. Then, 41.5 g of a 75% solution of Aerosol OT was prepared and 
homogenized. An initiator solution was prepared by dissolving 0.5 g of sodium persulfate and 
0.15 g of sodium bicarbonate in 5 ml previously N2-purged de-ionized water. In another 4 ml N2-
purged de-ionized water 1 g of sodium persulfate was dissolved to form the initial catalyst 
solution.  
Afterward, 280 ml of de-ionized water, 0.3 g of 2-sulfoethyl methacrylate, and 41.5 g of 75% 
solution of Aerosol OT surfactant (excess amount of surfactant above the CMC) were charged 





with condenser, magnetic stirrer operating at 400 rpm (the stirrer speed was adjusted to a level 
when a slight vortex on the surface of the liquid was evident), and under continuous N2 purge. 
After 30 minutes of heating the reactor at 80 oC, and the observation of clear solution which 
indicate micelle formation, 10 wt% of the monomer mixture, about 12.5 g, together with the 
catalyst solution was added to the reactor to initiate the reaction. Once the initial monomers had 
reacted for 1 hour to form in situ seed products, the remaining monomer and initiator mixtures 
were injected into the reaction flask by means of syringe pump over two hours under continuous 
N2 purge and stirring, the solution turned milky-white within 20 min of monomer mixture 
injection. 15 minutes before the addition of monomer and initiator mixture was completed, 10 g 
of PEGMEMA (20 wt% of total feed monomer) was poured into the flask to provide steric 
stabilization through free radical grafting reaction. Finally, the reaction was allowed to proceed 
for another two hours in order to consume the residual monomers. A stirred cell was used to 
filter the obtained nanogels through a 0.1 μm filter. Subsequently, the nanogels were dialyzed in 
de-ionized water using regenerated cellulose tubular membrane (Mw cut-off of 12,000-14,000 
Da) over two weeks and the water was replaced every 2-3 days after checking the conductivity 
(Tan et al., 2006). The dialysis process was conducted to remove the excess surfactant, initiator, 
unreacted monomers, and any homopolymer of PEGMA, which may have formed during 
grafting reactions. The final nanogels were about 10% (9.96%) by weight. We observed that the 






Figure 5.1 Sterically stabilized cross-linked MAA-DEAEMA nanogels.  
5.3 Cross-linked MAA-DMAEMA Nanogels  
5.3.1 Materials 
2 (di-methylamino) ethyl methacrylate (DMAEMA, 98%), and methacrylic acid (MAA, 99%) 
were both used as monomer. Ethylene glycol dimethacrylate (EGDMA, 98%) was used as cross-
linking agent, and poly (ethylene glycol) methyl ether methacrylate (PEGMEMA, Mn~300 Da) 
was used as macromonomer i.e., steric stabilizer. All of the mentioned above materials were 
purchased from Sigma-Aldrich, and were passed through a basic alumina column for purification 
and inhibitors removal. Non-ionic surfactants polyoxyethylene (2) oleyl ether (Brij 92V, 
HLB~4.9) and polyoxyethylene (10) oleyl ether (Brij 96V, HLB~12.4) were provided from 
Sigma-Aldrich and Fluka, respectively. Sodium persulfate as an initiator was purchased from 
Acros Organics. n-hexane was purchased from university chem-store. De-ionized water was 
obtained throughout experiments from Millipore Milli-Q purification system equipped with a 
0.22 μm filter, and has a resistivity of 18.2 μ.Ω.cm. 
5.3.2 Synthesis Approach 
Polyampholyte nanogels of methacrylic acid (MAA) and 2 (di-methylamino) ethyl methacrylate 





through an inverse emulsion polymerization. This technique was discussed in detail in section 
2.3.2, and the synthetic procedure is represented in Figure 5.2. Firstly, a non-ionic surfactant 
mixture was prepared by mixing 14.7 g of Brij 92 and 4.4 g of Brij 96. The combined HLB is 
this system is ~ 7 corresponding to a phase inversion temperature of around 65 oC.  This 
surfactant mixture was added to a 150 ml of n-hexane in a 500 ml three neck flask and 
homogenized for 30 min (Ho et al., 2008). Meanwhile, 1.72 g of MAA, 12.56 g of DMAEMA, 
and 0.45 g EGDMA was mixed in 150 ml of de-ionized water in a glass beaker to form a 
monomer mixture, in order to obtain nanogels consisting of 20 mol% PMAA, 80 mol% 
PDMAEMA, and 2 wt% EGDMA.  
In a typical procedure for synthesis of nanogels, the monomer mixture was added to the 
previously homogenized surfactant mixture. The final mixture was placed on the hotplate and 
equipped with a condenser, a magnetic stirrer performing at 400 rpm (adjust the stirrer speed to a 
level when you see a slight vortex on the surface of the liquid), continuous N2 purge, and the 
temperature was raised to 65 oC. Afterwards, 0.45 g of sodium persulfate was dissolved in 8 ml 
of de-ionized water to form initiator solution. After one hour of reaction, the initiator mixture 
was added to the reaction vessel to start the polymerization. The second initiator mixture 
comprising of 0.15 g sodium persulfate in 3 ml de-ionized water together with 5.3 g of PEGMA 
was added to the reaction vessel after the reaction was proceed for two hours to perform the free 
radical grafting reaction. Finally, the reaction was allowed to proceed for another three hours. In 
order to remove the hexane, the hot reaction mixture was poured into a rotary evaporator and 
hexane was removed under vacuum. The resulting thick nanogels sample were diluted in de-
ionized water and redispersed under vigorous shaking. The obtained nanogels were dialyzed in 





Da) over two weeks and the water was replaced every 2-3 days after checking the conductivity 
(Ho et al., 2008). The dialysis process was conducted to remove the excess surfactant, initiator, 
unreacted monomers, and any homopolymer of PEGMA that may have formed during grafting 
reaction. The final nanogels were about 6% (6.34%) by weight. We observed that the nanogels 
remained stable over a year.  
 
Figure 5.2 Sterically stabilized cross-linked MAA-DMAEMA nanogels. 
Moreover, to compare the result of sterically stabilized nanogels and also to observe the effect 
of PEGMA on nanogels stabilization, unstable nanogels were also synthesized through the same 
technique without the addition of PEGMA at the end of the reaction.    
5.4 Cross-linked EA-MAA Nanogel Coated with DMAEMA and MAA  
5.4.1 Materials 
Ethyl acrylate (EA, 99.50%) was purchased from Acros Organic. 2 (di-ethylamino) ethyl 
methacrylate (DEAEMA, 99%), and methacrylic acid (MAA, 99%) were both used as monomer, 
di-allyl phthalate  (DAP, 99%) was used as cross-linking agent, poly (ethylene glycol) methyl 
ether methacrylate (PEGMEMA, Mn 300 Da) was used as macromonomer, i.e., steric stabilizer. 
All of the above materials were purchased from Sigma-Aldrich, and were passed through a basic 






sulfosuccinate sodium salt (Aerosol OT, 96%) was purchased from Sigma-Aldrich. Sodium 
persulfate as an initiator was purchased from Acros Organics, and sodium bicarbonate was 
provided from Fisher Scientific to act as a buffer. They both were used as received. 2-sulfoethyl 
methacrylate as a stabilizing agent was purchased from Scientific Polymer Products. De-ionized 
water was obtained throughout experiments from Millipore Milli-Q purification system equipped 
with a 0.22 μm filter, and has a resistivity of 18.2 μ.Ω.cm. 
5.4.2 Synthesis Approach 
As illustrated in Figure 5.3, EA-MAA nanogels coated with DEAEMA and MAA were prepared 
through sequential addition of DEAEMA and MAA onto the EA-MAA nanogels. EA-MAA 
mixture consisting of 1 g Aerosol OT, 0.33 g MAA, 0.4 g EA, 0.04 g DAP and 4 ml de-ionized 
water used as seed formation solution was prepared. In another container DEAEMA solution 
comprising of 5 g of 75% solution of Aerosol OT, 6.5 g of DEAEMA, 0.2 g of DAP was 
introduced into 6 ml of de-ionized water. In a third container MAA solution including 5 g of 
75% solution of Aerosol OT, 4 g of MAA, 0.2 g of DAP in 6 ml of de-ionized water was 
prepared. Two initiator mixtures both comprising of 0.4 g of sodium persulfate, 0.015 g of 
sodium bicarbonate, and 5 ml of nitrogen-purged de-ionized water were prepared. A catalyst 
solution including 0.4 g of sodium persulfate dissolved in 5 ml of nitrogen-purged de-ionized 
water.  
In the first step, 0.4 g of 75% solution of Aerosol OT along with 40 ml de-ionized water and 
0.05 g 2-sulfoethyl methacrylate were charged into a 100 ml 3-neck flask equipped with a 
condenser and magnetic stirrer. Under a nitrogen purge, the reactor was heated to 70 oC and after 





to the reactor to initiate the in-situ seed formation. After 30 minutes, the DEAEMA solution 
along with one of the initiator solutions was conveyed into the reactor by syringe pump over one 
hour, while the reaction mixture was under continuous nitrogen purge. During this stage a white-
milky solution was formed corresponding to nanogels formation. After one hour interval, NaOH 
was added to maintain the pH level in the basic range (pH of 8-9) before adding the MAA 
solution. Next, the MAA mixture together with initiator solution was conveyed into the reactor 
through syringe pump over 1 hour. 1.2 ml PEGMA was introduced to the reactor over 15 
minutes before the MAA solution was completely reacted, in order to ensure the grafting of the 
stabilizer onto the surface of nanogels to provide steric stabilization to the system. Lastly, the 
reaction was left to proceed for another hour to react residual monomers.  
The obtained nanogels were dialyzed in de-ionized water using regenerated cellulose tubular 
membrane (Mw cut-off of 12,000-14,000 Da) over two weeks and the water was replaced every 
2-3 days after checking the conductivity. The dialysis process was conducted to remove the 
excess surfactant, initiator, unreacted monomers, and any homopolymer of PEGMA that may 
have formed during grafting reaction. The final nanogels were about 12% (12.83%) by weight. 






Figure 5.3 Cross-linked EA-MAA nanogels coated with DEAEMA and MAA. 
5.5 Cross-linked EA-MAA Nanogels Coated with MAA and DEAEMA  
5.5.1 Materials 
Ethyl acrylate (EA, 99.50%) was purchased from Acros Organic. 2 (di-ethylamino) ethyl 
methacrylate (DEAEMA, 99%), and methacrylic acid (MAA, 99%) were both used as monomer, 
di-allyl phthalate  (DAP, 99%) was used as cross-linking agent, poly (ethylene glycol) methyl 
ether methacrylate (PEGMEMA, Mn 300 Da) was used as macromonomer, i.e., steric stabilizer. 
All of the mentioned above materials were purchased from Sigma-Aldrich, and were passed 
through a basic alumina column for purification and inhibitors removal. Anionic surfactant 
dioctyl sulfosuccinate sodium salt (Aerosol OT, 96%) was purchased from Sigma-Aldrich. 





was provided from Fisher Scientific to act as a buffer. They both were used as received. 2-
sulfoethyl methacrylate as a stabilizing agent was purchased from Scientific Polymer Products. 
De-ionized water was obtained throughout experiments from Millipore Milli-Q purification 
system equipped with a 0.22 μm filter, and has a resistivity of 18.2 μ.Ω.cm. 
5.5.2 Synthesis Approach 
As illustrated in Figure 5.5, EA-MAA nanogels coated with MAA and DEAEMA were prepared 
through sequential addition of DEAEMA and MAA onto the EA-MAA nanogels. EA-MAA 
mixture consisting of 1 g Aerosol OT, 0.33 g MAA, 0.4 g EA, 0.04 g DAPand 4 ml de-ionized 
water used as seed formation solution was prepared. In another container DEAEMA solution 
comprising of 5 g of 75% solution of Aerosol OT, 6.5 g of DEAEMA, 0.2 g of DAP was 
introduced into 6 ml of de-ionized water. In a third container MAA solution including 5 g of 
75% solution of Aerosol OT, 4 g of MAA, 0.2 g of DAP in 6 ml of de-ionized water were 
prepared. Two initiator mixtures comprising of 0.4 g of sodium persulfate, 0.015 g of sodium 
bicarbonate, and 5 ml of nitrogen-purged de-ionized water were prepared. A catalyst solution 
including 0.4 g of sodium persulfate dissolved in 5 ml of nitrogen-purged de-ionized water.  
In the first step, 0.4 g of 75% solution of Aerosol OT along with 40 ml de-ionized water and 
0.05 g 2-sulfoethyl methacrylate were charged into a 100 ml 3-neck flask equipped with a 
condenser and magnetic stirrer. Under a nitrogen purge, the reactor was heated to 70 oC after 30 
minutes the EA-MAA solution was added. Subsequently, the catalyst solution was introduced to 
the reactor to initiate the in-situ seed formation. After 30 minutes the MAA mixture along with 
one of the initiator solutions was conveyed into the reactor by means of syringe pump over one 





NaOH was added to keep the pH level high before MAA solution was introduced. Next, the 
MAA mixture together with initiator solution was conveyed into the reactor through syringe 
pump over 1 hour. The 1.2 ml PEGMA was introduced into the reactor over 15 minutes before 
the DEAEMA solution was completely reacted, in order to ensure the grafting of the stabilizer 
onto the surface of nanogels to provide steric stabilization to the system. Lastly, the reaction was 
left to proceed for another hour to react residual monomers.  
The obtained nanogels were dialyzed in de-ionized water using regenerated cellulose tubular 
membrane (Mw cut-off of 12,000-14,000 Da) over two weeks and the water was replaced every 
2-3 days after checking the conductivity. The dialysis process was conducted to remove the 
excess surfactant, initiator, unreacted monomers, and any homopolymers of PEGMA, which may 
have formed during grafting reactions. The final nanogels were about 12% (12.20%) by weight. 













Characterization of MAAA-DEAEMA Nanogels 
 
6.1 Introduction 
As described earlier in section 2.4, various kinds of colloidal carriers have been reported for their 
applications in the field of drug delivery. Among all of the candidates, polyampholyte nanogels 
were chosen for the present study. Polyampholyte nanogels are known as cross-linked polymer 
particles whose constituent polymers possess both positive and negative charges on their 
backbone, which makes them capable of swelling at both high and low pH in a good solvent. The 
pH responsive behavior is the primary reason for synthesizing polyampholyte nanogels. As 
mentioned before in section 5.2.2, the amphoteric nanogels were synthesized via a semi-
continuous emulsion polymerization. Then, their swelling behavior and zeta-potential were 
examined as a function of pH. From the potentiometric titration experiment, the exact molar 
ratios of MAA and DEAEMA segments were determined, which were very close to the feed 
molar ratio. Moreover, isothermal titration calorimetry was employed to study nanogels and 
procaine hydrochloride (PrHy) interaction. Besides, the temperature sensitivity of the nanogels 
was also studied using the differential scanning calorimetry.  
6.2  Characterization of MAA-DEAEMA Nanogels 
The pH and conductivity curves were obtained simultaneously by means of the Metrohm 809 





microliter amounts of the titrants. All experiments were performed in a closed jacketed vessel 
with temperature maintained at 25 oC by a water bath, and the solution was stirred with a 
magnetic stirrer throughout the experiment. Initially, 0.1 M NaOH was added to increase the pH 
of the 0.1 wt% nanogels to 11. Subsequently, the sample was titrated with 0.1 M HCl and both 
the pH and conductivity were measured until the pH reached a value of 2. The actual molar ratio 
of MAA and DEAEMA in the nanogels was confirmed by plotting the pH and conductivity 
curves versus concentration of HCl.  
As illustrated in Figure 6.1, three transition points on the pH and conductivity curves were 
observed signifying the presence of amino and carboxylic acid groups on the nanogels. On the 
conductivity curve, the transition points were measured by the change in slope (inflexion points); 
while, on the pH curve the transition points were determined at intersection of vertical lines with 
the pH curve. These transition points on the pH curve were observed at pH values of 9.6, 7.9, 
and 3.7. The transition points on the conductivity curve exhibited four different regions. 
Beginning from far left of this graph, the first region before point 1 represents the neutralization 
of the excess amounts of NaOH in the nanogel solution. The first transition point at pH=9.6 
corresponds to the start of the protonation of (N (CH3CH2)2) groups to (N (CH3CH2)2 H+) on the 
DEAEMA segments.  
The second region indicates the protonation of (N (CH3CH2)2 H+) groups to (N (CH3CH2)2 H+) on 
the DEAEMA segments. The third transition point associates with completion of the protonation 
of 𝐶𝑂𝑂− groups on the MAA segments. The third region corresponds to the completion of 
protonation 𝐶𝑂𝑂−groups to COOH on the MAA segments. Lastly, the fourth region 





change in the clarity of nanogel solution during the titration process from clear at high pH values 
to cloudy and milky at moderate pH and slightly cloudy and milky at low pH values. The actual 
molar ratio of MAA to DEAEMA was determined by applying the Homola and James method 
(Homola and James, 1977). According to this technique, the feed monomer mole percent of 60% 
MAA and 40% DEAEMA was close to the amount of actual composition of 𝑀𝑀𝐴𝐴: 𝑀𝐷𝐸𝐴𝐸𝑀𝐴 = 
56:44. In the other words, the monomers in the system effectively participated in the 
polymerization.  
 
Figure 6.1 pH and conductivity titration curves for 0.1 wt% MAA-DEAEMA nanogels. 
The dynamic light scattering and zeta potential measurements were conducted to determine the 
hydrodynamic radius (𝑅ℎ), and electrophoretic mobility as a function of pH for 0.1 wt% 





experiments, the samples were allowed to equilibrate for 20 minutes to set the temperature 
before any measurements were performed. The refractive index, the dielectric constant and the 
dynamic viscosity of the dispersion medium were assumed to be similar to pure water for the 
calculation of the mobility, due to the dilute solution, soft, porous, and solvent-permeable 
structure of the nanogels.  
Figure 6.2 shows the hydrodynamic radius (𝑅ℎ), and electrophoretic mobility of nanogels 
without the addition of the PEGMA as a stabilizer; while, Figure 6.3 shows the hydrodynamic 
radius (𝑅ℎ), and electrophoretic mobility of sterically stabilized nanogels by PEGMA. For 
dynamic light scattering measurement, nanogel samples with concentration of 0.1 wt% at 
different pH values were prepared, and the measurements were conducted at 25oC and the laser 
wavelength was 636 nm. 
 A similar trend of swelling was observed for both nanogels system at high and low pH; 
however, at neutral pH or at isoelectric point (IEP) two distinct behaviors were observed: particle 
size of sterically stabilized nanogels was reduced at this pH, while particle size of unstabilized 
nanogels was increased dramatically. This phenomenon is associated with the fact that at the 
IEP, almost equal number of positive and negative charges is present in the nanogel; therefore, 
due to overall charge neutralization nanogels that induce the aggregation of the nanogels to form 
larger aggregates with as evident from Figure 6.2. Conversely, in Figure 6.3 aggregation at IEP 
was prevented due to the steric hindrance provided by grafted steric stabilizer on the MAA-
DEAEMA nanogels. Due to the smaller repulsive force, more compact and smaller nanogels 






Figure 6.2 Profiles of the hydrodynamic radius (Rh), and the electrophoretic mobility of 0.1 wt% MAA-













































Figure 6.3 Profiles of the hydrodynamic radius (Rh), and the electrophoretic mobility of 0.1 wt% MAA-
DEAEMA nanogels with steric stabilizer (PEGMA) as a function of pH at 25 oC. 
As illustrated on the left hand side of Figure 6.4, at low pH, the N (CH3CH2)2 groups on the 
DEAEMA segments in the nanogels were positively charged and fully protonated. This 
enhanced the intra-molecule Coulombic repulsive force between positively charge (N (CH3CH2)2 
H+) groups on the DEAEMA segments, and also increased the osmotic pressure due to the 
counter-ion present in the nanogels matrix, which consequently induced the swelling of 
nanogels, and increased the size of nanogels as shown in Figure 6.4. As the pH was increased, 
the amount of positively charged (N (CH3CH2)2 H+) groups on the DEAEMA segments start to 
decrease; reducing osmotic pressure associated with deprotonation of DEAEMA segments, and 
nanogels size start to decrease. This reduction in size continued until the IEP, where the amount 












































increased over IEP, the gradual swelling in nanogels was observed, which was due to the 
increased osmotic pressure as a result of trapped counter-ions within the nanogels. In addition, at 
high pH COOH groups on MAA segments became negatively charged because of the 
deprotonation of carboxylic groups. Consequently, the intra-molecule Coulombic repulsive force 
between COO- groups induced the swelling of nanogels.  
The electrophoretic mobility values as illustrated in Figure 6.3, corresponded to the zeta-
potential of the nanogels, which further confirmed the above results.  This data demonstrated the 
highest electrophoretic mobility values at both low and high pH since the nanogels possessed (N 
(CH3CH2)2 H+) groups and COO- groups, respectively. In other words, by increasing the pH from 
2, the electrophoretic mobility gradually decreased due to the deprotonation of DEAEMA 
segments; whereas, the curve reaches zero at IEP (pH=6-6.5), since all the positive and negative 
charges neutralized each other. By further increasing the pH from IEP; not only the 
electrophoretic mobility increased gradually, but also its value shifted to a negative value. The 






Figure 6.4 Schematic of pH-responsive behavior of MAA-DEAEMA nanogels. 
From Figure 6.3 a higher value for both hydrodynamic radius and zeta potential can be observed 
for high pH value comparison to the lower one. This can be attributed to the higher amount of 
COOH groups in the nanogels feed monomer compared to the amount of -N (CH3CH2)2 groups, 
60% and 40% respectively. Besides, zeta potential analyzer is only capable of measuring the 
charges on the surface of the particle, hence the lower positive zeta-potential values can also be 
associated to the fact that some of the surface -N (CH3CH2)2 groups took part in the PEGMA 
grafting reaction.  In addition, different IEP shown in Figure 6.2 and Figure 6.3 can be a result of 
different synthetic conditions, errors during light scattering, and zeta potential measurements.  
Figure 6.5 depicts several photographs of 0.1 wt% MAA-DEAEMA nanogels, further 
confirming the effect of PEGMA on the stability of nanogels, by presenting the difference in 





PEGMA. It can be seen that in both conditions, the nanogels demonstrated enhanced hydrophilic 
behavior in aqueous media at both high and low pH. In the former condition, when PEGMA was 
not grafted onto the nanogels, they aggregated and became very cloudy and as indicated by the 
milky solution at IEP. On the other hand, in latter condition, where PEGMA was grafted onto the 
nanogels, they became more stable and hydrophilic in aqueous media due to the steric hindrance 
provided by PEGMA, and the solution became clearer.  
 
Figure 6.5 Photographs of 0.1 wt% MAA-DEAEMA nanogels with and without PEGMA stabilizer. 
6.3 Drug Interaction with MAA-DEAEMA Nanogels 
The cationic drug utilized during the course of this research is procaine hydrochloride (PrHy). It 
was purchased from Sigma-Aldrich and was used without further purification. This drug is the 
first chemically synthesized, nonaddictive and injectable local anesthetic used in dental surgery; 
nevertheless, it is no longer used for this purpose because of the short anesthetic duration and 






Figure 6.6 Chemical structure of procaine hydrochloride (PrHy). 
The isothermal titration calorimetry was usedd to study the interactions between drug and 
nanogels at 25 oC. The titrant comprising of 282 μL of 600 mM procaine hydrochloride (PrHy) 
was titrated into 1.4551 ml of 0.1 wt% MAA-DEAEMA nanogels at different pH values. The 
differential enthalpies (ΔH) versus the concentration of titrant (PrHy) in the cell were plotted in 
Figure 6.7.  Based on the results, the enthalpy profile for titrating PrHy into MAA-DEAEMA 
nanogels at different pHs exhibited similar profiles as the dilution curve (titration of PrHy into 
10 mM NaCl solution). Besides, the enthalpies of dilution resembled that of all the other curves. 
Consequently, it can be concluded that PrHy did not bind to the MAA-DEAEMA nanogels 
through electrostatic attractions; this is, the titration results exhibited no evidence of electrostatic 
binding, between the negatively charged 𝐶𝑂𝑂− groups of MAA segments and positively charged 
𝑁+ of PrHy.  However, diffusion and hydrophobic interactions were the driving force for 
binding the drug molecules into the nanogels. This phenomenon can be due to the presence of 
two ethyl groups surrounded the 𝑁+, providing steric hindrance that shielded the positive charge; 
thus, preventing the binding of positively charged 𝑁+ to negatively charged 𝐶𝑂𝑂− groups at low 





Furthermore, by decreasing the pH to 4 and 2, higher values for differential enthalpy was 
observed. This is due to the fact that at this pH more positive charges were present on the 
nanogels inducing a higher hydrophobic interaction between MAA segments and benzene ring of 
PrHy molecules.  
 
Figure 6.7 Differential enthalpy profiles for titrating 0.6 M PrHy into 0.1 wt% MAA-DEAEMA nanogels 
in 10 mM NaCl solution at different pH values. 
Figure 6.8 shows the differential enthalpy curves for titrating 0.6 M PrHy into 0.1 wt% MAA-
DEAEMA nanogels in 500, 300, 200, and 10 mM NaCl solutions. By increasing the 
concentration of salt in the medium, the salt molecules Na+Cl- shielded the negatively charged 






























molecules; hence more energy is required to induce hydrophobic interaction. These results 
further confirmed that the PrHy interacted with nanogels through hydrophobic bonding and 
diffusion rather than electrostatic attraction, because in the latter case the ∆H would be larger. 
 
Figure 6.8 Differential enthalpy profile for titrating 0.6 M PrHy into 0.1 wt% MAA-DEAEMA nanogels 
at different NaCl concentration. 
Figure 6.9 illustrates the differential enthalpy curves for titrating 0.6 M PrHy into 0.1 wt% 
MAA-DEAEMA nanogels in 10 mM NaCl solution at different temperatures. The differential 
enthalpy (ΔH) profiles demonstrated higher value as a result of increasing the temperature from 
25 to 50 oC. This can be attributed to an increase in hydrophobic environment that induced 
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further confirmed that binding between the loaded PrHy and the nanogels occurred through 
diffusion and hydrophobic interactions rather than electrostatic interactions.  In other words, the 
concentration gradient difference between the interior and exterior of the nanogels was a driving 
force for the diffusion of drug molecules into the nanogels. A similar trend was reported by Tan 
et al. (Tan et al., 2007; Tan et al., 2008b) on the interaction between methacrylic acid-ethyl 
acrylate nanogels (HASE) and PrHy.  
Figure 6.9 Differential enthalpy curves for titrating 0.6 M PrHy into 0.1 wt% MAA-DEAEMA nanogels 
in 10 mM NaCl solution at different temperatures. 
6.3.1 Effect of Drug on Particle Size of the MAA-DEAEMA Nanogels 
The relaxation rate (Γ) as a function of q2 is shown in Figure 6.10 for 0.1 wt% MAA-DEAEMA 






















pH 7 50C 
pH 7 37C 





increasing the scattering angles, the decay function decreased. The fact that relaxation rate 
possessed q2 dependence confirmed that the scattering was associated to translational diffusion. 
The slope of these figures corresponds to the translational diffusion coefficients, and the 
hydrodynamic radius (Rh) for these nanogels was calculated using the Stokes-Einstein equation. 
The hydrodynamic radius (Rh) of the MAA-DEAEMA nanogels loaded with 0.6 M PrHy in 10 
mM NaCl solution at pH 2, 4, 7, and 8 were found to be 224.4, 177.1, 275.4, and 320.1 nm, 
respectively. According to the following equation the swelling degree of the nanogels can be 
calculated:  




C corresponds to the concentration of the drug. Based on the above equation the swelling 
degree of the drug loaded nanogels at pH 2, 4, 7, and 8 was 0.84, 0.90, 0.96, and 0.97, 
respectively. Therefore, the particle size decreased as a result of PrHy loading into the nanogels. 
These outcomes are in agreement with results reported by Xiong et al. {(Tan et al., 2008b; Xiong 
et al., 2005), and Lopez et al. (Lopez et al., 2005). A significant reduction in the size of the 
nanogels at pH 2 can be attributed to more dominant hydrophobic effect since there was larger 
proportion of hydrophobic MAA segments at low pH compared to DEAEMA segments in the 







Figure 6.10 Relationship between Γ and q2 for 0.1 wt% MAA-DEAEMA nanogels loade with 0.6 M 





In addition, the polymer-solvent interaction was reduced forming a less polar medium within the 
nanogels due to the hydrophobic behavior of PrHy and nanogels at pH=2, which led to reduction 
in nanogel size. Similarly, at pH=7 and pH=8 shielding effect on the COO- groups in the 
nanogels decreased the internal repulsion between negatively charged MAA segments, which 
decreased the nanogels size. Besides, reduction in polymer-solvent interaction as a result of drug 
incorporation formed a less polar medim within the nanogels and caused reduction in nanogel 
size. Furthermore, the smaller reduction in size at high pH compared to low pH can be 
contributed to aggregation of PrHy loaded nanogels because of a bridge effect formation; that is, 
PrHy incorporated on or near the surface of the nanogels could hydrophobically interact with 
another nanogels and consequently reduced the effect of charge shielding. However, at low pH, 
positively charged DEAEMA segments on the nanogels stabilized the nanogels and eliminated 
the bridge effect.  
As shown in Figure 6.11, the zeta-potential measurements were conducted which further 
confirmed the results. The reduction in nanogel size improved the zeta-potential of the nanogels 
and correspondingly their mobility. At low pH incorporation of the positively charged PrHy to 
the positively charged nanogels increased the mobility in comparison to nanogels without loaded 
drug. On the other hand, at high pH incorporation of the positively charged PrHy, neutralized the 
negatively charged nanogels and reduced the mobility in comparison to nanogels without drug. 
Although high mobility values revealed that nanogels maintained their stability at both high and 
low pH, there is a slight reduction in mobility value at high pH in comparison to results obtained 
without PrHy incorporation. This slight instability at high pH could have contributed to 














































Drug Release from the MAA-DEAEMA Nanogels 
 
7.1 Introduction  
Procaine hydrochloride (PrHy) was used as a model drug for the purpose of this research. In the 
previous chapter we demonstrated that PrHy was loaded into the MAA-DEAEMA nanogels 
through hydrophobic interaction at high pH and by hydrophobic and hydrogen bonding at low 
pH values. These results contributed to the steric hindrance provided by the two ethyl group 
surrounded the N+, which reduced the electrostatic interaction between positively charged N+ on 
PrHy and negatively charged COO- groups on MAA segments. At low pH, there is hydrophobic 
interaction between PrHy and MAA segments and also hydrogen bonding between COOH 
groups on MAA segments and amines on PrHy. Here, we demonstrated how the loaded drug will 
be released from the interior of nanogels under different conditions, such as pH and salt. In 
contrast with conventional methods of measuring drug released concentration, such as dialysis 
tubing or centrifugation, in this research the concentration of the drug released was obtained 
using the drug selective electrode method.   
7.2 Drug Selective Electrode  
The studies conducted on drug release behaviors were mostly reported as the ratio (𝑀𝑡 𝑀∞� ) of 
the drug released as a function of time t. 𝑀𝑡 indicates the amount of drugs released at time t; 





drugs released at infinite time. The following assumptions were made in order to study the drug 
release profile. First of all, the initial swelling occurred at the surface of the nanogels; secondly, 
the drug was distributed uniformly in the nanogels. According to these assumptions, the 
primarily release of the drug was attributed to drug molecules bound to the surface of the 
nanogels, that led to a higher release rate; whereas, the delayed release of the drug was due to the 
diffusion of drug from the interior of the nanogels. Drug release experiments were conducted 
using a 4-channel ion instrument and drug selective electrode technique at varying conditions 
such as pH, concentration gradient, drug loading ratio. The temperature was maintained at 37 oC 
corresponding to the normal body temperature using a water bath throughout the course of 
experiment.   
Drug membrane electrode was calibrated before and after each experiment to confirm the 
accuracy and stability of the electrode response time and also to ensure the reproducibility of the 
measurements. For calibration purpose of the PrHy membrane electrode, 10 ml of different 
concentrations of PrHy such as 10-5, 10-4, 10-3, 10-2, and 10-1 M in 10 mM NaCl solution was 
prepared, and then the membrane electrode was immersed into the solution under continuous 






Figure 7.1 Calibration curves of PrHy membrane electrode obtained, before and after the drug release 
experiment 1, in different PrHy concentration in 10 mM NaCl solution at 37 oC. 
 
Figure 7.2 Calibration curves of PrHy membrane electrode obtained, before and after the drug release 






As shown in Figures 7.1 and 7.2, calibration curves were obtained by plotting the measured 
electromotive force (EMF) versus different concentrations of PrHy in 10 mM NaCl solution. 
These figures demonstrated that the calibration curves obtained before and after the use of the 
membrane electrode in drug release experiment 1 and 2 respectively were reproducible. In each 
of the above figures, calibration curves obtained before and after experiment 1 and 2 were very 
identical, as they both possessed similar slopes and intercept, which proved that the results 
obtained during the course of experiment with unknown concentration of drug molecules were 
repeatable. 
Moreover, each drug release experiment was performed twice under identical condition to 
ensure the reproducibility and stability of the results. Figure 7.3 shows the reproducibility of two 
drug release profiles obtained from two identical experiments conducted under the same 
conditions on two different days. In order to further determine the stability of the PrHy electrode 
response, the following experiments were performed, and stable EMF measurements were 
obtained by immersing PrHy electrode into the solution of 10-3 M PrHy and 10 mM NaCl at a 
temperature of 37 oC, as shown in Figure 7.4. There was only a very small drift, which was less 
than 0.1 mV/hr. This experiment was conducted to ensure the stability and reproducibility of the 






Figure 7.3  Two drug release profiles of two identical experiments conducted under similar condition on 
two different days. 
 
Figure 7.4 Stability profile of PrHy membrane electrode obtained in the solution of 10-3 M PrHy and 10 
mM NaCl at 37 oC. 






7.3 Drug loading into the MAA-DEAEMA Nanogels 
In order to load the MAA-DEAEMA nanogels with hydrophilic drug PrHy, the following 
experiment was performed. 0.1 wt% of MAA-DEAMAE nanogels at pH=7 was prepared and 
based on the results and technique proposed by Tan et al. (Tan et al., 2007; Tan et al., 2008b) 
2.44 g drug/ g polymer was added into the nanogels solution under continuous stirring, and the 
nanogel-drug solution was left to equilibrate over 24 hours at constant temperature of 25oC, 
which was controlled by water bath. Afterwards, the loaded nanogels were passed through an 
ultrafiltration cell, which contain filter with a cut-off pore size of 0.02 µm. to ensure that free 
PrHy can pass through the filter, a pure solution of PrHy was passed through the membrane and 
the concentration of solution before and after filtration was measured, and it was found to be 
identical, confirming that free and unbound PrHy molecules can pass through the membrane.  
7.3.1 Effect of pH on PrHy Release Profile 
In order to investigate the effect of varying pH on the release of PrHy, the following experiment 
was conducted. 5 ml of 0.1 wt% nanogels loaded with 2.44 g drug/ g polymer was added into 50 
ml 10 mM NaCl solution at different pH and constant temperature of 37oC. Figure 7.5 illustrates 
the release profile under different pH conditions. All the profiles indicated a burst release of 
drugs in the first 10 minutes and afterwards the released slowed down and slightly drift after 
about 1.5 hour.  As mentioned earlier, the drug release from the nanogels comprised of two parts. 
The first part associated with the drug incorporated on the surface of nanogels that led to the 
burst released of drug in the first 10 minutes. The second part corresponded to drugs 
incorporated within the nanogel network that caused the delayed exponential release due to the 





The nanogels were swollen and possessed a high porosity at both high and low pH values. This 
increased the osmotic pressure and allowed the chains to accommodate more solvent molecules 
promoting the release of the drug from the nanogels by reducing the diffusion resistance. In 
addition, at both high and low pH, hydrophobic interactions were the predominant driving force 
for loading the drug molecules into the nanogels. However, the synthesized nanogels contain 60 
mol% MAA compare to 40 mol% DEAEMA. Therefore, higher osmotic pressure was produced 
due to the presence of negatively charged COO- and enhanced the swelling degree at high pH. 
Consequently, slightly higher fraction of drug will be released at high pH over longer period of 
time in comparison to low pH. Furthermore, at low pH as mentioned before, there was hydrogen 
bonding between COOH groups on MAA segments and amine groups on PrHy, which resulted 
in a lower release of PrHy from the nanogels. All these demonstrated that the surrounding pH 
values can effectively control the release rate from the nanogels.  
Figure 7.6 indicates the release of the drug from the nanogels as a fuction of pH and Rh. These 
graph further comfirmed and clarified the relationship between pH values and drug release 
profile as discussed above. In the other words, at pH=2 the nanogels swelled due to the 
electrostatic repuslsion between positively charges on the DEAEMA segments; therefore, at this 
pH nanogels promoted the higher release of the drug from their interior, which is Mt / M∞= 
0.968. By increasing the pH to 3, less positive charges present on the nanogels, which resulted in 
dewelling of the nanogels and less amount of drug released from the nanogels. By further 
increasing the pH to 6 the abrupt reduction in drug released was observed, this phenomenon can 
be contributed to the isoelectric point in which nanogels possessed the lowest Rh. Thus, 
minimum amount of drug, Mt / M∞= 0.213, was capable to release from the nanogels in 





the increment in osmotic pressure nanogels and electrostatic repulsion between negative charges 
on the MAA segments, nanogels swelled and subsequently released more amount of drug to the 
surrounding medium, Mt / M∞= 0.618 and 0.74, respectively. As can be seen in both Figure 7.5 
and 7.6, higher drug released was obtained at lower pH values such as pH= 2 and 3 in contrast to 
pH=7.4 and 8. This effect can be elucidated due to the incorporation of positively charged PrHy 
within the positively charged nanogels, caused less hydrophobic interaction the PrHy molecules 
and nanogels. 
 
Figure 7.5 PrHy release profile from 0.1 wt% MAA-DEAEMA nanogels in 10 mM NaCl at 37 oC at 






























Figure 7.6 Plot of PrHy release from 0.1 wt% MAA-DEAEMA nanogels in 10 mM NaCl at 37 oC as a 
function of pH. 
Figure 7.7 depicts the effect of varying pH on the release of PrHy from PrHy-loaded MAA-
DEAEMA nanogels. The amount of PrHy released at pH 4 was about 62% because at this pH the 
nanogels were positively charged, repulsion force between N (CH3CH2)2H+) groups on the 
DEAEMA segments, led to swelling of the nanogels. Moreover, the concentration gradient of 
PrHy between the nanogels network and the medium was very high. Thus, both of these factors 
promoted the higher release of the PrHy molecules from the nanogels. However, by increasing 
the pH to 5 and 6, the release of the PrHy reduced which can contributed to the more compact 
structure and overall charge neutralization of the nanogels at this pH. In addition, pH=5 
demonstrated more PrHy release in comparison to pH=6, which can be explained according to 
the zeta potential result obtained at this pH. The mobility at this pH was still positive indicating 
that nanogels contained slightly positive charges; besides the squeezing effect of the drug de to 























nanogels network. By increasing the pH to 7 and 8, the nanogels were still in their swollen state, 
the reduction in PrHy concentration gradient between the interior of the nanogels and the 
medium decreased the driving force for the release of the PrHy from the nanogels network. 
Figure 7.7, demonstrates that the drug release can be manipulated according to the different pH 
environments of body compartment. Therefore, the therapeutic window of the active drug can be 
increased and successful delivery of the drug to the targeted area is enhanced. Measurment of the 
concentration of the drug released in the medium with continuous change in the pH was 
achievable by applying the drug selective electrode rather than using conventional techniques of 
dialysis membrane or centrifugation (Tan et al., 2007).  
A schematic diagram in Figure 7.8 illustrates that at both high and low pH, the nanogels 
possess swollen structure and larger porosity, as result of electrostatic repulsion between like 
charges and also high osmotic pressure. This led to a higher release of PrHy from the interior of 








Figure 7.7 PrHy release profile from 0.1 wt% MAA-DEAEMA nanogels in 10 mM NaCl solution at 37 










































Figure 7.8 Schematic diagram of the drug release from nanogels matrix, at both high and low pH value 
high PrHy fractional released was observed due to the high swelling ratio and low resistance to diffusion. 
Represents drug molecule    
 Represents positive or negative segment 
 Represents cross-linked junction 
Represents DEAEMA-MAA segment 
                            Represents PEGMA segment     
Drug-loaded Nanogels 





7.3.2 Effect of Salt Concentration Gradient on PrHy Release 
In order to investigate the effect of varying salt concentration on the release of PrHy, the 
following experiments were conducted. Different volume of 0.1 wt% nanogels loaded with 2.44 
g drug/ g polymer was added to 50 ml 10 mM NaCl solution at pH 7.4 at 37 oC. The 
concentration gradient of 5, 7, 10, and 20 times was used. For example, to achieve the 
concentration gradient of 10 times, 5 ml of 0.1wt% nanogels loaded with drug was added to the 
50 ml of 10 mM NaCl solution. That is, the volume of salt used was 10 times the volume of 
nanogels solution. 
Figure 7.9 illustrates the effect of varying concentration gradient on the release profile of 
PrHy. It can be seen that the larger the concentration gradient difference, the higher the release 
rates. This result can be attributed to the fact that salt dissociated in the solution and formed very 
small size Na+ and Cl- ions. The very small Na+ ions can easily diffused into the nanogel’s 
network and replaced the positively charged PrHy molecules. Thus, the higher the concentration 
between the interior and exterior of the nanogels, the more Na+ ions were able to diffuse into the 
nanogels. In other words, the Na+ ions diffusion rate, which was the result of the concentration 
gradient between the interior and exterior of the nanogels, determined the rate at which PrHy was 
released from the nanogels. Since the driving force for loading PrHy into nanogels was 
controlled by diffusion and hydrophobic interaction, the presence of higher concentration 
gradient improved these driving forces and led to a faster release of PrHy from the nanogels. The 
larger concentration gradient created by a higher salt concentration led to a higher release rate of 
PrHy. On the other hand, the release rate was reduced as a result of smaller concentration 





gradient between the interior and exterior of the nanogels, the time required to achieve fully drug 
release was increased. In other words, the higher the concentration gradient between inside and 
outside of the nanogels, it required longer time to reach equilibrium. Once PrHy loaded nanogels 
were added to the solution at pH=7.4, nanogels swelled and due to the presence of concentration 
gradient between the exterior and interior of nanogels, it promoted the release of the drugs.        
 
Figure 7.9 PrHy release profile from 0.1 wt% MAA-DEAEMA nanogels in 10 mM NaCl solution at pH 































Layer by Layer Coating on the PrHy-Loaded 
Magnetic Iron-Oxide Nanogels 
 
8.1 Introduction  
As previously mentioned in section 2.4, different kinds of colloidal carriers have been 
investigated due to their potential in drug delivery applications. Among all of the potential 
candidates, polyampholyte nanogels are capable of swelling at both high and low pH in a good 
solvent, such as water. Aqueous magnetic fluids, possessing super-paramagnetic properties, are 
known as colloidal dispersions of magnetic nanoparticles in water. In this work, co-precipitated 
magnetic nanoparticles within nanogels were developed to investigate a more efficient approach 
to conduct layer-by-layer coating in order to control the burst release of drug molecules. 
Moreover, the nanogels developed in this research were capable of delivering drug under both 
spatial and temporal control. The spatially controlled delivery was achieved due to the presence 
of magnetic nanoparticles, which are able to respond to an externally applied magnetic field, 
placed on a defined location of the body. Temporally controlled delivery was obtained due to the 
pH responsive character of nanogels, in which varying pH value led to a different response from 
nanogels, like various pH values in the body compartment. Therefore, by combining both 






8.2 Synthesis of Magnetic Iron-Oxide Nanogels  
The co-precipitation of magnetic nanoparticles within nanogels was adopted and modified from 
the proposed method by Lee et al. (Lee et al., 2009; Lee et al., 2010). FeSO4.7H2O was 
purchased from Fisher Scientific. NaNO2 was obtained from Fisher Scientific.  
The MAA-DEAEMA nanogels as previously described were synthesized via semi-continuous 
emulsion polymerization. In a typical process, 120 ml of 0.5 wt% MAA-DEAEMA nanogels was 
added to a three-neck round bottom equipped with overhead stirrer, to prevent accumulation of 
magnetic nanoparticles around magnetic stirrer bar. Then, the pH of the solution was increased to 
7.5 using 1 M NaOH, in order to form negatively charged carboxyl groups on MAA segments, 
which enhanced the incorporation of positively charged ferric ions into the nanogels. In another 
container 2.5 g of FeSO4.7H2O was dissolved in 30 ml of de-ionized water and deoxygenated for 
30 minutes, in order to form pale green Fe2+ solution. The nanogels solution was heated to 75 oC, 
and FeSO4.7H2O solution was added dropwise to the nanogel solution by means of a double 
needle under continuous nitrogen purging and vigorous stirring and Fe2+ were bound to the 
carboxyl groups of MAA resulting in the formation of a dark green suspension. After 2 hours, 
subsequent addition of 0.25 g of NaNO2, as an oxidizing agent, and 15 ml of 28% NH4OH was 
conducted, to increase the pH of the solution to pH=10.5. The reaction was left to react for 
another hour, changing from the dark green suspension into a black precipitate of Fe3O4 (Lee et 
al., 2009; Lee et al., 2010). In order to separate non-magnetic nanogels, the suspension was 
purified by passing it through the high-gradient magnetic separator. The solid content of the 





there was an increment in size of the magnetic nanogels from bare nanogels, which was 277.7 
nm. 
8.3 Layer-by-Layer Coating of the Magnetic Iron-Oxide Nanogels 
A layer-by-layer coating of polyelectrolyte on drug-loaded magnetic MAA-DEAEMA nanogels 
grafted with PEGMA was performed in a 0.1 M NaCl solution at pH=7.5. There was no sign of 
aggregation of the coated nanogels; however, the swelling degree of nanogels decreased as the 
number of polyelectrolyte layers increased. Poly (sodium 4-styrenesulfonate) (PSS) (Tan et al., 
2008a; Wong et al., 2009), and low molecular weight chitosan (CS) (Diez-Pascual and Wong, 
2010), both purchased from Sigma-Aldrich, acted as polyanion and polycation electrolytes to 
prepare coated magnetic nanogels, respectively. The drug release from the coated magnetic 
nanogels showed a reduction in the burst release phenomenon. The structure of CS and PSS is 








Figure 8.1 Schematic of PSS and CS chemical structure. 
Chitosan (CS) is a linear copolymer comprising of 1, 4-linked 2-amino-2-deoxy- D 
glucopyranose and 2-acetamido-2-deoxy-D glucopyranose units. It is a weak cationic 
polysaccharide produced by the deacetylation of the natural polymer chitin. It has a variety of 
applications in food industry, pharmaceutical, biomaterials, medicine and cosmetic due to its 
attractive biological properties such as biocompatibility, biodegradability, and bioactivity. CS 
demonstrates great potential for its use as polycation in layer-by-layer coating. It has been 
revealed that low molecular weight CS possesses different biological properties such as 
antifungal, antibacterial, and antitumor in comparison to the high molecular weight chitosan 





The prepared magnetic nanogels were loaded with 2.44 g drug/ g of polymer, and added to the 
0.5 wt% magnetic nanogel solution and left to equilibrate over 24 hours at 25 oC. Afterwards, 
alternating layers of CS and PSS were deposited on the negatively charged nanogels through 
electrostatic attractive force. Bulk solution of 1 wt% CS was prepared by slow dissolution of CS 
in 3% w/v acetic acid. At the same time, 1 wt% PSS (Mw=70000) in 100 mM NaCl at pH=6 was 
prepared, and both solutions were highly charged according to their pKa in the experiment 
condition. 0.5 ml CS solution was added to 10 ml of drug-loaded magnetic nanogels under 
continuous stirring for 30 minutes in order for CS adsorption onto the negatively charged 
nanogels. Istead of using the repeated filtration technique, which was commonly employed by 
many research group (Blasi et al., 2010; Lopez et al., 2005; Nolan et al., 2005b; Tan et al., 2007; 
Tan et al., 2008b; Xiong et al., 2005), high-gradient magnetic field was utilized to remove excess 
CS. 1.5 ml of PSS was added to 10 mL CS coated nanogels, which are positively charged under 
continuous stirring for 30 minutes, in order for PSS to adsorb onto the positively charged CS 
coated nanogels. Subsequently, by passing the coated nanogel through the high-gradient 
magnetic field, the excess amount of PSS was removed. Until the desire number of CS and PSS 
was deposited onto the nanogels, this process was repeated.  
To achieve the optimum amount of CS and PSS layer to be deposited onto the PEGMA grafted 
nanogels the following experiment was performed. Different ratio of the volume of CS/PSS to 
volume of grafted nanogels was prepared and then the zeta potential and hydrodynamic radius 
were measured at 25 oC. For instance, a 0.5 ml of CS solution and 10 ml of nanogels solution had 





The ratio that corresponded to the maximum zeta-potential and minimum hydrodynamic radius 
(Rh) yielded the most stable system. In this research, a total of 5 polyelectrolyte layers were 
deposited onto the nanogels, where the first, third, and fifth layer comprised of CS (positively 
charged) layer; whereas, the second and fourth layer consisted of PSS (negatively charged) layer.   
Figures 8.3 to 8.7 demonstrate how the hydrodynamic radius and zeta potential changed with 
the ratio for different layers. The bare magnetic iron-oxide nanogels possessed a hydrodynamic 
radius (Rh) of 292.7 nm and zeta-potential of -35.63 mV. From Figure 8.3 it can be seen that by 
depositing a ratio of 0.05 in the first layer on the nanogels, the Rh increased significantly. This 
increment in Rh can be due to fact that the surface of the negatively charged magnetic nanogels 
was not completely covered by the small amount of CS deposited onto the surface of the 
nanogels; thus, nanogels aggregated and formed larger aggregates. The low value of zeta-
potential further confirmed the instability of the magnetic nanogels. In other words, small 
amounts of chitosan were not able to fully cover the surface of the nanogels and some areas of 
the nanogels surface remained bare, which were prone to associate with other exposed and 
uncovered nanogels and to form larger aggregates. By increasing the ratio to higher than 0.05, 
more stable nanogels were obtained.   
For the PSS (negatively charged) layers, similar trend were observed. At low PSS ratio, 
nanogels aggregate and the low value zeta potentials demonstrated the sign of instability. As a 
result, the optimum ratio used throughout the course of experiment for CS layers (first, third, and 
fifth layers) was 0.35, whereas the optimum ratio of 0.55 was taken into account for PSS layers 





polyelectrolytes CS and PSS onto the PrHy-loaded magnetic iron-oxide MAA-DEAEMA 
nanogels.    
 
Figure 8.2 Schematic of layer-by-layer coating of CS and PSS onto PrHy-loaded magnetic MAA-
DEAEAM nanogels. 
Figures 8.3 to 8.7 show the relationship between Rh and zeta-potential with the number of 
layers of CS and PSS deposited alternately onto the negatively charged MAA-DEAEMA 
nanogels. The bare magnetic iron-oxide nanogels had the Rh of 292.7 nm, which increased 
slightly to 293.1 nm by the addition of the first positively charged polyelectrolyte layer (CS) and 
subsequently increased to 304.3 nm with the addition of the second negatively charged 
polyelectrolyte layer (PSS). The slight increase in size can be attributed to electrostatic 
interaction between positively charged NH3+ groups on the CS and negatively charged COO- 
groups on MAA segments and negatively charged iron oxide. Another explanation could be 
attributed to the high charge density of CS, which was caused from strong acid solution of low 
ionic strength, and enhanced hydrophilicity of the positively charged CS. Hydrophilic behavior 
of charged CS, along with the porous structure of the nanogels allowed positively charged CS to 
easily diffuse into the nanogels and masked or neutralized the negative charges of nanogels; 
therefore, decreased the repulsion force between negatively charged COO- groups of nanogels, 





Besides, hydroxyl groups on the CS layer were able to form strong hydrogen bonds with solvent 
molecules, resulting in a reduction of nanogels Rh. The same trend was observed by Diez-Pascual 
and Wong (Diez-Pascual and Wong, 2010) as a result of layer by layer coating of chitosan as 
polycation and dextran as a polyanion onto Poly (NIPAm-MAA) microgels. The reason the size 
of the nanogels slightly increased rather that dramatic reduction can be contributed to the 
precipitation of iron oxide within the nanogels, occupying available space and preventing 
sufficient diffusion of positively charged CS layers. All these facts elucidate the difference in 
results obtained as a result of layer by layer coatings on nanogels versus those results achieved 
on layer by layer coating on film substrate.  
On the other hand, by depositing negatively charged PSS layer, containing SO-3 groups, onto 
the chitosan-coated iron-oxide magnetic nanogels Rh increased dramatically. This can be 
contributed to the fact that by adding the negatively charged layer to the positive surface of CS-
coated nanogels, the constant numbers of positive charges not only had to be shared between the 
negatively charged nanogels and the CS layer, but also had to be shared between the chitosan 
layer and the negatively charged PSS layer. The electrostatic interactions between the latter 
dominate the electrostatic interactions between the former, weaken the electrostatic interaction 
between positively charged CS layer and negatively charged nanogels, which consequently 
increased the Rh. In addition, the excess of negative charges on PSS layer due to lack of charge 
compensation, inducing enlargement of nanogels by repelling each other.  
Furthermore, PSS layer was highly hydrophilic capable of absorbing large amounts of water, 
which in turn reduced the entanglement of polyelectrolyte chains and subsequently expanded 





PSS into the nanogels, induced repulsion force between negative moieties of nanogels including 
COO- and iron oxide. However, because of the weak interactions between polyelectrolytes and 
lack of hydrogen bonds, osmotic pressure induced by negative ions distributions within the 
nanogels dominated the interactions between the polyelectrolytes and promoted nanogels 
swelling. This is in agreement with the results reported by Wong et al. (Wong et al., 2009) and 
Tan et al. (Tan et al., 2008a), in which Poly (NIPAM-MAA) microgels were alternately coated 
with different layers of poly(diallyldimethylammonium chloride) (PDADMAC) and PSS, and 
ethyl acryl acrylate-MAA (HASE) microgels were coated through alternate addition of PAH and 
PSS layers.   
 
Figure 8.3 Zeta-potential and Rh as a function of ratio of volume of CS versus volume of iron-oxide 










































Figure 8.4 Zeta-potential and Rh as a function of ratio of the volume of PSS versus the volume of 
magnetic iron-oxide MAA-DEAEMA nanogels for the second layer (PSS) in 0.1 M NaCl at pH=7. 
 
Figure 8.5 Zeta-potential and Rh as a function of ratio of the volume of CS versus the volume of magnetic 
















































































Figure 8.6 Zeta-potential and Rh as a function of ratio of the volume of CS versus the volume of magnetic 
iron-oxide MAA-DEAEMA nanogels for the fourth layer (CS) in 0.1 M NaCl at pH=7. 
 
Figure 8.7 Zeta-potential and Rh as a function of ratio of the volume of CS versus the volume of magnetic 













































































Figure 8.8 also illustrates the zeta potential of the coated magnetic nanogels as a function of the 
number of layers at 25 oC. The successful deposition of polyelectrolyte layers onto the magnetic 
nanogels was further confirmed through the zeta potential data. The bare nanogels were 
negatively charged and upon the deposition of a first layer, the zeta potential values shifted to a 
positive value corresponding to the net positive surface charge of the CS layer due to the 
protonation of amine groups; whereas, by adding the second layer, the zeta potential value 
shifted to a negative value due to the negative net surface charge of the PSS layer due to 
presence of SO3-. 
It can be observed that by depositing the first polyelectrolyte (chitosan), the zeta-potential 
increased to a higher value. This can be c nanogels due to the high charge density of CS in strong 
acid solution (3% w/v acetic acidexplained by the presence of higher excess of positive charges 
on the surface of coated-magneti) of low ionic strength. Similarly, upon the absorption of 
negatively charged PSS layer, the zeta-potential increased to negative value corresponding to a 
high surface charge density. A similar trend was reported by different research groups (Diez-
Pascual and Wong, 2010; Tan et al., 2008a; Wong et al., 2009).  
Furthermore, zeta-potential values decreased upon the addition of the fourth and fifth layers on 
the nanogels in contrast to the result achieved when solid substrate was used. This can be 
explained considering the fact that soft and porous structures of the nanogels provided easy 
diffusion and interpenetration of the polyelectrolytes, allowing the neutralization and shielding of 
charges trapped within the nanogels. Thus, by increasing the number of layers, the net surface 





disappearance of the excess charges from the surface of the nanogels (Diez-Pascual and Wong, 
2010; Wong et al., 2009). 
 
Figure 8.8 Hydrodynamic radius (Rh) and zeta-potential as a function of polyelectrolyte layer number. 
8.4 PrHy Release from Layer-by-Layer Coated Magnetic Iron-Oxide DEAEMA-
MAA Nanogels  
In order to control the initial burst release of the PrHy from DEAEMA-MAA nanogels, the 
layer-by-layer method was adopted in this study. First of all, previously prepared magnetic 
nanogels were loaded with 2.44 g drug/ g of polymer; afterwards, as mentioned earlier the 
required number of layers was deposited on the PrHy-loaded magnetic nanogels, and 
subsequently passed through high-gradient magnetic field to remove excess amount of drug and 
polyelectrolytes. Finally, the concentration of released PrHy was obtained by means of the PrHy 
selective electrode, once the coated PrHy-loaded magnetic nanogels were introduced to 50 ml of 











































The release profiles of PrHy from bare nanogels and layer coated nanogels are depicted in Figure 
8.9. As shown in Figure 8.9, the initial burst release was still present for nanogels coated with the 
first and second layer; whereas, by increasing the number of polyelectrolyte the initial burst 
released was significantly reduced, which was confirmed by the smoother slope of the profile 
instead of a steep slope. The initial burst release observed in the bare nanogels was due to the 
release of the PrHy molecules present on the surface of the nanogels. In order for the surface 
adhered PrHy molecules to be released from the coated nanogels, they had to diffuse through the 
different layers of polyelectrolyte until they reached the external medium. In other words, the 
higher the number of polyelectrolyte layers, the more time was required by PrHy molecule to 
diffuse to the medium; thus, the burst release was minimized. This phenomenon can be attributed 
to fact that polyelectrolyte layers not only acted as diffusion barrier, but also reducing the 
porosity of the nanogels. As mentioned earlier, positive first, third, and fifth layer possess very 
small thickness in comparison to the negative second and fourth layer; however, the release 
profile demonstrated that the release process was mainly controlled by the total increment in 
layer thickness rather than being influenced by the type of the polyelectrolyte within the layers.  
Figure 8.9 illustrates the schematic of drug release profile from bare and coated nanogels. 
Moreover, it was revealed that by increasing the nymber of coating layers, the time required for 
the drug molecules to reach the external medium significantly increased to 9 hours. Whereas, the 
bare nanogels with no coating, complete release occurred over 2 hours. In brief, it can be 
concluded that by manipulating the number of layers the drug release can be further controlled 






Figure 8.9 PrHy release profile from different layers of coated magnetic iron-oxide nanogels in 10 mM 

































Conclusion and Recommendation for Future 
Studies  
 
In this study, polyampholyte cross-linked MAA-DEAEMA nanogels were synthesized through a 
semi-continuous emulsion polymerization. Polyampholytic and pH-responsive behaviour was 
observed in these nanogels. Dynamic light scattering and zeta-potential analyzer were used to 
investigate the hydrodynamic radius and surface charge density of the nanogels, 
correspondingly. The synthesized nanogels demonstrated great swelling ability at both high and 
low pH conditions, contributing to the protonation of N (CH3CH2)2 groups on DEAEMA 
segments and ionization of COOH groups on MAA segments, respectively. However, at iso-
electric point (IEP), confirmed by zero mobility value, the nanogels attained the most stable 
compact structure due to presence of steric stabilizer, PEGMA, grafting onto the surface of the 
nanogels. Once the pH changed from low to high, the mobility shifted from positive to negative, 
attributed to the positively charged (N (CH3CH2)2 H+) groups on DEAEMA segments and 
negatively charged COO- groups on MAA segments.  
Isothermal titration calorimeter was used to investigate the interaction between hydrophilic 
drug, procaine hydrochloride (PrHy), and pH-responsive nanogels. It was revealed that the PrHy 
loaded into the polyampholyte nanogels network through hydrophobic interaction and hydrogen 





nanogels decreased and approached a more compact structure at high and low pH conditions 
comparedthe bare nanogels, as a result of hydrophobic interaction and hydrogen bonding.  
The release of PrHy from MAA-DEAEMA nanogels was investigated under various conditions 
such as pH, salt concentration in the medium and different concentrations of loaded PrHy. The 
release of the PrHy was increased at low pH value and high salt concentration, which is 
attributed to the elevated hydrophobic interaction and larger gradient of salt concentration, 
respectively.  
In order to induce magnetic properties to the nanogels, and also facilitate the purification step 
of the layer-by-layer coating of the nanogels, magnetic nanogels were synthesized through co-
precipitation technique. In this method iron oxide (Fe3O4) was precipitated within nanogels, 
providing nanogels with magnetic properties. The hydrodynamic radii of the magnetic nanogels 
were reduced to 245.7 due to the inter-particle electrostatic interaction between iron oxide and 
negatively charged COO- on MAA segments.  
To reduce the initial burst release of the PrHy from magnetic nanogels, the layer by layer 
technique was introduced to provide diffusion barrier and increased the time required for the 
drug molecules to diffuse out to nanogels. Chitosan (CS) was used as polycation and Poly 
(sodium 4-styrenesulfonate) (PSS) was used as polyanion in the formation of coated magnetic 
nanogels. It was revealed that the initial burst release of the PrHy was significantly reduced and 
can be controlled by manipulating and increasing the number of polyelectrolyte layers.    
Consequently, these coated pH-responsive magnetic iron oxide nanogels demonstrate very 
attractive features that make them a potential candidate for drug delivery systems. Combination 





materials that are capable of coupling the stimulus-response of these nanogels with the magnetic 
properties of the nanoparticles. There are many areas for further development of coated magnetic 
nanogels as multifunctional drug delivery systems. Improved magnetic properties of magnetic 
nanogels for MR contrast agents are one area that would greatly improve the sensitivity of 
magnetic nanogels’ detection in vivo. In order to increase the selectivity and safety of therapeutic 
nanogels, the development of a biosensor-controlled approach would be of great help. The 
incorporation of a biosensor-controlled therapeutic delivery would allow incorporation of more 
aggressive therapeutic agents without compromising safety of healthy cells and tissues.  
Moreover, by incorporating biomolecules-responsive moieties, such as phenyl borate 
derivatives as a glucose-sensing moiety a self-regulated insulin delivery system would be 
constructed to treat diabetes mellitus. In addition, results from these research studies indicated 
that by increasing the number of coated layers, the release of drugs could be prolonged. 
Therefore, by incorporating a mixture of drugs at different layers different released rates can be 
achieved with a single dosage of drug carrier, in order to meet therapeutic requirement. For 
instance, a drug incorporated nearer to the matrix of nanogels would be release later and less 
often in comparison to drugs incorporated nearer the surface of the coated nanogels. Moreover, 
by modifying the ion exchangers or plasticizers a more sensitive and accurate drug-selective 
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